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ABSTRACT
Coronins represent an evolutionary conserved family of WD-repeat actin-binding proteins for
which a role in regulating membrane and cytoskeleton related functions have been proposed.
In mammalian organisms seven members of the coronin protein family have been described
of which coronin-1 respresents the thus far best characterized molecule. Coronin-1 is
specifically expressed in leukocytes and was originally identified as a key player in mediating
the survival of pathogenic mycobacteria in infected murine macrophages by inhibiting the
fusion of the mycobacterial phagosome with lysosomes. Further analyses demonstrated the
capacity of coronin-1 to link the leukocyte plasma membrane with the underlying actin
cytoskeleton suggesting a regulatory role of coronin-1 in leukocyte specific functions.
However, a precise biological activity of coronin-1 in leukocytes and in mammalian
organisms in general has not yet been defined. The aim of the work described in this thesis
was to contribute to our understanding of the function of coronin-1 by generating and
phenotypically characterizing coronin-1 knock-out mice.
Coronin-1 deficient mice were found to be viable and fertile. In-depth analysis of the immune
system revealed that the lack of coronin-1 expression severly affected the homeostasis of
the peripheral T-cell pool. Whereas T-cell development could be shown to be independent on
coronin-1, peripheral T-cell numbers were found to be strongly reduced. The reduction of
peripheral T-cell numbers in coronin-1 deficient mice was accompanied by changes in the
composition and function of the peripheral T-cell pool. Coronin-1 deficient peripheral T-cells
were prone to apoptosis, less efficient in homing to secondary lymphoid organs and unable
to mount a proliferative response to allogeneic MHC stimuli. Cytoskeletal structures in
coronin-1 deficient T-cells were found to be normally organized. Coronin-1 deficiency did not
affect other leukocyte subsets, such as B-cells and macrophages. Macrophages isolated
from coronin-1 deficient mice did neiter show any abnormalities in the organization of the
actin cytoskeleton nor did the absence of coronin-1 expression affect their phagocytic
properties. We therefore conclude that coronin-1 plays a crucial role in maintaining T-cell but
not macrophage functions. Based on the results described in this thesis we propose a
function of coronin-1 in regulating T-cell homeostasis by modulating T-cell specific functions
such as T-cell activation.

TABLE OF CONTENTS
1 INTRODUCTION 1
1.1 The immune system 1
1.2 The mechanisms of adaptive immuninty: an overview 1
1.3 Antigen presenting cells and antigen processing 4
1.3.1 Types of antigen presenting cells 4
1.3.2 Antigen processing and presentation on MHC
           molecules 6
1.4 Development and function of the major cell types of the
           immune system 7
1.4.1 Development and functions of B-lymphocytes 9
1.4.1.1 The organization of the BCR complex 9
1.4.1.2 Development of B-cells in the bone marrow
  and the spleen 10
1.4.1.3 Functions of mature B-cells 12
1.4.2 Development of T-lymphocytes 14
1.4.2.1 Organization of the TCR complex 15
1.4.2.2 Development of T-lymphocytes in the thymus 16
1.5 Activation and homeostasis of T-lymphocytes 19
1.5.1 Formation of the immunological synapse and T-cell
                   activation 19
1.5.1.1 Architecture of the immunlogical synapse 19
1.5.1.2 The role of lipid rafts and cytoskeletal structures
             in the formation of the immunological synapse 20
1.5.1.3 Signaling events at the immunological synapse 21
1.5.2 T-cell activation and homeostasis 23
1.6 The coronin family of proteins 26
1.6.1 The mammalian coronin family: structure, function and
                  expression 27
1.6.1.1 Structure of the mammalian coronin proteins 27
1.6.1.2 Expression and function of mammalian
 coronin-2 – 7 28
1.6.2 Coronin-1 and its homologues in other eukaryotic
                   organisms 30
1.6.2.1 Coronin-1 homologues in Dictyostelium,
  yeast and Drosophila 30
1.6.2.2 Mammalian coronin-1 and its potential function
in leukocytes 31
1.7 Aims of this thesis 33
2 MATERIALS AND METHODS 35
2.1 Chemicals, reagents and kits 35
2.1.1 Chemicals 35
2.1.2 Kits and FPLC columns 37
2.2 General buffers and solutions 37
2.3 Cell culture media and supplements 39
2.3.1 Bacterial media and supplements 39
2.3.2 Mammalian cell culture media and supplements 39
2.4 Vectors 41
2.5 Primers 42
2.6 Antibodies 45
2.7 Bacteria and cell lines 48
2.7.1 Bacterial strains and culture conditions 48
2.7.2 Mammalian cells, cell lines and culture conditions 48
2.8 Molecular biological methods 49
2.8.1 Agarose gel electrophoresis of DNA fragments 49
2.8.2 Preparation of chemically competent E.coli DH10B
         and transformation 49
2.8.2.1 Preparation of ultra-competent E.coli
DH10B 49
2.8.2.2 Transformation of ultra-competent E.coli
DH10B 50
2.8.3 General cloning methods 50
2.8.3.1 Preparation of plasmid DNA from E.coli
cultures 50
2.8.3.2 Ethanol precipitation of DNA 50
2.8.3.3 Restriction enzyme digest of plasmid DNA
and PCR products 51
2.8.3.4 Dephosphorylation of DNA 51
2.8.3.5 Purification of DNA fragments from agarose
gels 51
2.8.3.6 Ligation of DNA fragments 51
2.8.3.7 Polymerase chain reaction (PCR) for the construction
of the coronin-1 targeting vectors 52
2.8.3.8 Sequencing of plasmid DNA 53
2.8.4 Southern blot analysis of genomic DNA isolated from ES
         cells and tail biopsies 55
2.8.4.1 Isolation of genomic DNA from ES cells and
 mouse tails biopsies 55
2.8.4.2 Preparation of digoxigenin labeled DNA probes 56
2.8.4.3 Digest of genomic DNA, gel electrophoresis and
 transfer to nylon membranes 57
2.8.4.4 Hybridization of the nylon membrane 57
2.8.4.5 Detection of digoxigenin labeled DNA probes
on the nylon membrane 57
2.8.5 Reverse transcriptase-PCR (RT-PCR) 58
2.8.5.1 Isolation of RNA from cell lines and murine tissue 58
2.8.5.2 DNAse I treatment and reverse transcription 59
2.8.5.3 PCR on reversely transcribed RNA 61
2.9 Cell culture methods 62
2.9.1 Determination of cell numbers 62
2.9.2 Preparation of L929-conditioned medium 62
2.9.3 Preparation of bone marrow-derived macrophages 62
2.9.4 Preparation of single cell suspensions from murine tissue 63
2.9.5 MACS-based isolation of murine T-lymphocytes 63
2.9.6 Mixed lymphocyte reaction 64
2.10 Generation and maintenance of coronin-1 deficient mice 65
2.10.1 ES cell culture, transfection and selection 65
2.10.1.1 ES culture: general methods 65
2.10.1.2 ES cell transfection and selection 68
2.10.1.3 PCR based screening of ES cell clones 69
2.10.2 Blastocyst injection and generation of chimaeric animals 70
2.10.3 Breeding of mice and backcrosses 71
2.10.4 PCR based genotyping of coronin-1 deficient mice 71
2.11 Flow cytometry based techniques 72
2.11.1 Staining of cells for flow cytometric (FACS) analysis 72
2.11.2 Collection and flow cytometric analysis of peripheral
blood 73
2.11.3 Analysis of apoptotic cells with Annexin V 74
2.11.4 Generation and analysis of mixed bone marrow chimaeras 75
2.11.5 T-lymphocyte homing assay 75
2.11.6 Assessing phagocytosis by flow cytometry 76
2.12 Microscopical techniques 77
2.12.1 Staining of cells for indirect immunofluorescence 77
2.12.2 Adherence of thymocytes on poly-L-lysine and antibody-
coated slides 78
2.12.3 Activation of bone marrow derived macrophages 79
2.12.4 Immunohistological analysis of cryosections 79
2.13 Biochemical methods 80
2.13.1 Preparation of total cell lysates from murine tissue 80
2.13.2 Determination of protein concentrations 80
2.13.3 SDS-PAGE using the Biorad Protean II minigel system 81
2.13.4 Coomassie staining of polyacrylamide gels 82
2.13.5 Western blot analysis 82
2.13.5.1 Transfer of proteins after SDS-PAGE on
   nitrocellulose membranes 82
2.13.5.2 Immunodetection 83
2.13.6 Preparation of an IgG fraction from rabbit serum 84
2.13.7 AlexaFluor‚633 labeling of rabbit IgGs 84
3 RESULTS 86
3.1 Analysis of coronin expression 86
3.1.1 Analysis of the expression of coronin-1 – 7 in murine tissues
         and cell lines by RT-PCR 86
3.1.2 Analysis of coronin-1 expression in leukocytes by flow cytometry 90
3.1.3 Summary 92
3.2 Analysis of the coronin-1 locus and generation of coronin-1 knock-out
      mice by targeting the coronin-1 gene in mouse embryonic stem cells 93
3.2.1 In silico analysis of the coronin-1 locus 94
3.2.2 Overview of the different targeting vectors 96
3.2.3 Construction of the targeting vectors 97
3.2.4 Screening of gene-targeted ES cell clones by Southern blot
          analysis 101
3.2.5 Blastocyst injection of positive ES cell clones and establishment
          of transgenic mouse lines 104
3.2.6 Summary 107
3.3 Phenotypic analysis of coronin-1 K.O. mice 108
3.3.1 Homozygous coronin-1 K.O. mice do not display an obvious
          phenotype 108
3.3.2 Homozygous coronin-1 K.O. mice do not express coronin-1 108
3.3.3 EGFP as a reporter for coronin-1 expression 109
3.3.4 Homozygous coronin-1 K.O. mice do not display developmental
          defects in the bone marrow and the thymus 111
3.3.4.1 Flow cytometric analysis of leukocyte subsets in the
 bone marrow 111
3.3.4.2 Analysis of T-cell development by flow cytometry and
 histology 112
3.3.5 Coronin-1 deficiency affects the peripheral immune system 114
3.3.5.1 Analysis of leukocyte populations in the spleen and
 lymph nodes of coronin-1 deficient mice 115
3.3.5.2 Coronin-1 deficient mice display abnormalities in
 peripheral blood composition 119
3.3.6 Reconstitution of hematopoietic and lymphoid organs in wildtype
          and coronin-1-/- mixed bone marrow chimaeras 120
3.3.6.1 Reconstitution of the bone marrow 120
3.3.6.2 Reconstitution of the thymus 120
3.3.6.3 Reconstitution of peripheral lymphoid organs 122
3.3.7 Summary 125
3.4 Phenotypic analysis of coronin-1 deficient T-cells 126
3.4.1 Coronin-1 deficient T-cells undergo apoptosis 126
3.4.2 Characterization of T-cell subsets in coronin-1 K.O. mice 127
3.4.3 Homing and survival of coronin-1 deficient T-cells in vivo 129
3.4.4 Coronin-1 deficient T-cells do not respond to allogeneic MHC
         stimuli in a mixed lymphocyte reaction 131
3.4.5 Coronin-1 deficient T-cells show no defects in the actin and
         tubulin cytoskeleton 132
3.4.6 Summary 135
3.5 Phenotypic analysis of coronin-1 deficient macrophages 136
3.5.1 Coronin-1 deficient bone marrow-derived macrophages do not
          show defects in actin cytoskeleton organization 136
3.5.2 Coronin-1 deficient bone marrow-derived macrophages are not
          defective in phagocytosis 137
3.5.3 Summary 138
4 DISCUSSION 139
4.1 Coronin-1 is required for peripheral T-cell survival but not for T-cell
       development 139
4.2 Towards a role of coronin-1 in regulating T-cell homeostasis 141
4.3 Potential molecular mechanisms of coronin-1 function in leukocytes 143
4.3.1 Coronin-1 could participate in regulating cytoskeletal rearrange-
          ments as required for the function of immune receptors 143
4.3.2 Coronin-1 could function in modulating the strength of signaling 
          downstream of the T-cell receptor 145
4.3.3 The absence of coronin-1 expression does not affect other
         leukocyte subsets 146
5 SUMMARY 147
6 REFERENCES 149
7 ABBREVIATIONS 170
______________________________________________________________INTRODUCTION
1
1 INTRODUCTION
1.1 The immune system
The vertebrate organism is constantly exposed to a variety of potentially pathogenic
microorganisms, like bacteria, viruses or fungi. As an effective and protective defense
mechanism against these infectious agents the immune system has evolved which ensures
reliable recognition and subsequent elimination of the pathogens. Vertebrate immunity relies
on two distinct but cooperating parts, the innate and the adaptive immunity. The mechanisms
of innate immunity constitute the first line of defense against pathogens. Beside being based
on a number of more unspecific barriers that are effective against a variety of pathogenic
organisms, such as the skin, mucous membranes, the complement system and enzymatic
mediators, innate immunity requires the involvement of phagocytic cells, namely
macrophages and neutrophils. These phagocytes are able to detect pathogens by the
presence of certain conserved, repetitive molecular structures the so-called PAMPs
(pathogen-associated molecular patterns). PAMP recognition is achieved by the expression
of pattern-recognition receptors (PRR) which represent a set of germline encoded cell bound
as well as soluble molecules (for review see Janeway, 1989, Gordon, 1995, Silverstein,
1995, Janeway and Medzhitov, 2002). PRR mediated recognition of a pathogen by
macrophages or neutrophils results in phagocytic uptake of the pathogenic organism and its
subsequent degradation in the microbicidal lysosomal compartments.
Under circumstances where pathogens have managed to evade the mechanisms of innate
host defense and an infection has been established, the adaptive immune response is
induced. While the innate immune system relies on germline encoded invariant receptors
recognizing common structural motifs on the surface of pathogens, the hallmark of the
adaptive immune system is its ability to recognize practically all pathogens specifically
through the generation of a diverse array of antigen-specific receptors expressed by
lymphocytes. Furthermore, in the course of an adaptive immune response an immunological
memory is established which ensures a more rapid and effective response upon a second
encounter with a pathogen, thereby potentially providing lasting protective immunity.
1.2 The mechanisms of adaptive immunity: an overview
The central players in establishing adaptive immunity are the lymphocytes, consisting of B-
and T-lymphocytes. Together, these are able to respond to virtually any kind of antigen by
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clonotypically expressing antigen specific receptors of the immunoglobulin superfamily, the
B-cell receptor (BCR) on B-cells and the T-cell receptor (TCR) on T-cells. The huge diversity
in the specificity of these receptors is generated by somatic gene recombination of
germline–encoded receptor gene segments, the so-called V, D and J genes (Tonegawa,
1988). The random process of V(D)J gene-segment rearrangements results in the production
of B- and T-cells carrying a diverse set of antigen-specific receptors.
The B- and T-cells together with antigen presenting cells (APCs) such as macrophages and
dendritic cells are the effector cells that ensure the efficient mounting of an adaptive immune
response. B- and T-cells fulfill distinct functions which are reflected by the existence of the
two types of adaptive immune response, the humoral and the cellular response (see Fig.1).
The humoral response that is mediated by secreted antibodies is directed against pathogens
present in the extracellular space. Upon encounter with an antigen, B-cells become activated
and differentiate into effector B-cells (also referred to as plasma cells). Effector B-cells
secrete their usually membrane-bound antigen receptor as a soluble version, which is then
referred to as antibody. Secreted antibodies subsequently bind to the antigen and thereby
facilitate its clearance from the body.
In contrast, the adaptive cellular immune response is directed against intracellularly residing
pathogens. The adaptive cellular immune response relies on the action of the T-lymphocytes.
T-lymphocytes occur in two flavors, the CD4 and CD8 positive T-lymphocytes. Unlike B-
lymphocytes, T-lymphocytes are not able to recognize free antigens but instead require the
presentation of antigens by antigen-presenting cells (APCs). APCs are specialized for the
sampling and processing of antigens. Processing of antigens refers to the mechanims of
converting either exogenous or endogenous antigenic proteins into peptide fragments that
are then bound and presented on the cell surface by the major histocompatibility complex
(MHC) molecules. Two subtypes of MHC molecules exist, MHC class I and class II
molecules. MHC class I molecules bind peptides that are usually derived from pathogens
residing in the cytosol. Recognition of MHC class I presented antigenic peptides is restricted
to CD8 positive T-lymphocytes resulting in the activation of the CD8 positive T-cell. Activated
CD8 positive T-lymphocytes, which are also called cytotoxic effector T-cells, are then able to
kill the infected cell by secreting cytotoxic effector proteins (e.g. granzymes and perforin) or
by inducing apoptosis in the target cell by the presence of apoptosis-inducing factors, such
as Fas-ligand (for review see Berke, 1997). Death of the target cell can then either result in
the simultaneous elimination of the infectious agent or its release into the extracellular space
where it is subsequently cleared by macrophages or by the antibody-induced activity of the
complement system (see Fig.1, reviewed in Liszewski et al., 1996).
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MHC class II molecules, on the other hand, are responsible for the presentation of peptide
ligands generated after internalization of extracellular material, e.g. bacteria and soluble
antigens, and its subsequent processing in the endosomal/lysosomal pathway. CD4 positive
T-lymphocytes are specialized in recognizing MHC class II bound antigenic fragments. Their
activation results in the release of cytokines aiming at either the activation of macrophages to
enhance their microbicidal activity or the induction of the differentiation of B-cells into
antibody secreting plasma cells. Based on this ability to stimulate and activate other immune
cells effector CD4 positive T-cells are also referred to as T-helper cells (for review see Abbas
et al., 1996, Asnagli and Murphy, 2001).
1.3 Antigen presenting cells and antigen processing
The two classes of MHC molecules, MHC class I and class II, are the basis for antigen
presentation to T-cells. They are expressed in a cell type specific manner; MHC class I
molecules are expressed on all nucleated cells whereas MHC class II molecule expression is
restricted to a set of specialized cells, the antigen-presenting cells (APCs). APCs comprise a
subset of cells to which B-cells, macrophages and dendritic cells belong. Depending on the
kind of antigen two different processing pathways can be employed by APCs to generate
ligands for binding to either MHC class I or class II molecules.
1.3.1 Types of antigen presenting cells
B-cells, macrophages and dendritic cells are referred to as professional antigen-presenting
cells due their ability to take up antigens, to process them for the loading on MHC molecules
and to eventually activate naïve T-cells. The capacity of B-cells to present antigens relies on
the surface expression of the antigen-specific BCR. Upon binding of an antigen, B-cells are
able to internalize antigens and process them in the MHC class II pathway (Lanzavecchia,
1990, Watts, 1997).
Macrophages play a central role in innate immune responses against microbial pathogens
but can also act as antigen-presenting cells due to their extraordinary capacity to internalize
infectious agents. Uptake of virtually any kind of soluble or cell-associated antigen occurs
either non-specifically or specifically through surface-expressed receptors. These receptors
are either pattern-recognition receptors (PRRs) recognizing conserved structures of microbial
origin (pathogen-associated patterns or PAMPs) or opsonic receptors mediating the binding
of antibody- or complement-coated microbes (reviewed in Taylor et al., 2005). Infectious
agents bind to their specific receptors which triggers the internalization of antigens via
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receptor-mediated endocytosis or phagocytosis (Lanzavecchia, 1990, Aderem and Underhill,
1999). Whereas receptor-mediated endocytosis allows macrophages to efficiently internalize
antigens that are present at low concentrations, phagocytosis enables the macrophage to
take up particulate material, such as whole microbes or apoptotic cells (Lauber et al., 2004,
Trombetta and Mellman, 2005). The endosomal and lysosomal compartments in
macrophages are adapted for the digestion of internalized material. This specialization
predominantly contributes to the function of macrophages in clearing invading
microorganisms but also provides antigenic peptides for presentation on MHC molecules.
Both classes of MHC molecules as well as costimulatory molecules are expressed on
macrophages but at significantly lower levels compared to B-cells and dendritic cells
(Steinman et al., 1997). Even after activation of macrophages by inflammatory cytokines or
microbial products the resulting upregulation of MHC class II and costimulatory molecule
expression does not reach levels comparable to those found on B-cells and DCs. This may
explain why macrophages were found both in vitro and in vivo to be less efficient than B-cells
and dendritic cells in antigen presentation and subsequent T-cell activation (Inaba et al.,
1990, Crowley et al., 1990, Banchereau and Steinman, 1998).
The primary function of dendritic cells (DCs) is, in contrast to B-cells and macrophages, to
present antigens. This specialization relies on the unique surveilance and migratory
properties of DCs (Randolph, 2001). DCs are present in almost all tissues in an immature
state. Immature DCs are highly endocytic and can therefore sample a broad range of
antigens non-specifically or via specific receptors. Upon receiving appropriate stimuli, like
receptor-mediated antigen recognition and inflammatory cytokines, immature DCs undergo a
dramatic reorganization in form and function to ultimately differentiate into mature DCs.
Mature DCs are characterized by upregulation of surface-expressed MHC class II and
costimulatory molecules and a markedly reduced endocytic capacity (Sallusto et al., 1994
and 1995, Cella et al., 1997, Engering et al., 1998, Garrett et al., 2000, Inaba et al, 2000).
Furthermore, mature DCs migrate from the periphery into lymphoid tissues allowing them to
transport antigens from the periphery to secondary lymphoid organs or to internalize antigens
directly from the lymph (Itano et al., 2003). Here they accumulate in regions where
macrophages and B-cells are generally excluded but which are instead enriched in T-cells.
This unique distribution of DCs in the T-cell zones of lymphoid tissues allows them to
efficiently activate naïve T-cells (von Andrian and Mempel, 2003, Catron et al., 2004,
Mempel et al., 2004).
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1.3.2 Antigen-processing and presentation of peptides on MHC molecules
Processing of antigens for their presentation by MHC molecules generally follows two distinct
pathways (for review see Trombetta and Mellman, 2005). The MHC class I pathway
generates 8-10 amino acid long antigenic peptides from proteins present in the cytosol.
These proteins have to be ubiquitinated to be a substrate for the proteasome (reviewed in
Baumeister et al., 1998) that degrades them and thereby provides peptide fragments for
MHC class I presentation. The source of proteasomal substrates is quite varied and includes
endogenous or viral proteins present in the cytosol, alternative translation products, defective
proteins and proteins retrotranslocated from the endoplasmic reticulum (ER) to the cytosol
(Boon and Van Pel, 1989, Bullock and Eisenlohr, 1996, Wang et al., 1996, Bacik, et al.,
1997, Saeterdal et al., 2001, Yewdell et al., 2001, and reviewed in Shastri et al., 2002, Watts,
1997). The peptides generated by the proteasome are subsequently transported into the ER
by the ATP-dependent transporter associated with antigen processing (TAP1/TAP2
heterodimer).
The heterodimer of the proteins TAP1 and TAP2 is an ATP-dependent transporter required
for the transport of antigens into the ER lumen (Spies et al., 1990, Androlewicz et al., 1993,
Neefjes et al., 1993). Once in the ER lumen the antigenic peptides are further proteolytically
processed and then loaded onto newly synthesized MHC class I molecules. The binding of
peptides to MHC class I molecules is mediated by chaperones such as calnexin, calreticulin,
and ERp57. Only those MHC class I molecules stabilized by binding antigenic peptide are
transported further to the cell surface (Grandea et al., 2000). The MHC class I pathway is
constitutively active in all nucleated cells which allows CD8 positive, cytotoxic T-cells to
survey protein expression for abnormalities caused by the presence of pathogens such as
viruses.
The expression of MHC class II molecules is usually restricted to APCs but can be induced
by interferon-g stimulation of many other cell types (Steimle et al., 1994). The peptides (13 -
25 amino acids long) generated in the MHC class II pathway originate from exogenous
proteins that have been internalized and processed along the endocytic route. Proteolytical
processing of internalized exogenous proteins occurs in specialized, acidic endosomal and
lysosomal compartments, which are also referred to as MHC class II compartments (Pieters
et al., 1991, Amigorena et al., 1994, Tulp et al., 1994, West et al., 1994, Engering et al,
1998). Newly synthesized MHC class II molecules are transported from the ER to the MHC
class II compartments. Targeting to MHC class II compartments relies on the binding of an
invariant chain (Ii) to newly synthesized MHC class II molecules (Bakke and Dobberstein,
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1990, Lotteau et al, 1990, Pieters et al., 1993, Brachet, 1997). As long as the invariant chain
occupies the peptide binding site of MHC class II molecules with its class II associated
invariant chain peptide (CLIP) unspecific binding of peptides is prevented (Roche and
Creswell, 1990, Teyton et al., 1990, Eynon et al., 1999). Upon arrival in the MHC class II
compartments the invariant chain is cleaved which results in the release of CLIP that is
subsequently exchanged for an antigenic peptide. Exchange of CLIP for antigenic peptides in
the binding sites of MHC class II molecules is assisted by HLA-DM, a chaperone related to
MHC class II molecules (Kelly et al., 1991, Denzin and Cresswell, 1995, Ferrari et al., 1997,
Kropshofer et al., 1997). Transport of loaded MHC class II molecules to the cell surface is
only initiated when MHC class II molecules form a stable complex with antigenic peptides
(Lanzavecchia et al., 1992). Recognition of MHC class II bound peptides is restricted to CD4
positive T-cells, which are also referred to as T-helper cells. Depending on the cytokines
released by activated CD4 positive T-cells two subpopulations of T-helper cells can be
distinguished, the TH1 and TH2 helper cells. Cytokines released by TH1 cells activate
professional phagocytes such as macrophages resulting in an enhancement of their
microbicidal mechanisms. The cytokines released by TH2 cells aim at initiating and regulating
antibody based immune responses mediated by B-cells (for review see Abbas et al., 1996,
Asnagli and Murphy, 2001).
Besides the above described mechanisms to generate ligands for MHC class I or class II
molecules another route for the generation of MHC class I molecules exists which is referred
to as cross-presentation (Bevan, 1976). Cross-presented antigenic proteins are of
exogenous origin but can gain access to the MHC class I processing pathway which
accounts for a variety of immune responses such as the tolerance against peripheral
antigens, anti-tumour response and the activation CD8 positive, cytotoxic T-cells by
professional antigen-presenting cells (reviewed in Trombetta and Mellman, 2005).
1.4 Development and functions of the major cell types of the immune system
The cells of the immune system are generated in the bone marrow. They subsequently
migrate out of the bone marrow into the peripheral tissues, the blood circulation and the
lymphatic system. Here they either mature further (as B-cells in the spleen or the progenitors
of T-cells in the thymus) or fulfill their cell-type specific functions. The bone marrow is
responsible for the generation of the cellular components of the blood which all are derived
from the same precursors, the hematopoietic stem cells (HSC). Initially, HSCs differentiate
into intermediate progenitors of limited potential that undergo further lineage commitment
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and subsequently develop along a single pathway. Although the precise definition of the
individual lineages is still a matter of debate, it is currently believed that the early steps of
HSC differentiation result in progenitors of three independent lineages: the erythroid-
megakaryocyte, the myeloid and the lymphoid lineages (see Fig.2, Katsura, 2002).
The progenitors of the erythroid-
megakaryocyte lineage give rise
to erythrocytes, platelets and
megakaryocytes. Erythrocytes,
also referred to as red blood
cells, are responsible for the
transport of oxygen through
blood vessels, whereas the
p la te le t s  de r i ved  f rom
megakaryocytes fulfill important
functions in maintaining the
vascular system. Within the
myeloid lineage dendritic cells,
macrophages, monocytes,
granulocytes and polymorpho-
nuclear cells (neutrophils, baso-
phils and eosinophils) develop.
Macrophages, which mature
from monocytes, dendritic cells
and neutrophils are the three
types of phagocytic cells in the immune system that play a crucial role in both innate immune
(clearance of infectious agents by phagocytosis) and adaptive immune responses (antigen
presentation). The function of granulocytes, basophils and eosinophils is less well
understood but seems to be important at sites of inflammation (granulocytes) and in the
defense against parasitic infections (eosinophils and basophils).
The lymphoid lineage gives rise to B- and T-lymphocytes and natural killer (NK) cells. The
natural killer cells are thought to be the prototype of T-cells. They have important functions in
innate immunity since they can detect and attack certain virus-infected cells despite their lack
of antigen-specific receptors. In the following, the function and development of B- and T-cells
will be discussed in more detail.
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1.4.1 Development and functions of B-lymphocytes
B-cell development takes primarily place in the bone marrow. Immature B-cells travel via the
blood to the spleen where they undergo further maturation. During B-cell development the
genes for the B-cell receptor (BCR) are rearranged from germline encoded receptor gene
segments. Depending on the rearrangement status of the heavy and light chains of the BCR,
discrete stages of B-cell development have been described for which we will use the
nomenclature suggested by Melchers and Rolink (1998).
1.4.1.1 The organization of the BCR complex
The BCR is a multiprotein protein complex that consists of clonally variable antigen-binding
chains – the heavy and light immunoglobulin chains –, which are associated with invariant
accessory proteins (see Fig.3). By disulfide bonds each light chain is covalently linked to one
of the two heavy chains. The heavy chains itself are also covalently associated by disulfide
bonds. The immunoglobulin complex constituting the BCR is normally membrane-bound but
upon activation of B-cells and their differentiation into plasma cells it is secreted in the form
of an antibody. Surface expression or secretion of the immunoglobulin complex is regulated
by alternative splicing of the primary mRNA which either retains or excises the exons
encoding the trans-membrane domain of the BCR (Early et al., 1980, Rogers et al., 1980).
The two invariant accessory proteins associated with the immunoglobulin chains in the BCR
complex are called Iga and Igb (Fig.3 B). They are both required for the transport of the
receptors to the cell surface (Hombach et al., 1990) and, more importantly, for signal
transduction upon engagement of the BCR. Since the immunoglobulin complex of the BCR
can itself not generate a signal, signal transduction relies on the presence of immunoreceptor
tyrosine-based activation motifs (ITAMs, Reth, 1989) in the cytosolic tails of Iga and Igb.
The huge diversity in the specificity of the BCR and antibodies is based on the variability of
the amino-terminal regions of the light and heavy chains which form the antigen binding site.
These domains of highly variable sequence are referred to as V regions. Beside the V
regions the immunoglobulin chains are made up of domains with relatively constant
sequence the so-called C-regions. The variety of the immunoglobulin chains of the BCR is
generated by the somatic rearrangement of germline encoded gene segments (V(D)J
recombination). Three different loci carry these gene segments: the immunoglobulin heavy
chain (IgH) locus and the two loci containing the gene segments for two types (k and l) of
light chains. Each of these loci is characterized by the presence of regions encoding various
variable (V), diversity (D), joining (J) and constant (C) segments. In the stochastic process of
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V(D)J recombination single variable regions are combined with joining (J) and, in the case of
the heavy chain, diversity (D) gene segments (Tonegawa, 1983). The somatic recombination
leads to the generation of a new exon encoding the variable region of a particular
immunoglobulin chain that is joined to a constant region gene segment by splicing of the
primary mRNA transcript. As we will see in the following, V(D)J recombination is tightly
regulated according to the developmental stage of B-cell development. Due to the random
specificities of the generated BCRs, B-cells are subjected to selection processes during
development leading to the elimination of cells which are potentially non- as well as self-
reactive. Only those B-cells that have been selected for their ability to recognize foreign
antigens specifically are clonally expanded.
1.4.1.2 Development of B-cells in the bone marrow and the spleen
The development of B-cells in the bone marrow has been elucidated to proceed through
discrete stages which are characterized by defined rearrangement intermediates of the
immunoglobulin chains and by the expression of a series of surface- and cytoplasmatically
expressed marker proteins (see Fig.4, for review refer to Melchers and Rolink, 1998).
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The earliest well-defined B-cell progenitors are the pre/pro-B cells. They are positive for the
pan B-cell marker B220 and express the interleukin 7 receptor a-chain (CD127) and the
receptor for stem cell factor CD117 (c-kit). The next stage, the pro-B cells, are phenotypically
similar but started to express CD19 and are characterized by undergoing rearrangement of D
and J regions on their IgH chain loci. Upon sucessful DJ rearrangement on both IgH alleles
pro-B cells develop into pre-B1 cells. Pre-B1 cells are indistiguishable from pro-B cells in
terms of surface expressed markers. In the following transition step from pre-B1 to large pre-
B2 cells rearrangement of a V region to the existing, recombined DJ segment of the IgH
locus is initiated. From the resulting V(D)J rearranged exon the so-called mH chain is
expressed which associates with the surrogate light chain components l5 and VpreB and
with the signal-transducing proteins Iga and Igb eventually constituting the pre-BCR complex
on the cell surface. Successful expression of the pre-BCR represents a first selective
checkpoint in B-cell development since surface deposition of the pre-BCR is required for the
induction of proliferation and differentiation of the large pre-B2 cells into the small, resting
pre-B2 cells (Nussenzweig et al., 1987, Grawunder et al, 1995, Rolink et al., 2000). The
small pre-B2 cells start to rearrange their k and l light chain loci which is prerequisite for the
differentiation into surface IgM (BCR) positive immature B-cells. Immature B-cells can
furthermore be identified by the expression of intermediate levels of B220. These cells are
subject to selection processes in the bone marrow which result in the removal of cells
expressing a BCR with autoreactivity. Only immature B-cells expressing high levels of
alloreactive IgM leave the bone to migrate into the spleen where they undergo further
maturation (Rolink et al., 2004).
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Immature B-cells originating from the bone marrow enter the spleen through the terminal
branches of central arterioles to reach the inner region of the white pulp which is divided into
a periarteriolar sheet (PALS), containing mainly T-cells, and a flanking B-cell corona (see
Fig.5 A). Here, the immature B-cells pass through further developmental stages which
require engagement of the BCR (Liu, 1997). The resulting mature B-cell types in the spleen
are the follicular and marginal zone B-cells. They can be identified by differences in the
expression of the surface markers CD21 and CD23. Follicular B-cells are highly positive for
CD21 and CD23, are topolocially found inside follicles and play a role in thymus-dependent
(also referred to as T-cell dependent) immune responses. In contrast, marginal zone B-cells
are CD21 positive but express CD23 at low levels. Marginal zone B-cells are found at the
outer rim of follicles which is adjacent to the marginal sinus. Here, these B-cells come into
close contact with macrophages and dendritic cells of the marginal zone which allows them
to participate in the early and therefore thymus-independent (also referred to as T-cell
dependent) response to blood-borne antigens.
1.4.1.3 Functions of mature B-cells
Mature B-cells as the main effector cells of the humoral adaptive immune response
recirculate among the lymphoid follicles of the spleen and lymph nodes (see Fig.5). The
antibodies produced by activated B-cells provide a first line of defense by neutralizing and
opsonizing free extracellular pathogens. Based on the recognition of epitopes formed by the
native three-dimensional structure of the antigen (Amit et al., 1985 and 1986, Colman et al.,
1987) antibodies are able to bind soluble or membrane-associated antigens. Binding of
antigens by antibodies confers to neutralization of extracellular pathogens and their products
and facilitates phagocytosis by opzonisation of antigenic structures. Furthermore, binding of
antibodies to antigens is crucial for the activation of the complement system and for the
induction of antibody-dependent cell-mediated cytotoxicity (ADCC; reviewed in Ward and
Ghetie, 1995). Therefore, antibodies as the mediators of the adaptive humoral response
ensure the clearance of extracellular pathogens.
Generally, activation of B-cells through their BCR can be initiated in two ways either by
binding of so-called thymus-dependent (T-cell dependent) or thymus-independent (T-cell
independent) antigens (reviewed in Parker, 1993, Mond et al., 1995a). Thymus-dependent
antigens are mostly protein antigens which are - after binding to the BCR - internalized,
processed and presented as peptides on MHC class II molecules by the B-cell. In order to be
activated, the B-cell requires a second signal that is provided by CD4 positive T-helper cells.
This second signal relies on the TCR-mediated recognition of the peptide/MHC complex by
______________________________________________________________INTRODUCTION
13
the T-helper cell and the subsequent clustering of the BCR together with the B-cell co-
receptor complex consisting of the proteins CD19, CD21 and CD81 (reviewed in O’Rourke et
al., 1997).
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Furthermore, upon binding antigen presented by B-cells, the expression of CD40 ligand
(CD40L) on T-helper cells is induced which binds to CD40 expressed on the surface of the
antigen-presenting B-cell (Lane et al., 1992, Jaiswal and Croft, 1997). Together with cytokine
release (Interleukin-4, Valle et al., 1989) by the T-cell, the T-cell mediated co-clustering of
the BCR with accessory molecules leads to activation of the B-cell and its subsequent
differentiation into long-lived antibody-producing plasma cells.
In contrast to protein antigens for which B-cells require T-cell help to be activated, many
microbial components are able to induce antibody production in the absence of T-helper cells
and are therefore referred to as thymus-independent antigens. The signals required to
activate B-cells are provided by inducing massive crosslinking of the BCR due to the
repetitive nature of microbial epitopes such as cell wall components (e.g. Lipopolysaccharide
(LPS), for review see Mond et al., 1995b).
Typically, the development of the humoral adaptive immune response requires several days
and results in the production of mono-specific, high-affinity antibodies, first of the
immunoglobulin M (IgM) and later of immunoglobulin G type (reviewed in MacLennan et al.,
1997). During the early phases of infection and before specific antibodies are produced, the
so-called natural antibodies are present in the serum and aim at limiting the spread of the
pathogens. Natural antibodies are mostly of IgM type and bind a variety of antigens with low
affinity (Ochsenbein et al., 1999 and 2000). They are produced by another mature B-cell
population, the B1 B-cells, in a thymus-independent manner. The developmental pathways
leading to the generation of B1 B-cells are fundamentally different from the other mature B-
cells (marginal zone and follicular B-cells). B1 B-cells originate from the fetal liver and require
the spleen for their maturation and survival (Herzenberg et al., 1986). In summary, the
function of B-cells lies in providing an initial as well as prolonged protection against free
extracellular pathogens by producing antibodies as mediators of the humoral adaptive
immune response.
1.4.2 Development of T-lymphocytes
Development of T-lymphocytes from progenitors originating from the bone marrow occurs in
the thymus (Miller and Osoba, 1967). Developing T-cells in the thymus are referred to as
thymocytes. Various thymocyte subsets representing particular developmental stages have
been identified based on the expression of surface markers of which the most prominent
ones are CD4 and CD8 (for review see Zuniga-Plücker, 2004). At each developmental stage
discrete rearrangement of the genes encoding the T-cell receptor takes places. Their
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successful completion together with the interaction of TCR expressing thymocytes with
stroma and antigen-presenting cells leads via the processes of positive and negative
selection to the generation of mature T-cells. Mature T-cells then leave the thymus to
establish the peripheral T-cell pool.
1.4.2.1 Organization of the TCR complex
The T-cell receptor molecule is a disulfide linked heterodimer made up of clonally variable,
membrane-bound polypeptide chains (see Fig.6 A). T-cells are grouped into a/b and g/d T-
cells, depending on the expression of one of the two types of TCR heterodimers. Similarly to
the immunoglobulin chains of the BCR, the T-cell receptor a and b chains are composed of a
variable (V) amino-terminal region forming the antigen binding site and a constant (C) region.
Generation of the diversity of TCR polypeptide chains relies, as for the immunoglobulin
chains, on the somatic recombination of various V, J and additionally for the b chain D gene
segments (Tonegawa, 1988, for review see Jung and Alt, 2004). The genomic organization
of the loci for the g and d chains resembles that for the a and b chains and somatic
rearrangement of appropriate V, D and J gene segments provides the template for the
expression of the g/d TCR.
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The expression and appropriate signal transduction of the TCR depends, as in the case of
the BCR, on the association of the TCR with accessory proteins, referred to as the CD3
complex (Samelson et al., 1985, Letourneur and Klausner, 1992). The CD3 complex
comprises four different chains (g, d, e and z) which form the two non-covalently linked
heterodimers CD3 g/e and CD3 d/e, and a disulfide linked homodimer made up of z chains
(see Fig.6 B). All the chains of the CD3 complex contain at least one ITAM which is important
for signal transduction upon TCR engagement (reviewed in Garcia et al., 1999, Germain and
Stefanova, 1999).
In contrast to the BCR and antibodies, the TCR is not able to recognize antigens in their
native, three-dimensional conformation but instead requires the presentation of short
antigenic peptides that have been processed and loaded onto MHC molecules by antigen
presenting cells. Optimal recognition of peptide loaded MHC molecules relies on the
association of the TCR complex with one of the two coreceptors, namely CD4 and CD8. T-
cells express either CD4 or CD8 which restricts them in their capacity to recognize
peptide/MHC complexes, CD4 positive T-cells recognize peptides bound to MHC class II
molecules whereas CD8 positive T-cells interact with peptides loaded onto MHC class I
molecules.
1.4.2.2 Development of T-lymphocytes in the thymus
T-lymphocytes are generated from hematopoietic stem cells that migrate to the thymus
(Wallis et al., 1975). Their development is not driven cell autonomously but relies on signals
from on the one hand non-hematopoietic stromal cells such as thymic epithelial cells and
mesenchymal fibroblasts and on the other hand antigen-presenting cells like dendritic cells
(reviewed in Anderson and Jenkinson, 2001). The intermediate stages of T-cell development,
also referred to as thymocytes, reside in distinct anatomical locations in the thymus which
provide exposure to appropriate differentiative signals. The anatomy of the thymus is
characterized by the presence of an outer cortex and an inner medulla. During their
development thymocytes migrate through these defined thymic regions (see Fig. 7). The
hematopoietic progenitors of T-cell development enter the thymus at the cortico-medullary
boundary, then migrate to the outer cortex, where most of the differentiation steps take place
and eventually reach the medulla, where thymocytes undergo the final maturation steps
before leaving the thymus as mature CD4 or CD8 positive T-cells (Lind et al., 2001, Prockop
et al., 2002, Porritt et al., 2003).
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Classically, thymocyte development can be tracked by the surface expression of CD4 and
CD8 (Ceredig et al., 1983). Thymocyte development starts from a subpopulation of CD4/CD8
double-negative (DN) cells, which then differentiate into CD4/CD8 double-positive (DP)
thymocytes and finally mature into T-cells being single-positive (SP) for either CD4 or CD8.
The use of additional surface-expressed markers, namely CD3, CD25 and CD44, allowed to
further subdivide the DN thymocytes into four subsets which appear sequentially on the way
of differentiation into DP thymocytes (Godfrey et al., 1993, Ceredig and Rolink, 2002): DN1
(CD3-, CD25-, CD44+++), DN2 (CD3-, CD25++, CD44+++), DN3 (CD3low, CD25++, CD44+) and
DN4 (CD3low, CD25-, CD44low). Along with thymocyte development through these distinct
stages rearrangement of the TCR genes occurs (Fowlkes and Pardoll, 1989). During the
DN1 to DN3 stages the loci encoding the b , g and d TCR chains are rearranged. DN3
thymocytes are characterized by the surface expression of a correctly assembled and CD3
complex associated TCR that is required for further survival and differentiation. While the
g/dTCR is expressed in the form typical for mature g/dT-cells, the a/bTCR goes through an
intermediate stage which is the assembly of a correctly rearranged b chain with the invariant
pre-TCRa chain resulting in the so-called pre-TCR. Expression of the pre-TCR is the first
crucial checkpoint in thymocyte development since without its expression there is no
progession of thymocyte development beyond the DN3 stage (Groettrup et al., 1993,
Groettrup and von Boehmer, 1993, Malissen et al., 1995, Fehling et al., 1995). Upon
expression of a signaling-competent pre-TCR, thymocytes are committed to the a/bT-cell
lineage and start to expand, to express the CD4 and CD8 coreceptors and to initiate
rearrangement of the TCR a chain locus (reviewed in von Boehmer et al., 1998). In contrast,
development of g/dT-cells for which a function in their mature stage is presently not precisely
defined, is unknown in its details.
At the DP stage of a/bT-cell development thymocytes have lost CD25 and CD44 expression
and now express high levels of proteins of the CD3 complex. From the successfully
rearranged TCRa chain locus TCR a-chains are generated which replace the surrogate pre-
TCRa chain. As soon as a functional a/bTCR is expressed, DP thymocytes are subjected to
the processes of positive and negative selection resulting in the elimination of cells which are
potentially non- as well as self-reactive (reviewed in Starr et al., 2003). The a/bTCR interacts
with peptide loaded MHC molecules present on the surface of thymic epithelial and dendritic
cells and initiates the corresponding downstream signaling cascades which respresent a
critical factor in the decision whether a thymocyte survives or dies. If the interaction of the
TCR with self-MHC/peptide complexes is too weak thymocytes die by `neglect`, if it is too
strong thymocytes undergo apoptosis which ensures the removal of potentially self-reactive
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cells (referred to as negative selection, Sprent and Webb, 1995). Only those thymocytes
which show a weak but significant reactivity of their TCR with self-MHC/peptide complexes
receive a survival signal and continue their development into self-restricted mature CD4 or
CD8 single positive (SP) thymocytes (referred to as positive selection, Marrack and Kappler,
1997). In summary, the processes of positive and negative selection generate self-restricted
and self-tolerant CD4 or CD8 T-cells which ultimately leave the thymus to establish the
peripheral T-cell pool.
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1.5 Activation and homeostasis of T-lymphocytes
Mature T-lymphocytes originating from the thymus seed the peripheral organs where they
cycle for prolonged times between the secondary lymphoid organs and the blood in a naïve
state. Following an infection, T-cells become activated by antigen-presenting cells within the
peripheral lymph nodes, which results in proliferation and differentiation into so-called
effector T-cells. Once an infection has been cleared successfully, effector cells are
eliminated through apoptosis to maintain the homeostasis of the peripheral T-cell pool.
Besides this, memory T-cells are generated which ensure a more rapid response upon a
second encounter with a particular antigen (reviewed in Sprent and Tough, 2001, Jameson,
2002). The signals that are responsible for selection, proliferation, survival and differentiation
of T-cells rely on the stimulation of the TCR by antigenic peptides bound to MHC molecules
on the surface of antigen-presenting cells (for review see Starr et al., 2003, Lanzavecchia
and Sallusto, 2000). In the following, the mechanisms of T-cell activation with a special
emphasis on the architecture and function of the immunological synapse will be discussed in
more detail.
1.5.1 Formation of the immunological synapse and T-cell activation
1.5.1.1 Architecture of the immunological synapse
Recognition of antigens by T-cells requires the engagement of their TCR with peptide/MHC
complexes displayed on the surface of APCs. Once a T-cell has encountered an APC
presenting their cognate peptide/MHC complex a tight, specialized contact is formed
between the two cells also referred to as immunological synapse (IS; Wülfing et al., 1998,
Grakoui et al., 1999). Formation of the immunological synapse is required for the specificity
of the immune response by stabilizing and favoring continous TCR-antigen interaction and
consequent activation of T-cells (reviewed in Dustin et al., 2000; Krummel et al., 2002; van
den Merwe, 2002).
Activation of T-cells by triggering of TCRs results in their proliferation and differentiation in a
variety of T-cell subtypes that determine the type of immune response. CD4 positive T-cells
diffferentiate into either TH1 and TH2 cells which release a distinct set of cytokines aiming at
the stimulation of professional phagocytes or B-cells as outlined previously (paragraph
1.3.2). CD8 positive T-cells develop into cytotoxic T-cells capable of killing the target cell
presenting a viral, bacterial or an otherwise foreign peptide via MHC class I molecules.
Furthermore, T-cells can differentiate into T-cells with regulatory function such as suppressor
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T-cells capable of downregulating immune responses through the secretion of inhibitory
cytokines. Most of these effector T-cells die after the antigen is cleared but some of the T-
cells generated during the primary response persist for years as memory T-cells which
ensure immediate protection and a rapid response upon reencountering a particular antigen.
Crucial for the decision of a T-cell’s fate - differentiation, survival or death upon activation - is
the duration of TCR stimulation (Lanzavecchia et al., 1999). The TCR as expressed on the
surface of T-cells is associated with a variety of costimulatory molecules, such as the CD3
complex proteins, the coreceptors CD4 and CD8 and the costimulator CD28. During
formation of the immunological synapse these costimulatory molecules are clustered
together with the TCR leading to serial triggering of the TCR and sustained downstream
signaling as long as the contact with the APC is maintained (reviewed in Germain and
Stefanova, 1999). TCR signaling is downregulated as soon as the antigen is removed
(Valitutti et al., 1995b, Valitutti and Lanzavecchia, 1997).
Whereas initiation of TCR signaling does not require formation of the immunological synapse
(Valitutti et al., 1995a), continuous and sustained TCR signaling activity is only achieved by
formation of the so-called mature immunological synapse as a stable and prolonged contact
between the T-cell and the APC (Valitutti et al, 1995b, Hudrisier et al., 1998, Itoh et al.,
1999). The mature immunological synapse is characterized by a distinct clustering pattern of
the TCR and costimulatory molecules (Monks et al., 1998 and reviewed in Bromley et al.,
2001). In the center of the synapse a structure referred to as central supramolecular
activation cluster (cSMAC) is formed which is enriched with TCR/CD3 complexes interacting
with the peptide/MHC complex. To the cSMAC a variety of costimulatory molecules and
intracellular signaling molecules do localize of which the most important ones are CD4 or
CD8, CD28, protein kinase C isoform q  (PKCq) and CD2. The cSMAC is surrounded by the
peripheral SMAC (pSMAC) which stabilizes the contact site and is composed of adhesion
molecules such as leukocyte function-associated antigen 1 (LFA-1) and cytoskeletal proteins
like talin.
1.5.1.2 The role of lipid rafts and cytoskeletal structures in the formation of the immunological
synapse
Crucial for the assembly of the immunological synapse are the lateral compartmentalization
of the plasma membrane into lipid micro-domains (rafts) and pronouced rearrangements of
the F-actin as well as microtubule cytoskeleton (reviewed in Harder, 2001, Acuto and
Cantrell, 2000, Das et al., 2002). Lipid rafts have been described as sphingolipid/cholesterol-
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enriched microdomains (Simons and Ikonen, 1997) which are located in the two-dimensional
lipid bilayer of the plasma membrane and allow the recruitment and organization of distinct
signaling components upon TCR engagement (Montixi et al., 1998, Xavier et al., 1998,
Leitenberg et al., 2001). Many constituents of the immunological synapse are either
constitutively associated with rafts like CD4, CD28 and CTLA-4 or are recruited to rafts upon
TCR triggering such as the TCR/CD3 complex or the intracellular signaling molecules PKCq
and ZAP-70 (for review see Harder, 2001). T-cell activation is perturbed if protein localization
to rafts is inhibited (Webb et al, 2000).
During formation of the immunological synapse both F-actin and microtubule cytoskeletal
structures undergo profound changes which provide an essential structural support for T-cell
activation (Cerottini and Brunner, 1972, Kupfer and Singer, 1989, Serrador et al., 1999). In a
T-cell interacting with an APC the cytoskeleton undergoes polarization towards the contact
site, actin accumulates at and the microtubule organizing center is localizes close to the
immunological synapse (Geiger et al., 1982, Ryser et al., 1982). Whereas the molecular
mechanisms governing the reorganization of the microtubule cytoskeleton are presently not
well understood the actin cytoskeleton rearrangements where shown to require the activity of
members of the Rho family of small GTPases, namely Rac1 and Cdc42 (Stowers et al.,
1995). Especially Cdc42 was found to be required for the APC-mediated polarization of the
actin cytoskeleton by activating the Wiskott-Aldrich syndrome protein (WASP; Snapper and
Rosen, 1999, Rohagti et al., 1999). Activated WASP in turn regulates the temporal and
spatial activation of the Arp2/3 complex that mediates actin nucleation and ultimately
polymerization (reviewed in Millard et al., 2004). Besides a general structural role by
stabilizing the immunological synapse, the precise function of cytoskeletal structures in T-cell
activation remains to be further characterized. Current experimental evidence suggests the
functional involvement of cytoskeletal structures in providing scaffolds for the recruitment of
signaling complexes (Valitutti et al., 1995b, Kaga et al., 1998) and for polarized vesicle
trafficking (Kupfer et al., 1991, Stinchcombe et al., 2001, Reichert et al, 2001, Das et al.,
2004) or in supporting the recruitment of rafts and associated proteins to the immunological
synapse (Harder and Simons, 1999).
1.5.1.3 Signaling events at the immunological synapse
Due to the lack of appropriate cytosolic tails the TCR itself is not able to generate intracellular
signals. Signaling downstream of the TCR therefore requires the clustering of the TCR with
the CD3 complex and other accessory proteins in the immunological synapse (see Fig.8).
During the early phase of IS formation when the TCR recognizes its cognate peptide/MHC
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complex membrane proximal
protein tyrosine kinases (PTKs),
like Lck and Fyn, are brought into
close contact with the TCR/CD3
complex mediated by the clustering
of lipid rafts (Chu et al., 1998,
Clements et al., 1999). Subsequent
activation of these PTKs leads to
rapid phosphorylation at tyrosine
residues of numerous proteins
(Korade-Mirnics and Corey, 2000).
Of special importantance is
tyrosine phosphorylation at the
ITAM of the CD3 z chain by Lck
and Fyn since this leads to the
recruitment of another PTK called
ZAP70 (Kersh et al., 1998). ZAP70
associated with the CD3 z chain is
phosphorylated by Lck and thereby
activated. Activated ZAP70 is then
able to phosphorylate and activate
its substrates, namely the linker of
activation of T-cells (LAT) and the
adaptor molecule SLP76 (Gong et
al., 2001, Magnan et al., 2001).
Phosphorylated LAT and SLP76
are adaptor molecules which are
capable of recruiting and thereby
activating other kinases and
adaptor molecules for signal
transduction downstream of ZAP70
(reviewed in Rudd, 1999,
Tomlinson et al., 2000). Especially
for LAT which contains nine
tyrosine residues the contribution of tyrosine phosphorylation to signal tranduction
downstream of the TCR has been well described. Depending on which of the LAT tyrosine
residue are phosphorylated distinct sets of cytosolic adaptor proteins (namely those bearing
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Src-homology 2 (SH2) motifs: Grb2, Gads and phospholipase C g (PLC g)) are recruited
which in turn mediate the activation of small GTPases (Paz et al., 2001, Lin and Weiss,
2001, Sommers, 2001). These small GTPases are responsible of regulating the activity of
Erk, Jnk and MAP kinase which eventually control the activity of a variety of transcription
factors, such as NF-kB, Jun and Fos (reviewed in Henning and Cantrell, 1998). The LAT
mediated activation of PLCg induces calcium and protein kinase C (PKC) dependent
signaling pathways which eventually feed into MAP kinase pathways and lead to activation of
nuclear factor of activated T-cells (NFAT, for review see Crabtree, 1999, Rao et al., 1997).
Although the diversity of components involved in signaling downstream of the TCR has been
elucidated, it still remains to be established what precisely allows the TCR to generate
signals governing opposing outcomes such as positive and negative selection during T-cell
development in the thymus or survival or death of peripheral T-cells. Currently it is believed
that the kinetics and quality of signal transduction is decisive as reflected by the duration and
intensity of the activity of distinct signal transducing molecules depending on the affinity of a
given peptide/MHC ligand (reviewed in Werlen et al., 2003).
Another important contribution to the type of cellular response mediated by the TCR is
provided by coreceptors. CD4 and CD8 are coclustered with the TCR/CD3 complex upon
peptide/MHC ligand binding. Concomitant binding of these molecules to either MHC class I
(CD8) and MHC class II molecules (CD4) enhances clustering of raft-associated proteins and
brings Lck and other coreceptor-interacting molecules into close vicinity to the TCR/CD3
signaling complex (Bosselut et al., 2000, Harder and Kuhn, 2000, Arcaro et al., 2001,
Doucey et al., 2001, Dornan et al., 2002). Recruitment of the costimulatory molecules CD28
and cytotoxic T lymphocyte antigen 4 (CTLA-4) to the immunological synapse and
subsequent PKCq mediated downstream signaling was shown to be differentially regulated
depending on the expression of their ligands, B7-1 (for CTLA-4) and B7-2 (for CD28), by the
APC (Pentcheva-Hoang et al., 2004, Tseng et al., 2005).
1.5.2 T-cell activation and homeostasis
Upon generation in the thymus, naïve T-cells reside in the peripheral recirculating
lymphocyte pool as long-lived resting cells. They constantly migrate between the blood and
the lymph through specialized T-cell zones in secondary lymphoid tissues such as the spleen
and the lymph nodes (see Fig.5). T-cell responses upon infection are initiated in these T-cell
zones by mature dendritic cells. Recognition of the antigenic peptides presented on MHC
molecules by the APC leads to selective accumulation and subsequent activation of antigen-
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specific recirculating T-cells entering the lymphoid tissue from the blood. Activation of T-cells
results in differentiation and proliferation of effector T-cells. Once an infection has been
cleared most of the effector cells are eliminated while memory T-cells persist. These
mechanisms ensure a relatively constant size of the lymphocyte pool in both the resting and
the actively responding adaptive immune system (reviewed in Jameson, 2002). In the
following the main factors regulating the homeostasis of the peripheral T-cell pool will be
discussed.
The survival of naïve T-cells requires the constant TCR mediated recognition of self-peptides
bound to MHC molecules and the exposure to the cytokine interleukin-7 (Takeda et al., 1996,
Tanchot et al., 1997, Rathmell et al., 2001, Vivien et al., 2001). These two ligands are
proposed to initiate moderate levels of downstream signaling activity which is sufficient to
allow the naïve T-cell to survive but to not enter the cell cycle (Boise et al., 1995, Ernst et al.,
1999, Sprent and Surh, 2001). In contrast, naïve T-cells recognizing a foreign MHC-bound
peptide undergo pronounced proliferation along with their differentiation into effector T-cells.
Crucial for the proliferation and differentiation into effector T-cells is sustained downstream
signaling via the TCR which relies on the contribution of costimulatory molecules like CD4,
CD8 and CD28 to the formation of a mature immunological synapse (Kundig et al., 1996,
reviewed in Lanzavecchia and Sallusto, 2000a and 2000b). Prolonged TCR stimulation in the
mature immunological synapse maintains transcription factors such as NFAT in the nucleus
which regulate gene expression depending on the differentiation program of the activated T-
cell (Weiss et al., 1987, Timmerman et al., 1996). Differentiation of T-cells into distinct
effector subsets also requires the presence of cytokines. Exposure to interleukin-2 (IL-2) is
required right after TCR engagement for the survival of activated T-cells keeping them
susceptible for subsequent differentiation steps (for review see Ma et al., 2006). The
polarization of CD4 positive T-cells into TH1 and TH2 helper cells relies on the presence of
interleukin-4 and -12 (Iezzi et al., 1999, O’Garra and Arai, 2000). TH1 differentiation is
promoted rapidly by interleukin-12 whereas TH2 cells need prolonged signaling from both the
TCR and IL-4 receptor to develop. Mature CD4 T helper cell subsets as well as differentiated
cytotoxic CD8 T-cells are dependent on IL-2, IL-4, IL-7 and IL-15 to survive and further
proliferate (Vella et al., 1998).
After an infection has been cleared, most of the effector cells are eliminated by mechanisms
which are not yet clearly understood (for review see Sprent and Surh, 2001). Rather than
being short-lived cells which die by a default pathway, effector cells seem to require
instructive signals to undergo apoptosis. Mutant mouse strains for a variety of molecules
which are involved in regulating signaling pathways resulting in the survival or apoptosis of
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effector T-cells - including Fas and Fas-ligand (FasL), PD-1, CTLA-4, NFAT, CD25, CD122
and CD45 - show massive accumulation of effector T-cells. These molecules are part of a
tightly regulated network required to provide several death signals for effector cells (Nagata,
1997, Rathmell and Thompson, 1999, Sprent and Surh, 2001). Although the precise
molecular mechanisms are not yet well defined, death of effector cells seems to be induced
by prolonged TCR stimulation and stimulatory cytokines and then to involve negative
signaling through CTLA-4 and PD-1 (Chambers and Allison, 1997, Freeman et al., 2000).
Furthermore, activation of Fas-mediated apoptosis pathways as well as an increased
sensitivity to inhibition by otherwise stimulatory cytokines like IL-2 are crucial steps in the
clearance of effector T-cells (Irmler et al., 1997, Inaba et al., 1999). A tightly regulated
proportion of effector T-cells are not eliminated but differentiate into memory T-cells by yet ill-
defined mechanisms (reviewed in Sprent and Surh, 2001, Kalia et al., 2006). Proliferation
and survival of CD4 and CD8 positive memory cells is independent of TCR stimulation and
requires, at least in the case of CD8 positive memory cells, in addition IL-15 (Murali-Krishna
et al., 1999, Swain et al., 1999, Becker et al., 2002, Goldrath et al., 2002, Schluns et al.,
2002). Memory cells can be distinguished from naïve T-cells by the surface expression of
cell-type specific markers. Both naïve as well as memory T-cells do not express markers of
activated T-cells, namely CD69 and CD25, but they differ in the expression of CD44 which is
upregulated during memory cell development. Naive CD4 T-cells are CD45RBhiCD44lo and
CD8 T-cells express CD44loLy-6CloIL-2Rblo in their naïve state. In contrast, CD4 positive
memory T-cells are CD45RBloCD44hi and CD8 positive memory cells express
CD44hiLy6ChiIL-2Rbhi (reviewed by Jameson, 2002).
The homeostatic regulation of the peripheral T-lymphocyte pool not only relies on the
duration and quality of TCR stimulation and cytokines but is also dependent on the action of
regulatory CD4 positive T-cells also referred to as Treg cells (reviewed in Stockinger et al.,
2004). Of the several Treg populations identified, the so-called naturally arising CD4
+CD25+
Treg population is most studied (Shevach, 2000, Sakaguchi, 2004). This population develops
in the thymus along a specific lineage and makes up 5 – 10% of the peripheral CD4 positive
T-cell pool. The key factor for the Treg lineage decision is expression of the transcription
factor scurfin, encoded by the foxp3 gene (Fontenot et al., 2003, Hori et al., 2003, Khattri et
al., 2003). The regulatory properties of Treg cells were first identified through their capacity to
prevent the development of auto-immune diseases that arise upon transfer of naïve CD4
positive peripheral T-cells into lymphopenic mice (Sakaguchi et al., 1995). Isolated Treg cells
are able to suppress the proliferation of conventional CD4 and CD8 positive T-cells in vitro.
In vivo Treg cells can prevent effector functions by inhibiting IL-2 transcription a process which
is dependent on cell-cell contacts (Read et al., 1998, Takahashi et al., 1998, Thornton and
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Shevach, 1998). The molecules involved in the formation of these contacts with their
inhibitory effect on the target cell have not yet been defined.
As outlined above, by mechanisms regulating the quality and duration of TCR stimulation, by
differential cytokine requirements and by the activity of regulatory T-cells, the size and the
diversity of the T-lymphocyte pool after an adaptive immune response is re-established to its
characteristic resting state. However, under circumstances of extreme disturbance of the
peripheral T-cell pool, the balance cannot be kept. A partial or complete lack of T-cells, also
referred to as T-lymphopenia, as induced by irradation usually results in pronouced changes
of the composition of the T-cell pool despite the return of total lymphocyte number to normal
levels (La Gruta et al., 2000). Under lymphopenic conditions, naïve T-cells were shown to
start to proliferate a process called homeostatic or lymphopenia-driven proliferation.
Lymphopenia-driven proliferation of naïve T-cells requires IL-7, TCR interaction with self-
antigen and is enhanced by the availability of space, i.e. the lack of competition for limiting
resources such as stimulatory cytokines due to the reduction in overall lymphocyte numbers
(Goldrath and Bevan, 1999, Dummer et al., 2001, Seddon and Zamoyska, 2002, Troy and
Shen, 2003). During lymphopenia-driven proliferation, expanding naïve T-cells adopt a
memory-like phenotype as characterized by the upregulation of CD44 expression (Kieper
and Jameson, 1999, Goldrath et al., 2000).
The mechanisms regulating lymphopenia-driven proliferation have been studied intensively
in the context of autoimmune diseases. Several studies suggested a causal link between
lymphopenia and autoimmune diseases based on the lymphopenia-driven proliferation of
potentially autoreactive T-cells (Gleeson et al., 1996, King et al., 2004, Khoruts and Fraser,
2005). However, the full impact of mechanisms regulating T-cell homeostasis on the diversity
and functionality of the naïve and memory T-cell pools is still unclear. In particular,
appropriate model systems in which only specific peripheral T-cell subsets are defective are
thus far rare. In these models, an analysis of the requirements for survival and proliferation of
the remaining T-cell subsets would provide valuable insight into how T-cell homeostasis is
differentially regulated.
1.6 The coronin family of proteins
The prototype coronin has been described in the slime mold Dictyostelium discoideum as an
actin-binding protein containing five WD domains and being involved in a variety of actin-
based processes such as phagocytosis, cell motility and cytokinesis (de Hostos, 1991 and
1993, Maniak, 1995, Hacker, 1997, Fukui, 1999). Subsequently, coronin-like proteins have
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been found in many species, from yeast to mammals. Based on their structural features,
coronins constitute an evolutionary conserved family of WD-repeat containing proteins which
are collectively defined as actin-binding molecules. In mammalian organisms, the coronin
family of proteins consists of seven members (coronin 1 – 7, see table 1) for which the
degree of homology exceeds 60% amino acid identity depending on the region (reviewed in
de Hostos, 1999; Rybakin and Clemen, 2005). In the following an overview is given on what
is known about the mammalian coronins with a special emphasis on coronin-1 and its
functions in leukocytes.
1.6.1 The mammalian coronin family: structure, expression and function
1.6.1.1 Structure of the mammalian coronin proteins
Alignment of the complete protein sequences of the seven mammalian coronin protein family
members revealed that all coronins are characterized by the presence of WD40 repeats.
With the exception of coronin-7, the most C-terminally located 25-40 amino acids of the
coronin proteins are predicted to have a high tendency to fold into a coiled coil structure.
According to a recent sequence analysis the WD repeat containing region is flanked by so-
called highly conserved N- and C-terminal extensions (Uetrecht and Bear, 2006). In each
coronin the C-terminal extension is preceeded by a stretch of variable length (50 - 200 amino
acids) which is highly divergent and unique for each individual coronin family member. It is
thought that this unique region contributes to functional diversity among the different coronins
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(de Hostos, 1999; Rybakin and Clemen, 2005). Structural data as obtained for coronin-1
revealed that the WD repeat regions fold into a seven bladed b-propeller with the N- and C-
terminal extensions forming the first and the last blade respectively (Gatfield et al., 2005,
Appleton et al., 2006). This structure is reminiscent of the b-propeller fold of the b-subunit of
trimeric G proteins and mediates protein-protein interactions of G proteins suggesting a
similar function in coronin proteins (Neer et al., 1994, Sondek et al., 1996).
The most C-terminal sequences predicted to fold into a coiled-coil domain were shown to
mediate homo-oligomerization of coronin proteins, namely homotrimerization of coronin-1
and homo-oligomers of not yet defined stochiometry for the coronin homologue in Xenopus
and for mammalian coronin-3 (Asano et al., 2001, Spoerl et al., 2002). For coronin-1,
homotrimerization was shown to be indispensable for association with the actin cytoskeleton
(Gatfield et al., 2005).
Structurally, coronin-7 substantially differs from the other mammalian coronins. Coronin-7 is
much longer and contains two complete copies of the basic coronin domain organization into
the WD-repeat regions with flanking N- and C-terminal extensions. In addition, coronin-7
possesses a highly conserved acidic domain with a characteristic tryptophan residue at its
very C-terminus. This domain is homologous to acidic domains found in the SCAR/WASP
family of proteins regulating the activity of the actin nucleating complex Arp2/3 (Rybakin et
al., 2004, Uetrecht and Bear, 2006).
1.6.1.2 Expression and function of mammalian coronin-2 – 7
Based on their homology to coronin-1 the members of the coronin protein family are
presumed to play an important role in the regulation of cytoskeletal dynamics. Whereas for
coronin-2, -3 and -7 functional data and biochemical properties are partially known, similar
data for coronin-4, -5 and -6 are currently not available. Coronin-1 expression and function
will be discussed in the following paragraphs.
Coronin-2 (originally termed coroninse) has first been identified in rabbit as a phosphoprotein
in hydrochloric acid secreting gastric parietal cells (Brown and Chew, 1989, Chew et al.,
1999). Expression of coronin-2 in mouse tissue was found to be ubiquitous with highest
levels in kidney, liver, lung and spleen (Okumura et al., 1998, Parente et al., 1999). On a
subcellular level, coronin-2 was found to colocalize with the Arp2/3 complex at the leading
edge and on vesicular structures in fibroblasts (Cai et al., 2005). This distribution was
dependent on the phosphorylation of coronin-2 on serine residues by protein kinase C
(Parente et al., 1999). Furthermore, coronin-2 was identified as a component of macrophage
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phagosomes (Morrissette et al., 1999). Downregulation of coronin-2 expression by RNAi led
to a reduction of neurite outgrowth in the neuroblastoma cell line PC-12 (Di Giovanni et al.,
2005).
Coronin-3 expression in human and mouse tissue appeared to be ubiquitous and most
prominent in brain, lung, intestine and kidney (Okumura et al., 1998, Iizaka et al., 2000,
Spoerl et al., 2002, Hasse et al., 2005). In human embryonic kidney cells (HEK293) and
mouse fibroblasts (3T3) coronin-3 was shown to localize to both the cytosol as well as the
cortical cytoskeleton with pronouced accumulation in lamellipodia and membrane ruffles.
Biochemical analysis of coronin-3 revealed a high degree of phosphorylation on so far
unidentified residues. Using truncated versions of coronin-3 established a role for the C-
terminus in mediating oligomerization, membrane association and actin binding of coronin-3.
However, removal of the very C-terminal coiled coil sequence abolished membrane
association presumably due to disturbance of the oligomerization state of coronin-3 (Spoerl
et al., 2002).
Coronin-4 was shown to be exclusively expressed in colon, brain, prostate and testis at a low
level (Okumura et al., 1998). Coronin-5 has been originally described to be expressed in
neuronal tissue but presence in other tissue cannot be excluded (Nakamura et al., 1999).
Coronin-6 is present in the genome but its expression as well as the protein have not yet
been described (Uetrecht and Bear, 2006). Functional or biochemical data for the latter three
coronins are currently not available.
Coronin-7 was identified as the mammalian homologue of POD-1 in Drosophila (Dpod-1) and
C. elegans (Rybakin et al., 2004). The protein is expressed throughout mouse
embryogenesis with pronouced upregulation in developing brain and hemato-/lymphopoietic
tissues. In adult animals, coronin-7 appears to be ubiquitously expressed with highest levels
in thymus, spleen and brain. Analysis of its subcellular localization revealed recruitment to
Golgi membranes in a tyrosine-phosphorylation dependent manner. In contrast to other
coronins, coronin-7 does not colocalize with actin and disturbance of actin cytoskeletal
structures by the actin depolymerizing drug latrunculin B does not influence its distribution
(Rybakin et al., 2004). Functional data for the mammalian coronin-7 are not available but
results obtained for Drosophila and C. elegans suggest a role in regulating vesicle trafficking
dependent on cytoskeletal structures. Depletion of POD-1 by RNAi severly affects early
development of C.elegans due to defects in polarized vesicle transport (Aroian et al., 1997,
Rappleye et al., 1999). Drosophila POD-1 was shown to be required for the development of
the nervous system since flies mutant for dpod1 displayed aberrant axonal guidance and
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subsequent failure in innervation (Rothenberg et al., 2003). However, in contrast to their
mammalian homologue both C.elegans and Drosophila POD-1 interact with actin. For
Drosophila POD-1 a role in crosslinking the actin and microtubule cytoskeleton could be
established. Further experimental work is required to analyse to which extent coronin-7 and
its POD-1 counterparts are involved in regulating cytoskeleton dynamics as well as vesicle
trafficking dependent on the actin or microtubule cytoskeleton.
1.6.2 Coronin-1 and its homologues in other eukaryotic organisms
Since its original discovery in Dictyostelium substantial biochemical, functional and structural
data have been obtained for mammalian coronin-1 and its homologues in various other
eukaryotic organisms. In the following an overview is given for what has been established for
coronin-1 homologues in Dictyostelium, yeast and Drosophila before discussing available
data on mammalian coronin-1.
1.6.2.1 Coronin-1 homologues in Dictyostelium, yeast and Drosophila
In Dictyostelium, coronin was shown to be associated with F-actin structures at crown-
shaped phagocytic cups and macropinosomes. In mutants for coronin a variety of actin-
based processes such as cytokinesis, cell locomotion, phagocytosis and macropinocytosis
are impaired, although none of them is completely abolished (de Hostos, 1991 and 1993,
Maniak, 1995, Hacker, 1997). Further analysis using a coronin fusion to GFP revealed that
coronin is accumulated at all sites where the actin cytoskeleton is actively remodeled
including the leading edge of pseudopods as formed during movement of cells, the cleavage
furrow during cytokinesis and the sites of active macropinocytosis and phagocytosis (Fukui,
1997 and 1999).
In contrast to Dictyostelium, mutants for the coronin homologue in the yeast Saccharomyces
cerevisiae (Crn1p) showed no obvious phenotype (Heil-Chapdelaine et al., 1998). Crn1p
represents the only coronin protein in yeast and was originally identified by homology cloning
and microtubule affinity chromatography (Heil-Chapdelaine et al., 1998, Goode et al., 1999).
Crn1p colocalizes with cortical actin patches in a latrunculin A sensitive manner suggesting
that its subcellular localization is dependent on F-actin. In vitro Crn1p was shown to bind to
actin as well as microtubules implying a function of Crn1p in crosslinking these two
cytoskeletal structures (Goode et al., 1999). Further in vitro analysis of the capacity of Crn1p
to regulate the actin cytoskeleton revealed that Crn1p can bundle actin filaments. The direct
interaction of Crn1p with the Arp2/3 complex could be demonstrated in vivo and in vitro
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leading to inhibition of the ability of the Arp2/3 complex to nucleate and thereby promote
actin polymerization (Goode et al., 1999, Humphries et al., 2002). It was therefore suggested
that the interaction of Crn1p with the Arp2/3 complex regulates actin polymerization and
branching as it is important for the formation of actin filament network supporting cell motility
and vesicle transport.
A role for coronin-1 in cytoskeleton-based intracellular membrane and protein trafficking is
further corroborated by the analysis of the coronin-1 homologue in Drosophila (Dcoro,
Bharathi et al., 2004). Dcoro is highly and ubiquitously expressed in all cell types with
exception of the larval central nervous system. Mutation of Dcoro resulted in a lethal
phenotype at the early to late pupal stages concomitant with severe defects in the
morphogenesis of appendages. These defects were on one hand correlated with the
disruption of the actin cytoskeleton in embryonic imaginal disks and on the other hand with
the impairment of the intracellular transport of the morphogen Dpp resulting in a failure to
generate a Dpp morphogen gradient as required for proper appendage development
(Bharathi et al., 2004). Interestingly, genetic evidence has been provided that Dcoro interacts
with syx1A a gene encoding a Drosophila SNARE protein involved in exocytosis and calcium
channel function (Schulze et al., 1995, Wu et al., 1999).
1.6.2.2 Mammalian coronin-1 and its potential function in leukocytes
Coronin-1 as identified in human and mouse is a 57 kDa protein that is highly and specifically
expressed in leukocytes (Okumura et al., 1998, Ferrari et al., 1999, Nal et al., 2004). The
subcellular localization of coronin-1 is characterized by the accumulation of coronin-1 at sites
of actin cytoskeleton remodeling such as the cortical region, sites of phagocytosis and the
immunological synapse (Ferrari et al., 1999, Nal et al., 2004). In human neutrophils, coronin-
1 was shown to colocalize with F-actin around early phagocytic vacuoles (Itoh et al., 2002).
Downregulation of coronin-1 expression or function by RNAi or expression of dominant-
negative coronin-1 constructs resulted in the partial impairment of internalization of red blood
cells by murine macrophage cell lines (Yan et al., 2005). Coronin-1 localization to the
phagosome appears to be dependent on phosphorylation mediated by protein kinase C (Itoh
et al., 2002). The phosphorylated residues have not yet been identified but coronin-1 seems
to be differentially phosphorylated at multiple sites in vivo (Gatfield et al., 2005). In murine
macrophages, coronin-1 was shown to be actively recruited and retained at the phagosome
by pathogenic mycobacteria thereby allowing them to inhibit lysosomal delivery and to
subsequently survive within the host cell in a specialized compartment, the mycobacterial
phagosome (Ferrari et al., 1999).
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As an interaction partner for coronin-1 besides F-actin, p40phox was identified. p40phox
represents a cytosolic subunit of the NADPH oxidase complex which is responsible for the
generation of the microbicidal superoxide burst in neutrophils (Grogan et al., 1997). Based
on the results obtained for Crn1p in yeast an interaction of coronin-1 with the Arp2/3 complex
in mammalian cells has been proposed. The only available data substantiating this
hypothesis came from a study examining the composition of the Arp2/3 complex, in which
coronin-1 co-purified as a main protein with Arp2/3 isolated from neutrophil lysates
(Machesky et al., 1997). Furthermore, coronin-1 is recruited to F-actin tails by ActA-positive
Listeria monocytogenes in infected host cells. F-actin based intracellular motility of Listeria
relies on similar mechanisms as conventional actin polymerization (David et al., 1998).
In summary, the biochemical and functional data obtained for coronin-1 so far suggest that
coronin-1 plays a role in membrane- and cytoskeleton-based leukocyte-specific processes.
______________________________________________________________INTRODUCTION
33
1.7 Aim of this thesis
The mammalian coronin-1 is the closest homologue of coronin in Dictyostelium. Although
subject of extensive functional and biochemical studies in various eukaryotic organisms such
as Dictyostelium and yeast no precise biological activity has been assigned to coronin and
other members of the coronin family of proteins. Especially for mammalian organisms,
coronin-1 lacks detailed functional description. In mammalian organisms coronin-1 was found
to be restricted in its expression to leukocytes. Experimental work from Dictyostelium and
yeast suggests a role of coronin proteins in regulating cytoskeletal dynamics. Careful
biochemical characterization of mammalian coronin-1 established this protein as a linker of
the leukocyte plasma membrane with the actin cytoskeleton. Furthermore, coronin-1 was
found to be recruited to and retained at the mycobacterial phagosome in murine
macrophages thereby allowing pathogenic mycobacteria to persist within host cells
presumably due to the coronin-1 mediated inhibition of phagosome-lysosome fusion. Taken
together, these data led to the hypothesis that coronin-1 plays a role in regulating leukocyte-
specific membrane- and cytoskeleton-based functions.
The aim of this thesis was to gain insight into the cell biological function of coronin-1 in
leukocytes. For this purpose the coronin-1 gene was targeted by homologous recombination
in murine embryonic stem cells which subsequently where used to generate coronin-1
deficient mices. Coronin-1 deficient mice where subjected to an extensive phenotypic
analysis focusing on the following questions:
Can coronin-1 deficient mice be generated and do they display an obvious phenotype ?
The narrow expression pattern of coronin-1 together with its appearance only late during
embryogenesis made coronin-1 a successful candidate for the generation of viable knock-out
mice. However, due to the yet incomplete description of its expression and function it could
not be excluded that the absence of coronin-1 causes severe deficiencies such as embryonic
lethality, behavioural abnormalities and immunodeficiency.
If coronin-1 K.O. mice are viable, which cell types are affected by the lack of coronin-1
expression ?
The specific expression of coronin-1 in leukocytes suggested a phenotype of coronin-1
deficient mice within leukocyte subsets. Of special interest for our phenotypical analysis was
the T-lymphocyte population. Coronin-1 has been described to be differentially expressed
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during T-cell development and was suggested to play a role in regulating T-cell activation by
being recruited to the immunological synapse. Both developing as well as peripheral
leukocyte populations were therefore carefully studied for their cellularity and composition in
coronin-1 K.O. mice.
In which cell types is coronin-1 expressed ?
The targeting construct for the coronin-1 locus was designed to replace coronin-1 exons by
the coding region of the green fluorescent protein (GFP). Fusion of GFP in frame with the
original start codon of the coronin-1 locus should allow analysis of coronin-1 expression by
the means of GFP as a reporter gene. Heterozygous coronin-1 K.O. mice were used to study
the reliability of GFP as a reporter for coronin-1 expression and to therefore draw detailed
conclusion on coronin-1 expression in the various leukocyte subsets.
Given a cell type specific defect caused by the absence of coronin-1, what can be deduced
on the precise cell biological function of coronin-1 in leukocytes ?
Cell types affected by coronin-1 deficiency were subjected to a functional analysis to
understand the question at which point coronin-1 could play a regulatory role. Based on the
proposed role of coronin-1 in regulating leukocyte-specific membrane and cytoskeleton-
based functions a potential disturbance of cytoskeletal structures as well as defects caused
in receptor-mediated processes, such as activation of T-cells and phagocytosis, were
studied.
In summary, the generation and phenotypic analysis of coronin-1 deficient mice should
provide a versatile model system to study the precise role of coronin-1 in regulating
leukocyte-specific functions. Of special importance for immune cell function is the
contribution of potentially disturbed cytoskeletal structures or receptor-mediated processes to
the phenotype of coronin-1 deficient mice. The analysis of coronin-1 deficient mice could be
valuable in demonstrating an involvement of coronin-1 in regulating cytoskeletal
rearrangements or signaling downstream of immune receptor in a discrete and cell-type
specific manner.
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2 MATERIALS AND METHODS
2.1 Chemicals, reagents and kits
2.1.1 Chemicals
Acetic acid Merck
Acetone Merck
Acrylamide Biorad
Agarose Eurobio
Albumine, bovine, 96% pure Equitech-Bio Inc.
Ammonium citrate Sigma
Ammonium persulfate (APS) Biorad
Ammonium sulfate [(NH4)2SO4] Merck
Ampicillin Sigma
Antipain Fluka
Aprotinin Merck
Bacto-Tryptone Difco
Bacto-Yeast Extract Difco
Bisacrylamide (N’,N-methylenbisacrylamide) Biorad
Blocking reagent (for Southern blotting) Roche
Boric acid Merck
Bradford reagent Biorad
Bromophenol blue Merck
Calcium chloride [CaCl2 x H2O] Sigma
Chloroform Merck
Chymostatin Merck
Coomassie brilliant blue R-250 Merck
Deoxynucleotides (dNTPs, PCR nucleotide mix) Roche
Dimethylsulfoxide (DMSO) Fluka
Dithiothreitol (DTT) Sigma
DNA molecular weight standards Roche
T4 DNA ligase New England Biolabs
EBSS (10x) Gibco BRL
Erythromycin Sigma
Ethanol Merck
Ethidium bromide Sigma
Ethylendiamine tetraacetate (EDTA), sodium salt Fluka
Ficoll-Paque Pharmacia
FluoroGard Antifade reagent Biorad
Formamide Merck
Hi-Di‰ Formamide Applied Biosystems
D(+)-glucose Fluka
Gelatine Sigma
Glycine Fluka
Glycerol Fluka
Hydroxymethylpiperidine-ethanesulfonic acid (HEPES) AppliChem
Hydrochloric acid (HCl) Merck
Interferon-g, murine, recombinant BD Pharmingen
Isopropanol (2-propanol) Merck
Ketalar Parke-Davis
L-cysteine Fluka
Leupeptin Fluka
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Lipopolysaccharide (LPS) Sigma
Liquemine‚ (Heparin solution at 5'000 U/ml) Roche
Magnesium chloride [MgCl2] Sigma
Magnesium sulfate [MgSO4] Sigma
Maleic acid Sigma
Manganese chloride [MnCl2] Sigma
Manganese sulfate [MnSO4] Sigma
Methanol Merck
Microscint‰40 Packard
Mitomycin C Sigma
Paraformaldehyde, powder, 95 % pure Sigma
PCR primer Microsynth
Pepstatin Fluka
Phalloidin, fluorescently labeled with Alexa‚dyes Molecular Probes
Phenylmethylsulfonylfluoride (PMSF) Sigma
Phorbol-12-myristate-13-acetate (PMA) Sigma
Piperazine-1,4-bis(2-ethanesulfonic)acid (PIPES) Sigma
Poly-L-lysine Sigma
Ponceau S Sigma
Potassium chloride [KCl] Sigma
Potassium dihydrogen phosphate [KH2PO4] Merck
Potassium hydroxide [KOH] Sigma
Propidium iodide Sigma
Proteinase K Roche
Random hexanucleotide primers Promega
Restriction enzymes New England Biolabs
Rompun Bayer Healthcare
rRNAsin (recombinant RNAse inhibitor) Promega
Saponin (from Quillaja bark) Sigma
Sarcosyl Sigma
SDS-PAGE molecular weight standards Biorad
Shrimp alkaline phosphatase (SAP) Roche
Sodium acetate Fluka
Sodium chloride [NaCl] Merck
Sodium citrate Sigma
Sodium dihydrogen phosphate [NaH2PO4] Fluka
Sodium dodecylsulfate (SDS) Biorad
Sodium hydroxide [NaOH] Merck
Di-sodium hydrogenphosphate [Na2HPO4] Fluka
Sucrose BDH
Sulfuric acid [H2SO4] Fluka
N,N,N’,N’-tetramethylenethylendiamine (TEMED) Biorad
[methyl-3H]-thymidine Amersham
Trichloroacetic acid (TCA) Merck
Tris(hydroxymethyl)aminomethane (Tris/TRIZMA base) Sigma
Triton X-100 Boehringer Mannheim
TriZOL reagent Invitrogen
Trypan blue Sigma
Trypsin-EDTA in HBSS Gibco BRL
Trypticase peptone Becton Dickinson
Tryptose Difco
Tween 20 Merck
Tween 80 Merck
Water, molecular biology grade Eppendorf
Xylene cyanol FF Sigma
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Zymosan Sigma
2.1.2 Kits and FPLC columns
AlexaFluor‚633 Protein Labeling Kit Molecular Probes
BCA protein detection kit Pierce
BigDye1.1‚Terminator v1.1 Cycle Sequencing Kit Applied Biosystems
DNA-free kit (for DNAse I treatment of RNA) Ambion
Enhanced Chemiluminescence (ECL) kit Amersham
Expand Long Template PCR System Roche
Hi-Trap‰ Protein A HP 1 ml Amersham
Lysing Matrix D Qbiogen
Plasmid DNA Mini/Maxi-prep kit Qiagen
QIAquick Gel Extraction Kit Qiagen
QIAquick PCR Purification Kit Qiagen
pGEM‚-T-Easy Vector Kit Promega
SuperScript III (reverse transcriptase + buffer) Invitrogen
Taq polymerase + PCR buffer Pharmacia
2.2 General buffers and solutions
Ammoniumchloride/Potassium (ACK)- 0.15 M NH4Cl
erythrocyte lysis buffer 10 mM KHCO3
0.1 mM EDTA
pH 7.2
filter sterilized through 0.2 mm filter
DNA loading buffer (6x) 0.25% bromophenol blue
0.25% xylene cyanol
1 mM EDTA pH 8.0
30 % glycerol
Lysis buffer (10x) 200 mM HEPES pH 7.4
1 M NaCl
50 mM MgCl2
10 % Triton X-100
PBS 137 mM NaCl
2.7 mM KCl
8 mM Na2HPO4
1.5 mM KH2PO4
PBST PBS + 0.2 % (v/v) Tween 20
SDS-PAGE electrophoresis buffer (10x) 1.9 M glycine
250 mM Tris
SDS added to the 1x buffer at a final
concentration of 0.1 % (w/v) just before use
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SDS-PAGE reducing sample buffer (5x) 10% (w/v) SDS
20% (v/v) glycerol
500 mM DTT
300 mM Tris-HCl pH 6.8
0.015% (w/v) bromophenol blue
Semi-dry transfer buffer (10x) 480 mM Tris
390 mM glycine
0.375% (w/v) SDS
Methanol added to a final concentration of 20%
(v/v) to the 1x buffer just before use
TBE (5x) 54 g Tris
27.5 g Boric acid
 20 ml 0.5 M EDTA (pH 8.0)
dissolved in destilled water to a total
volume of 1 l
TE buffer 10 mM Tris-HCl pH 8.0
  1 mM EDTA
SSC (20x) 3 M NaCl
300 mM sodium citrate
pH 7.0 
CLAAP (100x) 100 mg/ml chymostatin
100 mg/ml leupeptin
100 mg/ml antipain
100 mg/ml aprotinin
100 mg/ml pepstatin
PMSF (100x) 87.1 mg PMSF dissolved in 5 ml 100% ethanol
(corresponds to 1 mM PMSF)
storage: -20°C
3% paraformaldehyde in PBS 100 ml 3% paraformaldehyde solution in PBS was
prepared by dissolving 3 g paraformaldehyde in 90 ml
destilled water containing 300 ml 0.1 M NaOH. Complete
dissolution of paraformaldehyde was achieved by
heating the solution to 60°C while stirring. The solution
was then cooled down to 37°C, 10 ml 10x PBS were
added and the pH was adjusted to 7.2.
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2.3 Cell culture media and supplements
2.3.1 Bacterial media and supplements
Luria-Bertani (LB medium+glucose+MgSO4) 10 g Bacto-tryptone (Difco)
  5 g Bacto-yeast extract (Difco)
10 g NaCl
dissolved in 1 l destilled H2O
sterilized by autoclaving
(prior to use added: glucose (final
concentration 0.1%) and MgSO4 (final
conc. 10 mM))
Lactobacillus medium 12.5 g trypticase peptone (Becton
Dickinson)
6.25 g Bacto-yeast extract (Difco)
3.75 g tryptose (Difco)
2.5 g ammonium citrate (Sigma)
1.25 ml Tween-80 (Sigma)
 1.25 g sodium acetate x 3 H2O
0.25 g L-cysteine (Fluka)
0.6 g MgSO4 x 7 H2O
0.05 g MnSO4
dissolved in 800 ml destilled water,
autoclaved and supplemented with 200 ml
0.5 M potassium phosphate buffer pH 6.9
and glucose (final conc. 1%)
Ampicillin Sigma, stock in destilled water at 100
mg/ml, used for cultures at 100 mg/ml
Erythromycin Sigma, stock in ethanol 20 mg/ml, used
for cultures at 5 mg/ml
2.3.2 Mammalian cell culture media and supplements
DMEM Sigma
DMEM (for ES cell medium) PAN Biotech
RPMI-1640 Gibco BRL
IMDM Sigma
Fetal calf serum (FCS) Gibco BRL
ES cell qualified FCS HyClone
Human serum Blutspendezentrum Basel, Switzerland
100x L-glutamine (200 mM) Gibco BRL
50 mM b-mercaptoethanol Gibco BRL
100x sodium pyruvate (100 mM) Gibco BRL
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100x MEM non-essential amino acids Gibco BRL
1M HEPES Gibco BRL
G418, powder Sigma
Penicillin (10'000 U/ml) / Streptomycin (10 mg/ml) Sigma
Murine recombinant LIF (ESGRO) Gibco BRL
Trypsin-EDTA in HBSS Gibco BRL
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2.4 Vectors
Table 2 Vectors used in this study.
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2.5 Primers
Table 3 Primers used in this study. Primers were obtained from Microsynth GmbH, Balgach,
Switzerland. As a source of the sequence for primers annealing to the murine coronin-1 locus, the
position is given relative to the start codon of coronin-1 (position of the start codon arbitrarily set to
+1). Negative position values indicate position of the primer 5’ of the coronin-1 start codon, positive
position values indicated location of the primer 3’ of the coronin-1 start codon.
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Table 3 (continued) Primers used in this study. Primers were obtained from Microsynth GmbH,
Balgach, Switzerland. As a source of the sequence for primers annealing to the murine coronin-1
locus, the position is given relative to the start codon of coronin-1 (position of the start codon arbitrarily
set to +1). Negative position values indicate position of the primer 5’ of the coronin-1 start codon,
positive position values indicated location of the primer 3’ of the coronin-1 start codon.
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Table 3 (continued) Primers used in this study. Primers were obtained from Microsynth GmbH,
Balgach, Switzerland.
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2.6 Antibodies
Table 4 Antibodies and flow cytometry reagents used in this study.
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Table 4 (continued) Antibodies and flow cytometry reagents used in this study. * SBTA: Southern
Biotechnology Associates.
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Table 4 (continued) Antibodies and flow cytometry reagents used in this study. * SBTA: Southern
Biotechnology Associates.
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2.7 Bacteria and cell lines
2.7.1 Bacterial strains and culture conditions
Table 5 Bacterial strains used in this study.
2.7.2 Mammalian cells, cell lines and culture conditions
Table 6 Mammalian primary cells and cell lines used in this study. If not otherwise stated, cells and
cell lines were cultured at 37°C / 5 % CO2.
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2.8 Molecular biological methods
2.8.1 Agarose gel electrophoresis of DNA fragments
For analytical as well preparative purposes DNA was separated on agarose gels prepared in
0.5 % TBE. Agarose was purchased from Eurobio and used at 0.8 % for the separation of
DNA fragments of 25 –2 kb size or at 1.6 % to separate 0.1 to 2 kb sized fragments. To
visualize DNA fragments using UV-light (280 nm) ethidium bromide (final concentration 10
mg/ml) was added to the liquid agarose solution prior to casting the gel. DNA samples were
prepared for gel electrophoresis by adding 6x DNA loading buffer. Gel electrophoresis was
performed at 50 – 80 V in electrophoresis chambers (type: M.A.K. I, Baechler, Switzerland).
2.8.2 Preparation of chemically competent E.coli DH10B and transformation
2.8.2.1 Preparation of ultra-competent E.coli DH10B
Materials:
- SOB medium 0.5% (w/v) yeast extract, 2% (w/v) tryptone, 10 mM NaCl, 2.5
mM KCl, 10 mM MgCl2, 10 mM MgSO4 dissolved in 1l ddH2O
and sterilized by autoclaving.
- TB solution 10 mM PIPES, 15 mM CaCl2, 250mM KCl dissolved in ddH2O.
pH was adjusted to 6.7 with KOH or HCl prior to the addition of
MnCl2 at a final concentration of 55 mM. The solution was
brought to a total volume of 1l by adding ddH2O and then
sterilized by filtration (0.45 mm).
- DMSO before use stored at –20°C o/n.
Ultra-competent E.coli (strain: DH10B, kind gift from S.Arber, Biozentrum, University of
Basel) were prepared based on a protocol from Inoue et al. (1990). 250 ml SOB medium
were inoculated with 10 colonies of E.coli DH10B grown on LB plates. The culture was
incubated in a 1l Erlenmeyer flask at 19°C with vigorous agitation to an OD600 of 0.5. Bacteria
were harvested by centrifugation for 10 min, 4°C at 4000 rpm (Sorvall RC5C, rotor GS3). The
resulting pellet was gently resuspended by pipetting in 80 ml ice-cold TB solution and stored
on ice for 10 min. By centrifugation at 4000 rpm (10 min, 4°C) the bacteria were pelleted
again and then resuspended in 20 ml TB solution supplemented with 1.4 ml DMSO. Bacteria
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were flash-frozen in liquid nitrogen and stored at –80°C in 1.5 ml Eppendorf tubes as 250 ml
aliquots.
2.8.2.2 Transformation of ultra-competent E.coli DH10B
For transformation, 50 ml of ultra-competent E.coli DH10B were used after thawing the
bacteria on ice. An appropriate amount of plasmid DNA or 5 – 10 ml of a ligation reaction
were gently mixed with the bacteria (maximal 5 pipetting strokes) followed by 5 min
incubation on ice. For recovery and expression of the resistance gene bacteria were then
transferred to 1 ml antibiotic-free LB supplemented with 0.1% glucose in 14 ml polypropylene
round-bottom tubes (BD Falcon) and incubated for 1 hr at 37°C with agitation (150 rpm,
Kuehner shaker). After incubation, bacteria were plated on LB agar plates containing the
appropriate antibiotic and incubated o/n at 37°C. The resulting colonies were then used to
inoculate 5 ml cultures for mini-prep of plasmid DNA.
2.8.3 General cloning methods
2.8.3.1 Preparation of plasmid DNA from E.coli cultures
Plasmid DNA from E.coli cultures was prepared using Maxi- and Mini-Prep Kits from
QIAGEN according to the manufacturer’s protocol. Purified plasmid DNA was dissolved in
either molecular biology grade H2O (Eppendorf) for immediate use in cloning procedures or
in TE buffer for long-term storage at –20°C.
2.8.3.2 Ethanol precipitation of DNA
Precipitation of DNA was performed by adding 1/10 volume of 3M Na-acetate pH 5.2 and 2
volumes of 100% ethanol to the DNA solution. After mixing by inverting the tube a few times,
the solution was incubated at –20°C for at least 15 min. The precipitated DNA was then
pelleted by centrifugation (20’000 x g, 15 min, 4°C), washed twice with 70% ethanol (5 min
centrifugation steps) and air-dried. The DNA pellet was dissolved in ddH2O or TE buffer
depending on further use.
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2.8.3.3 Restriction enzyme digest of plasmid DNA and PCR products
For restriction enzyme digest of plasmid DNA or PCR products restriction enzymes were
purchased from New England Biolabs (NEB) and used with the supplied buffers. Generally,
0.5 – 5 mg DNA were digested at 37°C in a total volume of 30 ml with 5 – 60 U of restriction
enzyme either for 1 – 2 hrs for analytical purposes or o/n for preparative purposes as
required for further cloning steps.
2.8.3.4 Dephosphorylation of DNA
To prevent religation of digested vectors 5’-phosphate groups were removed by treating
linearized plasmid DNA with shrimp alkaline phosphatase (SAP, Roche). 1U SAP per 250 ng
DNA together with the supplied SAP reaction buffer were directly added to the restriction
digest reaction and incubated for 10 min at 37°C. SAP was inactivated by incubation at 65 °C
for 15 min and the linearized and dephosphorylated vector was isolated by agarose gel
electrophoresis and subsequent gel extraction.
2.8.3.5 Purification of DNA fragments from agarose gels
DNA fragments of interest as visualized by UV light were excised from the agarose gel with a
ethanol cleaned razor blade and purified using the gel extraction kit (QIAGEN) according to
the manufacturer’s protocol.
2.8.3.6 Ligation of DNA fragments
Ligation of DNA fragments with cohesive or blunt ends was performed at a molar ratio
between vector and insert of 1: 2 – 4 in a volume of 20 ml using the T4 ligase from New
England Biolabs (NEB) or the Rapid DNA Ligation Kit (Roche). Ligation reactions with T4
ligase were set up at RT as follows:
x ml vector DNA (up to 100 ng vector)
x ml insert DNA (as required for a certain ratio relative to the vector DNA)
2 ml 10x ligation buffer
1 ml T4 ligase
x ml molecular biology grade water (to a total reaction volume of 20 ml)
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Ligation reactions were then incubated for 1 hr at RT and 2 – 5 ml of the reaction were
transformed into ultra-competent E.coli DH10B.
Ligations with the Rapid DNA Ligation Kit were set up as given below:
x ml vector DNA (up to 100 ng vector)
x ml insert DNA (as required for a certain ratio relative to the vector DNA)
2 ml 5x DNA dilution buffer
10 ml 2x T4 DNA ligation buffer
1 ml T4 ligase
x ml molecular biology grade water (to a total reaction volume of 20 ml)
Ligation reactions were then incubated for 30 min at RT and 2 – 5 ml of the reaction were
transformed into ultra-competent E.coli DH10B.
2.8.3.7 Polymerase chain reaction (PCR) for the construction of the coronin-1 targeting
vectors
Materials:
- Molecular biology grade water (Eppendorf, Cat.No. 0032 006 302)
- 10 mM PCR nucleotide mix (Roche, Cat.No. 11 581 295 001)
- Expand Long Template PCR System (Roche, Cat.No.  1 681 834)
- Primer (15 mM solution in molecular biology grade water)
- T3 thermocycler (Biometra)
The individual parts of the targeting vector for the coronin-1 locus were amplified by PCR
using ES cell genomic DNA as a template and the Expand Long Template PCR System.
Primers were designed to insert appropriate restriction sites for subcloning the PCR
products. PCR products were purified using the gel extraction kit (Qiagen) and subcloned
either directly in pBluescript SK(+) or via T/A cloning in the vector pGEM‚-T easy (Promega)
according to the manufacturer’s protocol. PCR reactions were set up as follows:
x ml  template DNA (500 ng)
1 ml  10 mM PCR nucleotide mix
1 ml  15 mM forward primer
1 ml  15 mM reverse primer
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5 ml  10x PCR buffer 1
0.75 ml polymerase mix (corresponds to 2.5 units)
x ml  molecular biology grade water (to a total reaction volume of 50 ml)
PCR reactions were then run on a T3 thermocycler employing the following program:
Step 1 94°C, 2 min (initial denaturation of DNA)
Step 2 94°C, 20 sec (denaturation of DNA)
Step 3 56 – 62°C, 30 sec (annealing temperature depending on primer)
Step 4 68°C, 1 - 4 min (elongation time depending on product length)
Return to step 2, 10 times
Step 5 94°C, 20 sec (denaturation of DNA)
Step 6 56 – 62°C, 30 sec (annealing temperature depending on primer)
Step 7 68°C, 1 - 4 min + 20 sec each cycle (elongation time depending on product
length, 20 sec elongation of time to compensate for loss in enzyme activity)
Step 8 68°C, 10 min (elongation of incomplete products)
Step 9 4°C, • (storage until further processing)
2.8.3.8 Sequencing of plasmid DNA
Sequencing of plasmid DNA was performed according to the manufacturer’s protocol
supplied with the Big Dye 1.1® Terminator v 1.1 Sequencing Kit.
Materials:
- Big Dye 1.1® Terminator v 1.1 Sequencing Kit
(Applied Biosystems, Cat No. 4337452)
- 96 well optical reaction plate (Applied Biosystems, Cat No. 4306737)
- Primus 96 plus thermocycler (MWG Biotec)
- Molecular biology grade water (Eppendorf)
- 95% and 70% ethanol
- Hi-Di™ formamide (Applied Biosystems, Cat.No. 4311320)
- Plasmid DNA to be sequenced in ddH2O or TE buffer
- Sequencing primers (Microsynth) as 5 mM solution in ddH2O
For sequencing of plasmid DNA the following components were mixed in one well of a 96
well optical reaction plate:
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x ml plasmid DNA (100 – 500 ng)
1 ml primer (equals 5 pmol)
4 ml Big Dye 1.1 Terminator Ready Reaction Mix
x ml molecular biology grade H2O (to a total reaction volume of 10 ml)
These reactions were run in a Primus 96 plus thermocycler with the following program:
Step 1 96°C, 2 min (initial denaturation of DNA)
Step 2 96°C, 30 sec (denaturation of DNA)
Step 3 50°C, 15 sec (annealing of primers)
Step 4 60°C, 4 min (elongation)
Return to step 2,  25 times
Step 5 4°C for storage until further processing
Prior to analysis the DNA needed to be precipitated from the sequencing reaction according
to the following protocol:
- per well 8 ml molecular biology grade H2O were added
- 32 ml 95% ethanol were added and the solution was gently mixed by pipetting up
and down 2 – 3 x
- the samples were incubated at room temperature for 15 min to allow precipitation
- the 96 well plates were then centrifuged for 45 min at 2'000 x g
- the supernatant was discarded by inverting the plate onto a papertowel
- 150 ml 70% ethanol were used to wash the barely visible pellets by pipetting up
and down 2 – 3 x
- another centrifugation at 2'000 x g for 10 min was performed to pellet the DNA
- the supernatant was discarded by inverting the plate onto a papertowel
- the DNA pellets were dried by placing the 96 well reaction plate inverted onto a
papertowel in the plate holder of the centrifuge and spinning at 700 x g for 1 min
- the pellets were resuspended in 20 ml diluted Hi-Di™ formamide for analysis (2
parts Hi-Di™ formamide + 1 part molecular biology grade H2O)
Analysis of the sequencing reactions was performed by capillary electrophoresis on an ABI
PRISM Genetic Analyzer 3700. Sequences were analysed using the MacVector software
package (version 7.2.2).
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2.8.4 Southern blot analysis of genomic DNA isolated from ES cells and tail biopsies
        (protocol courtesy of S.Arber, Biozentrum, University of Basel)
2.8.4.1 Isolation of genomic DNA from ES cells and mouse tail biopsies
Materials:
- Tail buffer: 100 mM Tris-HCl pH 8.5, 5 mM EDTA, 0.2 % SDS, 200 mM NaCl, 100
mg/ml Proteinase K (stock solution: 20 mg/ml Proteinase K in destilled water)
- Phenol:Chloroform:Isoamylalcohol (25:24:1, Sigma, Cat.No. P3803)
- 3 M sodium-acetate pH 5.2
- 100 % and 70 % ethanol (prepared with molecular biology grade water)
- Isopropanol
Lysates for the isolation of genomic DNA from ES cells were prepared by incubating a
confluent ES cell layer in a 10 cm tissue culture dish with 5 ml tail buffer o/n at 37 °C. Tail
biopsies were lysed o/n in 500 ml tail buffer at 55°C on a thermoshaker (600 rpm, Eppendorf).
500 ml of the lysates were then cleared by centrifugation in a table top centrifuge (20'000 x g,
5 min, RT) and the supernatant was transferred to a fresh 1.5 ml Eppendorf tube. An equal
volume of phenol:chloroform:isoamylalcohol was added to the tubes which were
subsequently vigorously shaken for 3 min at RT.  To allow phase separation tubes were spun
at 20'000 x g for 5 min at RT and the upper, aqueous phase was transferred to a fresh tube.
DNA was then precipitated as described in paragraph 2.8.3.2.
For PCR screening purposes genomic DNA was precipitated from ES cell lysates by
isopropanol. To that end, ES cells grown to confluency in 24-well plates were lysed with 500
ml tail buffer per well o/n at 37°C. The next day 300 ml isopropanol were added to each well
and the plates were incubated for 1 hr at RT on a shaking platform. Genomic DNA
precipitated as a clearly visible string under these conditions which was taken out with a
forceps, dipped 2 x into fresh 70 % ethanol for washing, briefly air-dried and finally
resuspended in 50 ml molecular biology grade water.
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2.8.4.2 Preparation of digoxigenin labeled DNA probes
Materials:
- 1 mM DIG DNA labeling mix (Roche Cat.No. 127 70 65)
- Taq DNA polymerase + corresponding 10 x PCR buffer (Pharmacia, Cat.No.
270799)
- Primer (50 mM solution in molecular biology grade water)
- T3 thermocycler (Biometra)
Digoxigenin labeled DNA probes for Southern blot analysis of genomic DNA were prepared
by PCR. As template for the PCR genomic fragments of the coronin-1 locus cloned in the
pBluescript SK(+) vector were used. PCR reactions were set up as follows:
x ml plasmid DNA (100 ng)
1 ml forward primer (equals 50 pmol)
1 ml reverse primer (equals 50 pmol)
5 ml 1 mM DIG DNA labeling mix
5 ml  10 x PCR buffer
0.5 ml Taq polymerase (5U/ml stock)
x ml molecular biology grade H2O (to a total reaction volume of 50 ml)
The PCR reactions were run on a T3 thermocyler using the following program:
Step 1 95°C, 5 min (initial denaturation of DNA)
Step 2 95°C, 45 sec (denaturation of DNA)
Step 3 58°C, 60 sec (annealing of primers)
Step 4 72°C, 2 min (elongation)
Return to step 2,  40 times
Step 5 72°C, 5 min (elongation of incomplete products)
Step 6 4°C for storage until further processing
PCR products were separated by electrophoresis on 1.5 % agarose gels and purified using
the gel extraction kit (as described in paragraph 2.8.3.5). The digoxigenin labeled probes
were stored in molecular biology grade water at –20°C until use.
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2.8.4.3 Digest of genomic DNA, gel electrophoresis and transfer to nylon membranes
Five to ten microgram genomic DNA were digested o/n at 37 °C with 60 U of restriction
enzyme in a total volume of 30 ml. DNA fragments were separated by electrophoresis on 0.8
% agarose gels at 60 V. Under UV light the position of the DNA molecular weight marker
bands was marked by cutting the gel with a syringe needle. In order to prepare the gel for
transfer to nylon membranes it was first incubated with 0.25 M HCl for 10 min and then two
times for 15 min with 0.4 M NaOH under agitation at RT. For transfer positively charged
nylon membranes (Roche, Cat. No. 1 209 272) were used. On a saran wrap 15 ml 0.4 M
NaOH were supplied, the DNA gel was inverted on the solution and covered with the nylon
membrane which has been soaked in destilled water and 0.4 M NaOH before hand. Finally 3
sheets of filter paper (type: 3MM Chr, Whatman) and a pile of paper towel (10 cm height)
was placed on the membrane. To promote close contact between the layers a plate and
weight were put on top of the sandwich. Transfer was performed o/n at RT.
2.8.4.4 Hybridization of the nylon membrane
After transfer the blot was disassembled, the position of the wells and the molecular weight
markers were marked on the membrane with a pen and the membrane was neutralized in
0.5 M Tris-HCl for 1 min. The membrane was dried between two filter papers (type: 3MM
Chr, Whatman) and crosslinked by UV light on both sides (AutoCrosslink function, UV
Stratalinker, Strategene). Prehybridization of the membrane was performed in hybridization
tubes in a hybridization oven with rotating wheel at 42°C for 1 hr using 15 ml of hybridization
solution (5 x SSC, 2 % (w/v) blocking reagent, 0.1 % (w/v) sarcosyl, 0.02 % SDS, 50 %
formamide in destilled water; blocking reagent for Southern blot was obtained from Roche,
Cat.No. 11 0961 76001).
For hybridization 100 ng digoxigenin labeled DNA probe were added to 10 ml hybridization
solution, denatured for 10 min at 68°C and filtered through a 0.2 mm syringe filter prior to
addition to the prehybridized membrane. Hybridization was performed o/n at 42°C in a
hybridization oven.
2.8.4.5 Detection of digoxigenin labeled DNA probes on the nylon membrane
After hybridization the membrane was subjected to the following stringency washing steps:
- 2 x 15 min at RT with 50 ml 2 x SSC, 0.1 % SDS (performed in trays on a rocking
platform)
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- 2 x 15 min at 68°C with 50 ml 0.2 x SSC, 0.1 % SDS (performed in hybridization
tubes and oven)
The membrane was then washed with DIG wash buffer (0.1 M maleic acid, 0.15 M NaCl, 0.3
%  Tween 20, pH 7.5) for 1 min in a tray under agitation. Subsequent blocking of the
membrane was performed with 20 ml 1 % (w/v) blocking solution (blocking reagent dissolved
in 0.1 M maleic acid, 0.15 M NaCl, pH 7.5) in hybridization tubes and oven at RT for 1 hr.
After blocking, the membrane was incubated with alkaline phosphatase labeled anti-
digoxigenin Fab fragments (anti-DIG-AP, Roche Cat.No. 1 093 274, diluted 1:20'000 in 1 %
blocking solution) for 30 min at RT in hybridization tubes. Following 2 x 15 min washing steps
in 100 ml DIG wash buffer at RT in trays under agitation the membrane was incubated for 2
min in CDP-Star detection buffer (0.1 M Tris-HCl, 0.1 M NaCl, pH 9.5). Detection of alkaline
phosphatase labeled anti-digoxigenin Fab fragments bound to the nylon membrane was
performed using the CDP-Star reagent (Roche, Cat.No. 1 759 051) diluted 1:100 in CDP-
Star detection buffer. The membrane was incubated with CDP-Star (2 ml) inverted on a layer
of Parafilm for 5 min at RT. For exposure to ECL film (Amersham) the membrane was
drained from excess liquid with a filter paper and mounted into an autoradiography cassette
between transparent plastic sheets.
2.8.5 Reverse transcriptase-PCR (RT-PCR)
2.8.5.1 Isolation of RNA from cell lines and murine tissue
Materials:
- Sterile filter tips (Rainin)
- Molecular biology grade water, fresh vial (Eppendorf, Cat.No. 0032 006 302)
- Isopropanol, chloroform and ethanol p.a. (to be used for RNA work only)
-  TriZOL reagent (Invitrogen Cat.No. 15596-026)
- Lysing matrix D: tubes containing beads to lyse tissue samples on the FastPrep
device (Qbiogen, Cat.No. 6913-100), in the following referred to as ‚lysis tubes’
- FastPrep FP120 device (Qbiogen)
After dissection, 50 –100 mg of murine tissue of interest were placed on ice into lysis tubes
which have been supplied with 1 ml TriZOL reagent. Tissue homogenization was performed
at 4°C by running the lysis tubes for 2 x 45 sec at speed 6 in the FastPrep device. Lysates
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from cell lines were prepared by homogenizing 5 x 106 cells with a syringe and a 22G needle
(10 strokes) in 1 ml TriZOL reagent.
The resulting lysate was cleared by centrifugation (10'000 x g, 10 min, 4°C) and transferred
to a fresh 1.5 ml Eppendorf tube. After incubation at RT for 5 min 0.2 ml chloroform were
added to the lysate and tubes were vigorously shaken for 15 sec. An additional incubation
step at RT for 3 min followed by centrifugation at 12'000 x g (15 min, 4°C) allowed phase
separation. The upper aqueous phase was collected, transferred to a fresh 1.5 ml Eppendorf
tube and mixed with 0.5 ml isopropanol by inverting the tube to precipitate the RNA. The
RNA pellet was recovered after a 10 min incubation at RT and subsequent centrifugation
(12'000  x g, 10 min., 4°C). 75 % Ethanol was used to wash the RNA pellet twice
(centrifugation steps for washing: 7'500 x g, 5 min, 4°C). Finally, the RNA pellet was
dissolved in molecular biology grade water by gentle pipetting before and after heating the
sample to 55°C for 10 min.
The concentration and quality of the isolated  RNA was determined using a RNA NanoChip
and the corresponding 2100 BioAnalyzer instrument according to the manufacturer’s protocol
(AGILENT Technologies).
2.8.5.2 DNAse I treatment and reverse transcription
Materials:
- DNA-free kit (Ambion, Cat.No. 1906): contains DNAse I and appropriate buffer
- PCR nucleotide mix (Roche, Cat.No. 11 581 295 001)
- Random primers at 0.5 mg/ml (Promega, Cat.No. C 1181 )
- SuperScript III (Invitrogen, Cat.No. 18080-044): reverse transcriptase +
corresponding buffers
- rRNAsin (40 U/ml, Promega, Cat.No. N 251 A ): RNAse inhibitor
- 0.1 M DTT (supplied with SuperScript III)
- T3 thermocycler (Biometra)
In order to remove DNA contamination from the RNA preparation 10 mg purified RNA were
treated with DNAse I according to the following protocol:
- in a total reaction volume of 50 ml 10 mg RNA were mixed with 1x DNAse I buffer
and 2 ml DNAse I (corresponds to 4U)
- samples were incubated for 1 hr at 37°C in a waterbath
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- 10 ml inactivation reagent (supplied with the DNA-free kit) were added, the sample
was mixed by pipetting and incubated for 2 min at RT
- after centrifugation at 10'000 x g for 1 min the supernatant was transferred to a
fresh 1.5 ml Eppendorf tube and incubated for 3 min at 90°C for full DNAse I
inactivation
- prior to reverse transcription RNA concentration and integrity was checked on a
RNA NanoChip as described in paragraph 2.8.5.1
Reverse transcription of DNAse I treated RNA was performed using random hexanucleotide
primers. The reverse transcription reactions were set up in two steps according to the
following scheme:
STEP 1: in a PCR tube were first combined:
1 ml random primers (stock concentration: 0.5 mg/ml)
x ml DNAse I treated RNA (corresponding to 2 mg RNA)
1 ml PCR nucleotide mix (dNTPs at 10 mM)
x ml molecular biology grade water (to a total volume of 13 ml)
 STEP 2: in a separate tube the following components were mixed:
4 ml 5 x first strand buffer (supplied with SuperScript III)
1 ml 0.1 M DTT
1 ml rRNAsin (corresponds to 40 U)
1 ml SuperScript III (as a control for amplification from contaminating
 DNA, samples were also prepared without SuperScript III)
Finally, the 7 ml from step 2 were added to the reagents from step 1, mixed by pipetting and
run on a T3 thermocycler with the following program for reverse transcription:
Step 1 25°C, 5 min (annealing of random primers)
Step 2 50°C, 1 hr (reverse transcription)
Step 3 70°C, 15 min (inactivation of reverse transcriptase)
Step 4   4°C, • (storage until further processing)
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2.8.5.3 PCR on reversely transcribed RNA
Materials:
- 10 mM PCR nucleotide mix (Roche Cat.No. 11 581 295 001)
- Taq DNA polymerase + corresponding 10 x PCR buffer (Pharmacia, Cat.No.
270799)
- Primer (10 mM solution in molecular biology grade water)
- T3 thermocycler (Biometra)
Reversely transcribed RNA was diluted 1:10 in molecular biology grade water and used for
the setup of PCR reactions as follows:
1 ml 1:10 diluted reversely transcribed RNA
0.5 ml forward primer
0.5 ml reverse primer
0.5 ml PCR nucleotide mix
2.5 ml 10 x PCR buffer
0.3 ml Taq polymerase
x ml molecular biology grade water (to a total reaction volume of 25 ml)
The PCR reactions were run on a T3 thermocycler with the program given below:
Step 1 95°C, 3 min (initial denaturation of DNA)
Step 2 95°C, 30 sec (denaturation of DNA)
Step 3 56°C, 30 sec (annealing of primers)
Step 4 72°C, 1 min (elongation)
Return to step 2,  35 times
Step 5 72°C, 10 min (elongation of incomplete products)
Step 6 4°C for storage until further processing
10 ml of the samples were then run on 1.8 % agarose gels to analyze them for the presence
of coronin and control transcripts.
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2.9 Cell culture methods
2.9.1 Determination of cell numbers
Cell counting was performed using a Neubauer counting chamber (0.1 mm depth). An aliquot
of the cell suspension was diluted 1:10 in trypan blue solution (0.1%, Sigma) to distinguish
living from dead cells. Living and therefore colourless cells present in the 4 outer squares
were counted and the cell number per ml was calculated by dividing the result by 4 and
subsequently multiplying it with 1x104.
2.9.2 Preparation of L929-conditioned medium
In order to condition cell culture medium 107 L929 cells were plated out in 100 ml L929
medium in 15 cm cell culture dishes (BD Falcon). After seven days in culture at 37°C, 5%
CO2 the medium was harvested, filtersterilized (0.22 mm) and stored at 4°C until further use.
New medium was added to the dish and the procedure was repeated 3 times before the cells
were discarded.
2.9.3 Preparation of bone marrow-derived macrophages
Bone marrow-derived macrophages (BMM) were obtained by differentiation of bone marrow
cells in the following medium (referred to as ‚BMM-culture medium’): DMEM / 10% FCS /
2mM glutamine / 50mM b-mercaptoethanol / 30% L929-conditioned medium. Bone marrow
cell suspensions were prepared from 6 – 8 week old, female C57Bl/6 mice (RCC,
Füllinsdorf). Mice were sacrified by CO2 asphyxiation, their hind legs were isolated and freed
from all muscle tissue. Subsequently, the femura were cut open at the upper most part and
placed in a blunt-ended yellow pipette tip with the open end of the femur pointing
downwards. The loaded pipette tip was placed in a 5 ml polystyrene tube (BD Falcon,
Cat.No. 352063) supplied with 500 ml BMM-culture medium. Centrifugation (7 min, 800 x g,
RT) allowed retrieval of the bone marrow cells into a pellet which was subsequently
resuspended. The resulting cell suspension was added to 10 cm Teflon dishes (one plate per
femur) with 15 ml BMM-culture medium. Cells were cultured for at least 5 days to allow their
differentation into BMM at 37°C, 5% CO2. BMM were used for experiments at day 6. Their
identity was assessed by microscopy looking at typical macrophage morphology and by flow
cytometry analysing the expression of macrophage markers such as CD11b and F4/80.
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2.9.4 Preparation of single cell suspensions from murine tissue
In order to obtain single cell suspensions of spleen, thymus or lymph nodes mice were
sacrified by CO2 asphyxiation. The dissected organs were placed in a tissue culture dish
containing 10 ml DMEM / 10 % FCS / 2 mM glutamine and mashed between two nylon nets
with a syringe plunger. Single cell suspensions of bone marrow were prepared by flushing
isolated hind leg femura with a syringe and a needle (22 Gauge) loaded with 2 ml DMEM / 10
% FCS / 2 mM glutamine. To ensure full dissociation of the tissue the homogenate was
passed 2 – 3 times through and collected with a Gilson P1000 (blue pipette tip) and
eventually transferred to a 15 ml polystyrene tube (BD Falcon, Cat.No. 352095). After
centrifugation at 300 x g for 5 min at 4°C the pellet was resuspended with several gentle
pipetting strokes (Gilson P1000) in an appropriate volume of DMEM / 10 % FCS / 2 mM
glutamine for further processing.
2.9.5 MACS-based isolation of murine T-lymphocytes
Materials:
- Cell culture medium (e.g. the medium used for mixed lymphocyte reactions as
described in paragraph 2.9.6)
- Pan T-cell isolation kit (Miltenyi, Cat.No. 130-090-861): contains the cocktail of
biotin-labeled antibodies and streptavidin-coated magnetic microbeads. Both
solutions are ready for use.
- MACS LS Separation Columns (Miltenyi, Cat.No. 130-042-401)
- ACK erythrocyte lysis buffer
- MACS buffer: PBS / 0.5 % (w/v) BSA / 2mM EDTA
T-lymphocytes were isolated from splenic cell suspensions using magnet assisted cell
sorting (MACS). The principle of this method relies on the incubation of a splenic cell
suspension with biotin-labeled antibodies directed against B-lymphocytes and
myeloid/erythroid cells. Following an incubation with streptavidin coated magnetic beads, the
labeled cell suspension is run over a column placed in a magentic field which allows
collection of non-labeled T-lymphocytes in the flow-through whereas the labeled fraction of
the cell suspension remains bound to the column (i.e. negative selection of T-lymphocytes).
As described in paragraph 2.9.4 single cell suspensions were prepared from isolated spleen
and transferred to 50 ml polypropylene tubes (BD Falcon, Cat.No. 352070). Cells were
pelleted by centrifugation (300 x g, 5 min, RT), resuspended in ACK erythrocyte lysis buffer
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(5 ml per spleen) and incubated at RT for 5 min with slight, occasional agitation. To quench
the lysis buffer culture medium was added to a total volume of 30 ml and cells were
harvested by centrifugation. Cells were resuspended in 10 ml culture medium, counted and
pelleted again by centrifugation. The resulting pellet was then taken up in 40 ml cold MACS
buffer per 107 cells and 10 ml of biotin-labeled antibody cocktail were added per 107 cells.
The cell suspension was mixed by swirling the tube and incubated at 4 – 8°C (fridge !) for 10
min. After incubation, 30 ml cold MACS-buffer and 20 ml streptavidin-coated microbeads per
107 cells were added to the suspension, samples were mixed by swirling the tube and
incubated for 15 min in the fridge. In order to wash away excess antibodies and microbeads
the sample volume was then brought to a total volume of 20 ml with cold MACS buffer and
the cells were harvested by centrifugation (300 x g, 10 min, 4°C). The supernatant was
removed completely, the cells were resuspended in 1.2 ml cold MACS buffer and filtered
through a syringe equipped with parachute silk to remove cell clumps. For magnetic
separation at RT a MACS LS separation column was installed into the magnetic holder and
equilibrated by running 3 ml MACS buffer through the column. Subsequently, the cell
suspension was loaded onto the column and allowed to flow through. The flow through from
the loading and the three following washing steps (each with 3 ml MACS buffer) was
collected in a 15 ml polystyrene tube (BD Falcon) on ice. Cells were finally pelleted by
centrifugation (300 x g, 10 min, 4°C), resuspended in culture medium, counted and checked
by FACS staining for purity.
2.9.6 Mixed lymphocyte reaction
Splenic T-lymphocytes were isolated from homozygous coronin-1 knock-out mice and
wildtype littermates using magnetic bead isolation as described in paragraph 2.9.5. For
allogeneic stimulation of T-lymphocytes spleen cell suspensions were isolated from BALB/c
mice (RCC) and treated with 50 mg/ml Mitomycin C (Sigma) in PBS for 30 min at 37°C after
erythrocyte lysis. Cocultures of responding T-lymphocytes (2x105) and either 2x105 (1:1 ratio)
or 4x105 (2:1 ratio) stimulating spleen cells were set up in flat-bottom 96-well plates (BD
Falcon) using the following medium: RPMI-1640 (Gibco BRL) / 1x MEM non-essential amino
acids (Gibco BRL) / 1 mM sodium pyruvate (Gibco BRL) / 100 U/ml Penicillin (Sigma) / 100
mg/ml  Streptomycin (Sigma) / 10 mM b-Mercaptoethanol (Gibco BRL) / 10% FCS (Gibco
BRL). After 3 days incubation at 37°C / 6% CO2 and 20 hours before harvesting, 1 mCi [
3H]-
thymidine (Amersham) was added to each well. Incorporation of the isotope was measured
in a liquid scintillation counter (Packard TopCount) and expressed as the average cpm (±
SD) per well of triplicate cultures.
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2.10 Generation and maintenance of coronin-1 deficient mice
2.10.1 ES cell culture, transfection and selection
The culture and manipulation of murine ES cells for the generation of coronin-1 deficient
mice was performed in the tissue culture facility of the transgenic mouse core facility (TMCF)
at the Biozentrum. The ES cell strain used (E14.1, supplier: TMCF, Biozentrum) was
originally isolated from blastocysts of Sv129/Ola background. In contrast to other protocols
ES cell culture procedures at the TMCF were carried out in the absence of a layer of mouse
embryonic fibroblasts as feeder cells. This required special care in handling ES cells in order
to keep them in the undifferentiated stage necessary for successful germline transmission.
In the following, general ES culture procedures will be intoduced (paragraph 2.10.1.1) before
the scheme of ES cell transfection and selection will be described in more detail (paragraph
2.10.1.2 and 2.10.1.3).
2.10.1.1 ES cell culture: general methods
Preparation of complete ES cell medium:
Materials:
- DMEM 500 ml (PAN Biotech)
- MEM non-essential amino acids (100x stock, Gibco BRL)
- Glutamine (100x stock, Gibco BRL)
- Sodium pyruvate (100x stock, Gibco BRL)
- 50 mM b-mercaptoethanol for cell culture purposes (Gibco BRL)
- Murine recombinant LIF (ESGRO, 1x106 units/ml, Gibco BRL)
- ES culture qualified FCS (HyClone)
- 10x G418 stock (concentration: 3 mg/ml, Sigma) in complete ES cell medium
To prepare complete ES cell medium the following components were mixed
500 ml DMEM
 5.2 ml 100x Non-essential amino acids
 5.2 ml 100x Glutamine
 5.2 ml 100x Sodium pyruvate
520 ml  50 mM b-mercaptoethanol
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  60 ml  murine recombinant LIF
  52 ml FCS
For the selection of ES cells after transfection complete ES cell medium containing G418 at a
final concentration of 300 mg/ml was prepared freshly before use by mixing complete ES cell
medium with an appropriate amount of 10x G418 stock.
Preparation of culture dishes:
Materials:
- 10 cm tissue culture dishes (BD Falcon)
- 6-well tissue culture dishes (BD Falcon)
- 24-well tissue culture dishes (BD Falcon)
- 96-well tissue culture dishes (BD Falcon)
- 0.1 % (w/v) gelatine (Sigma) solution
All tissue culture dishes were gelatinized before adding ES cells by incubating tissue cultures
plates with an appropriate amount of 0.1 % gelatine for 5 min at RT followed by aspiration of
the solution.
Passaging of ES cells:
Materials:
- Prewarmed PBS (PAN Biotech)
- Trypsin-EDTA in HBSS (Gibco BRL)
- Prewarmed complete ES cell medium
Confluent ES cell culture were passaged by aspirating the medium, washing the cells once
with prewarmed PBS and incubation with Trypsin-EDTA (2 ml per 10 cm dish, 500 ml per well
of a 6-well plate, 100 ml  per well of a 24-well plate, 20 ml per well of a 96-well plate) at 37 °C
until the cell layer lost contact to the substrate (this usually took 0.5 - 5 min). Incubation with
Trypsin-EDTA was kept as short as possible to avoid damage of ES cells after prolonged
contact to trypsin and was supported by agitation of the culture dish. Cells were collected
from the culture dish by adding an excess of prewarmed complete ES cell medium (4 x the
volume of trypsin-EDTA), dissociated by gentle pipetting and transferred to 15 ml polystyrene
____________________________________________________MATERIALS AND METHODS
67
tubes (BD Falcon, Cat No. 352095). ES cells were then pelleted by centrifugation (300 x g, 3
min, RT) and resuspended in complete ES cell medium. Cells were seeded onto new
gelatinized culture dishes. Trypsinized cultures in 96-well plates were quenched by adding
per well 200 ml of a prewarmed 1:1 mixture of complete ES cell medium and FCS. Cells were
then seeded into a new, gelatinized 24-well plate (100 m l cell suspension + 900 m l
prewarmed, complete ES cell medium per well). To avoid any harmful effect of trypsin the
medium was exchanged after 4 hrs. Generally, ES cells were cultured in a cell culture
incubator at 37°C / 6 % CO2.
 Thawing and freezing cells in 96-well plates and cryovials:
Materials:
- 2 ml cryogenic vials (NUNC)
- 2x freezing mix (20% DMSO (Fluka) in complete ES cell medium)
At multiple steps of the selection process ES cells were frozen. Picked ES cells clones were
first grown in 96-well plates until confluency, then trypsinized as described above and 100 ml
were transferred in one well of a 24-well plate. After expansion in these 24-well plates the ES
cells were used for the preparation of genomic DNA.  The remaining 100 ml cell suspension
were mixed by gentle pipetting with 100 ml 2x freezing mix and the whole 96-well plate was
transferred to a –80°C freezer. Positive ES cell clones frozen in 96-well plates were taken in
culture by thawing the plate at 37°C in the cell culture incubator. The cell suspension of one
well was then transferred as passage 1 to one well of a 24-well plate containing 2 ml of
prewarmed, complete ES cell medium. To avoid any harmful effects of residual DMSO the
medium was exchanged after o/n incubation at 37°C / 6% CO2.
Passage 1 cells were split 1:6 into 6 wells of a new 24-well plate as passage 2, grown to
confluency and trypsinized as described above. The resulting cells suspensions out of 6
wells of passage 2 cells were then pooled, pelleted by centrifugation and resuspended in 2.5
ml complete ES medium. Of this suspension 1 x 0.1 ml were transferred for DNA preparation
into one well of a new 24-well plate containing 900 ml prewarmed, complete ES cell medium,
1x 0.5 ml together with 1.5 ml prewarmed, complete ES medium were added per well of a
new 6-well plate (=passage 3) and 4x 0.5 ml were transferred to cryogenic vials. The cell
suspensions for freezing were mixed with 2x freezing mix, frozen at –80°C and finally
transferred to liquid nitrogen for long-term storage.
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Passage 3 cells from one well of a 6-well plate were splitted as described above into 5 wells
of a new 6-well plate resulting in passage 4. As soon as passage 4 was grown to confluency
cells of these 5 wells were trypsinized, pooled and resuspended in 2 ml ES cell medium. 4x
0.5 ml cell suspension were then frozen as described above for passage 2 cells.
Cells frozen in cryogenic vials were thawed in a waterbath at 37°C then transferred to a 15
ml polystyrene tube (BD Falcon, Cat.No. 352095) containing 10 ml of prewarmed, complete
ES cell medium, pelleted by centrifugation and resuspended in prewarmed, complete ES cell
medium for seeding onto new culture dishes.
2.10.1.2 ES cell transfection and selection
Electroporation with the linearized targeting construct:
100 mg of the targeting vector were digested o/n at 37°C with 400 U ClaI (NEB) in a total
digest volume of 200 ml. After having confirmed linearization on an agarose gel, the plasmid
DNA was precipitated from the digestion reaction as described in paragraph 2.8.3.2. After the
last 70% Ethanol washing step the DNA pellet was air-dried under sterile conditions and
resuspended in sterile PBS to a final concentration of 30mg/100ml. ES cells were trypsinized
and resuspended in sterile PBS to a final density of 1x108 cells/ml. 1 ml ES cell suspension
was mixed with 100 ml of above mentioned DNA solution (i.e. 30 mg DNA per 1x108 ES cells)
and transferred to an electroporation cuvette (4 mm gap, Biorad). Following an incubation of
the cuvette on ice for 10 min cells were electroporated in a GenePulser II electroporator
(Biorad) under the following conditions: 0.8 kV, 3 mFd, time constant: 0.08. After
electroporation the cuvette was incubated for another 10 min on ice and subsequently the
cells were added to 8 ml prewarmed complete ES cell medium. The resulting 9 ml cell
suspension were seeded according to the following scheme onto a total of 20 gelatinized 10
cm culture dishes containing each 10 ml complete ES cell medium:
4x 1ml seeded on 4 x 10 cm dishes (= 1 ml aliquots)
4ml new medium added to the remaining 5ml cell suspension, then:
4x 1 ml seeded on 4 x 10 cm dishes (= 0.5 ml aliquots)
4ml new medium added to the remaining 5ml cell suspension, then:
4x 1 ml seeded on 4 x 10 cm dishes (=0.25 ml aliquots)
4 ml new medium added to the remaining 5 ml cell suspension, then:
8x 1 ml seeded on 8 x 10 cm dishes (=0.125 ml aliquots)
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This seeding scheme served the purpose of having plates with the optimal density of clones
independently of the transfection efficiency. Cells were incubated o/n at 37°C / 6 % CO2. The
next morning the medium was exchanged by complete ES cell medium. Only 24 hrs after
electroporation the selection with 300 mg/ml G418 was started. Regular medium changes
were then performed every 2-3 days until the appearance of the first clones. 8 –12 days after
transfection clones were picked into 96-well plates.
Further processing and expansion of picked ES cell clones:
ES cell clones initially picked in 96-well plates were grown in these plates until confluency.
As described in paragraph 2.10.1.1, the cells were then on one hand frozen in these 96-well
plates and on the other hand splitted to 24-well plates. ES cell clones in 24-well plates were
grown until confluency and then used for the preparation of genomic DNA as described in
paragraph 2.8.4.1. Positive ES cell clones were selectively thawed from the original 96-well
plate and expanded over four passages as described in paragraph 2.10.1.1.
2.10.1.3 PCR based screening of ES cell clones
Materials:
- 10 mM PCR nucleotide mix (Roche Cat.No. 11 581 295 001)
- Taq DNA polymerase + corresponding 10 x PCR buffer (Pharmacia, Cat.No.
270799)
- Forward primer  PSC1 (10 mM solution in molecular biology grade water)
- Reverse primer  PSC2 (10 mM solution in molecular biology grade water)
- T3 thermocycler (Biometra)
ES cell clones were screened for integration of the targeting construct first by PCR in pools
of five. Primers used for the PCR were designed to give a 2.5 kb product only if the targeting
vector has integrated in the coronin-1 locus. Pools giving the expected PCR product were
then split up and the positive clones within a pool were identified by PCR and confirmed by
subsequent Southern blot analysis. The genomic DNA pool was made by mixing 1 ml
genomic DNA of each of the five ES cell clones. PCR reactions were set up and run on a T3
thermocycler as follows:
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  1 ml genomic DNA pool
  2 ml 10x PCR buffer
 0.4 ml 10mM PCR nucleotide mix
 0.4 ml 10 mM forward primer PSC1
 0.4 ml  10 mM reverse primer PSC2
 0.2 ml  Taq polymerase (5U/ml stock)
15.6 ml  molecular biology grade water
PCR program:
Step 1 96°C, 5 min (initial denaturation of DNA)
Step 2 95°C, 30 sec (denaturation of DNA)
Step 3 51°C, 30 sec (annealing of primers)
Step 4 72°C, 2 min (elongation)
Return to step 2,  40 times
Step 5 72°C, 10 min (elongation of incomplete products)
Step 6 4°C, • (storage until further processing)
The PCR reactions were mixed with 4 ml 6x DNA loading buffer and 10 ml were loaded onto a
0.8 % agarose gel for the visualization of PCR products.
2.10.2 Blastocyst injection and generation of chimaeric animals
Identified and confirmed positive ES cell clones were expanded from passage 2 frozen
stocks by Daniela Nebenius-Oosthuizen in the TMCF and used for injection into blastocysts
derived from a cross of a C57Bl/6 female with a BDF-1 male. Injected blastocysts were then
transferred into pseudo-pregnant NMRI foster mothers. The offspring was checked for coat
colour chimaerism. Since the injected ES cell clones were of Sv129/Ola background they
carried a dominant agouti allele that was lacking in the C57Bl/6 x BDF-1 blastocysts. Highly
chimaeric animals were therefore identified by a high degree of agouti (brown) coat colour.
Only highly chimaeric animals were used for further crosses to C57Bl/6 females to check for
germline transmission of the coronin-1 K.O. transgene by PCR.
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2.10.3 Breeding of mice and backcrosses
Mice were kept under special pathogen free (SPF) conditions in the mouse facility of the
Biozentrum of the University of Basel. C57Bl/6 mice were obtained from RCC (Füllinsdorf,
Switzerland).
In order to bring the coronin-1 K.O. allele into the defined C57Bl/6 inbred background male
mice heterozygous for the coronin-1 K.O. allele were crossed to C57Bl/6 females (RCC,
Füllinsdorf, Switzerland). The offspring was genotyped by PCR and male, heterozygous
animals were again crossed to C57Bl/6 females. This procedure is referred to as
backcrossing and is currently going on. For the experiments presented in this thesis
homozygous coronin-1 K.O. and wildtype littermates were used which originated from
breedings of backcross 3 heterozygous male and female coronin-1 K.O. mice.
2.10.4 PCR based genotyping of coronin-1 deficient mice
Materials:
- Tail buffer: 100 mM Tris-HCl pH 8.5, 5 mM EDTA, 0.2 % SDS, 200 mM NaCl, 100
mg/ml Proteinase K
- 10 mM PCR nucleotide mix (Roche Cat.No. 11 581 295 001)
- Taq DNA polymerase + corresponding 10 x PCR buffer (Pharmacia, Cat.No.
270799)
- Forward primer WTCor1 (10 mM solution in molecular biology grade water)
- Reverse primer WTCor2 (8 mM solution in molecular biology grade water)
- Reverse primer KOCor1 (8 mM solution in molecular biology grade water)
- T3 thermocycler (Biometra)
For routine genotyping of coronin-1 K.O. mice a PCR was performed using three primers
simultaneously. The forward primer WTCor1 and the reverse primer WTCor2 were used for
the detection of the wildtype allele by amplifying a 392 bp product whereas the forward
primer WTCor1 together with the reverse primer KOCor1 led to the amplification of a 478 bp
product specific for the K.O. allele. PCR reactions were performed using diluted tail biopsie
lysates as a template. To do so, tail biopsies (5-8 mm in size) were digested in 500 ml tail
buffer o/n at 55°C on a thermoshaker (600 rpm, Eppendorf) and subsequently cleared by
centrifugation (20'000 x g, 5 min, RT). For dilution 10 ml tail lysate were then added to 100 ml
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molecular biology grade water. PCR reactions were set up and run on a T3 thermocycler as
follows:
1 ml diluted lysate
2 ml 10x PCR buffer
0.4 ml 10mM PCR nucleotide mix
0.4 ml 10 mM forward primer WTCor1
0.4 ml  8 mM reverse primer WTCor2
0.4 ml  8 ml reverse primer KOCor1
0.2 ml  Taq polymerase (5U/ml stock)
15.2 ml  molecular biology grade water
PCR program:
Step 1 96°C, 5 min (initial denaturation of DNA)
Step 2 95°C, 30 sec (denaturation of DNA)
Step 3 56°C, 30 sec (annealing of primers)
Step 4 72°C, 45 sec (elongation)
Return to step 2, 35 times
Step 5 72°C, 10 min (elongation of incomplete products)
Step 6 4°C, • (storage until further processing)
The PCR reactions were mixed with 4 ml 6x DNA loading buffer and 10 ml were loaded onto a
1.8 % agarose gel for the visualization of PCR products.
2.11 Flow cytometry based techniques
2.11.1 Staining of cells for flow cytometric (FACS) analysis
For FACS staining single cell suspensions were prepared as described in paragraph 2.9.4
and adjusted to contain 10 – 20 x 106 cell/ml. Antibodies used for staining were either directly
labeled with fluorescent dyes or were coupled to biotin and detected in a second staining
step with fluorescently labeled streptavidin. The appropriate dilution for the antibodies was
determined before hand by titration. Commercial antibodies were mostly used at a dilution of
1:200 (see table 2.6 Antibodies). Staining, washing and analysis of the cells was performed
in PBS / 2 % FCS (referred to as FACS buffer).
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In 96-well V-bottom plates (Corning Costar) 200 ml of antibody solution in FACS buffer were
provided per well and 50 ml single cell suspensions were added. Samples were then mixed
by pipetting and incubated on ice in the dark for 30 min. As a first washing step after
incubation 100 ml FACS buffer were added, cells were pelleted by centrifugation (300 x g,
4°C, 3 min) and the supernatant was discarded by rapidly inverting the plate and draining off
excess liquid from the inverted plate with a paper towel. Cells were resuspended in the
remaining drop of FACS buffer by vortexing the 96-well plate. Subsequently, the cells were
washed additional two times with 200 m l FACS buffer. The cells were then either
resuspended in 200 ml FACS buffer for analysis or in 200 ml 1:400 diluted fluorescently
labeled streptavidin. Incubation with streptavidin was performed on ice in the dark for 15 min
and cells were washed two times in 200 ml FACS buffer prior to analysis.
For intracellular coronin-1 staining, cells were stained for surface markers as described
above, then resuspended in 100 ml PBS and fixed by adding 100 ml of 3 % paraformaldehyde
in PBS. Incubation with paraformaldehyde was performed for 1 hr on ice and cells were
subsequently washed two times with PBS / 2% (w/v) BSA / 0.2 % saponin for quenching of
paraformaldehyde and permeabilization. AlexaFluor‚633 labeled anti-coronin-1 IgGs were
diluted 1:250 in PBS /  2% (w/v) BSA / 0.2 % saponin. Cells were incubated with this solution
(200 ml per well) for 30 min on ice in the dark, then washed two times in 200 ml PBS / 2%
(w/v) BSA / 0.2 % saponin and resuspended in 200 ml FACS buffer for analysis.
For all stainings negative (no staining or second step reagent only), background stainings
(AlexaFluor‚633 labeled anti-coronin-1 preimmune IgGs) and single stained compensation
controls were always included. Flow cytometric analysis was carried out on a FACSCalibur
(Becton Dickinson) and data were analyzed with the FlowJo software (version 4.3.2).
2.11.2 Collection and flow cytometric analysis of peripheral blood
Materials:
- Microvette‚ blood collection tubes (Sarstedt, Cat.No. 20.1288)
- Ketalar (50 mg Ketamine/ml, Parke-Davis)
- Rompun (23 mg/ml Xylazine/ml, Bayer Healthcare)
- Liquemine‚ (Heparin solution at 5'000 U/ml, Roche)
- ACK erythrocyte lysis buffer
- 0.9 % physiological NaCl solution (Bichsel, Interlaken, Switzerland)
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Peripheral blood for flow cytometric analysis was collected in two ways: either by bleeding of
mice via the tail vein which keeps the animals alive (referred to as tail blood, 200 – 300 ml
collection volume, for small scale analysis) or by bleeding out anaesthesized mice to collect
large amounts of peripheral blood for the preparation of peripheral blood lymphocytes
(PBLs).
Tail blood was collected in blood collection tubes after cutting the tail vein with a clean
scalpell. The collected volume of tail blood was then determined with a Gilson P200 (yellow
pipette tip). After addition of 200 ml 0.9 % physiological NaCl solution, samples were mixed
by pipetting and analyzed on a fully-automated ADVIA 120 hematology system (Bayer) at the
Hämatologielabor, Kantonspital Basel. Blood cell counts were then corrected taken the initial
tail blood sample volume and dilution factors into account.
For the preparation of PBLs mice were anaethesized by peritoneal injection of 200 ml of the
following mix: 0.5 ml Ketalar / 0.25 ml Rompun / 2 ml 0.9 % physiological NaCl solution.
Peripheral blood was collected through the retro-orbital vene into 1.5 ml Eppendorf
containing 30 ml liquemine. In order to open the retro-orbital vene one eye of anaesthesized
mice was torn out with a forceps. The collected volume of peripheral blood (usually between
500 - 800 ml) was determined with a Gilson P1000 (blue pipette tip) pipette and then brought
to a total volume of 10 ml by adding PBS. Cells were pelleted by centrifugation (300 x g, 7
min, RT) and resuspended in 10 ml ACK erythrocyte lysis buffer. After incubation for 2 min at
RT with occasional agitation (inverting the tubes), 20 ml PBS / 2 % FCS were added and
cells were collected by centrifugation (300 x g, 5 min, RT). The resulting pellet was
resuspended in DMEM / 10 % FCS / 2 mM glutamine and total cell counts were determined.
PBLs prepared in this way were analysed by flow cytometry after staining as described in the
previous paragraph. Lymphocyte specific cell counts per ml of blood were calculated under
consideration of the sample volume by referring the percentage of a particular lymphocyte
subset (as determined by flow cytometry) to the total cell counts.
2.11.3 Analysis of apoptotic cells with Annexin V
Materials:
- Recombinant human Annexin V coupled to allophycocyanin (AV-APC, BD
Pharmingen, Cat.No. 550 474 )
- 10x Annexin V binding buffer: 0.1 M Hepes (pH 7.4), 1.4 M NaCl, 25 mM CaCl2
(always prepared freshly)
- 2 mg/ml propidium iodide (Sigma) in destilled water
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One hundred thousand (1x105) cells per well of a 96-well V-bottom plate were stained for
leukocyte surface markers as described in paragraph 2.11.1. Following antibody incubation
cells were washed two times with 200 ml ice-cold PBS and one time with 200 ml 1x Annexin
V-binding buffer (centrifugation steps: 300 x g, 3 min, 4°C). The cells were then resupended
by gentle pipetting in 100 ml Annexin V-binding buffer containing propidium iodide (diluted
1:30'000 from above mentioned stock). 3 ml AV-APC was added per well and the cells were
incubated 15 min at RT in the dark after gentle mixing of the suspension by pipetting. Cells
were then pelleted by centrifugation (300 x g, 3 min, 4°C) and resuspended in 200 ml 1x
Annexin V-binding buffer. Analysis was performed within one hour after staining on a BD
FACSCalibur flow cytometer. Whereas specific binding of Annexin V identified apoptotic
cells, cells positive for propidium iodide are considered to be necrotic.
2.11.4 Generation and analysis of mixed bone marrow chimaeras
Donor bone marrow cells were isolated from either Ly5.2 positive homozygous coronin-1
knock-out mice or from Ly5.1 positive C57Bl/6 mice. Bone marrow cells were harvested by
flushing isolated femurs and tibias with a syringe and needle using serum-free IMDM. Six
weeks old recipient C57Bl/6 mice (Ly5.2 positive) were irradiated with 950 rad and received
then 2 x 106 bone marrow cells comprising of a 1:1 mixture of Ly5.2+ coronin-1-/- and Ly5.1+
C57Bl/6 cells. As controls irradiated recipients also received 2 x 106 of either Ly5.2+ coronin-
1-/- or Ly5.1+ C57Bl/6 cells alone. Composition and origin of lymphoid cells in chimaeric mice
was analyzed six weeks later by flow cytometry employing antibody stainings specifically
detecting the Ly5.1 or Ly5.2 markers.
2.11.5 T-lymphocyte homing assay
In order to assess the capacity of coronin-1 deficient T-cells to survive in the periphery and to
home to lymph nodes of wildtype mice a T-lymphocyte homing assay was performed in
collaboration with Daniela Finke at the University of Basel. To that end, single cell
suspensions of spleen were prepared in PBS as described in paragraph 2.9.4 from either 6
weeks old coronin-1 deficient mice or as a control for the homing of wildtype T-cells from 6
weeks old C57Bl/6 mice transgenic for GFP under the control of the ubiquitin promotor (kind
gift of D. Finke, University of Basel). After having determined the percentage of CD4 and
CD8 positive cells by flow cytometry, the cell suspensions were adjusted with PBS to contain
an equivalent amount of CD4 and CD8 positive cells (8x106 CD4 and CD8 positive T-cells
per 200 ml PBS). Six weeks old recipient C57Bl/6 wildtype mice then received via tail vein
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injection 200 ml cell suspension. Four or twenty hours post injection the mice were sacrified
and peripheral blood lymphocytes (PBLs) as well as single cell suspensions of spleen,
inguinal and mesenteric lymphnodes were prepared. Flow cytometry using fluorophore-
labeled monoclonal antibodies directed against CD4 and CD8 allowed to determine the
percentage of GFP positive T-cells (this means injected T-cells) within a given cell
suspension.   
2.11.6 Assessing phagocytosis by flow cytometry
To study Fc-receptor mediated phagocytosis 10 ml of a 2% aqueous suspension of yellow-
green fluorescent polystyrene beads (Molecular Probes FluoSpheres beads) were washed
twice with PBS and then incubated for 1 hour at 37°C on a shaking thermoblock in 1 ml PBS
containing 50 mg/ml rabbit IgG (Cappel/ICN). After two additional washing steps in PBS, the
IgG-opsonized beads were resupended in 3 ml DMEM / 10% FCS / 2mM glutamine.
For complement receptor-mediated uptake Lactobacillus casei expressing GFP was treated
at an OD600 of 0.2 with 1:10 diluted fresh or heat-inactivated (56°C, 30 min) human serum in
PBS for 30 min at 37°C on a rotator. Serum treated bacilli were then washed twice in an
excess volume of PBS and resuspended in DMEM / 10% FCS / 2mM glutamine at an OD600
of 2. Bone marrow derived macrophages were seeded to 80 % confluency in 24-well cell
culture plates (BD Falcon) and shifted to 4°C followed by the addition of 250 ml per well of the
above mentioned suspensions of fluorescent beads or serum treated Lactobacilli. To allow
phagocytosis, cells were then incubated for 30 min at either 37°C or 4°C (cold control) and
subsequently washed five times with 1 ml PBS / 5% FCS on ice. Cells were harvested by
scraping and subjected to flow cytometry (FACSCalibur, Becton Dickinson) to determine
uptake of fluorescent cargo in the FL-1 channel.
Only living cells as assessed by the forward- and side-scatter profile were considered for the
analysis. Rate of uptake was measured as the increase in fluorescence as expressed by the
median fluorescence intensity.
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2.12 Microscopical techniques
2.12.1 Staining of cells for indirect immunofluorescence
Materials:
- Teflon-coated 10-well slides (Polyscience Inc., Cat.No. 18357)
- 20 x 55 mm cover slips (Menzel)
- Staining buffer: PBS / 2 % BSA (w/v) / 0.1 % (w/v) saponin
- Washing buffer: PBS / 0.1 % saponin (w/v)
- Q-tips (cotton swaps)
- Wet chamber (assembled from a slide archive box and wet paper towels)
- Slide jars (Glaswerk, Germany)
- FluoroGard Antifade Reagent (Biorad)
- Nail polish
- 3 % paraformaldehyde in PBS
Microscopes and associated software:
- Confocal laser scanning microscope: Axiovert 200M with the laser scanning
module LSM 510 Meta (Zeiss), LSM 510 software (version 3.2 SP2)
- Fluorescence microscope: Axiovert 100 TV (Zeiss), OpenLab software (version 2)
For the detection of intracellular membrane components and cytosolic proteins, cells were
stained with appropriate antibodies under permeabilizing conditions employing the mild
detergent saponin. Cells were either grown o/n on teflon-coated 10-well slides or adhered to
these slides to an approximate density of 10'000 cells/well. After aspiration of the medium,
cells were briefly washed by transferring the slide into a slide jar containing PBS. The cells
were then fixed in a slide jar containing 3 % paraformaldehyde in PBS for 10 min at 37°C.
For the complete removal and quenching of remaining paraformaldehyde after fixation cells
were washed 1x 5 min PBS / 1x 5 min PBS + 5 mM glycine / 1x 5 min PBS.
 Permeabilization and blocking was performed by incubating the slides first for 15 min in
washing buffer and then in staining buffer for 15 min at RT. Slides were placed in a wet
chamber, liquid around the wells was removed with Q-tips and 30 ml of primary antibody
solution or undiluted hybridoma supernatant was added to the wells. Primary antibodies were
diluted in staining buffer. Incubation with primary antibodies was carried out at RT for 30 – 60
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min depending on the affinity of the antibody. Following incubation with the primary antibody
slides were washed in slide jars at RT: 2x 5 min washing buffer / 1x 10 min staining buffer.
Slides were transferred back into the wet chamber, the space around the wells was dried
with Q-tips and the secondary antibodies or phalloidin coupled to appropriate fluorescent
dyes were added to the wells. Secondary antibodies and/or phalloidin were diluted in staining
buffer. Incubation with secondary antibodies and/or phalloidin was performed for 30 min at
RT with 30 ml antibody solution per well. Subsequently slides were washed 1x 5 min staining
buffer / 2x 5 min washing buffer/ 3x 5 min PBS. For mounting, slides were briefly dipped in
destilled water, then dried with Q-tips around each well and received a drop of Fluorogard
Antifade reagent on each well. A cover slip was placed on top, excess liquid was removed by
gently pressing the slides between two paper towels and finally slides were sealed with nail
polish. If not analyzed immediately slides were stored at 4°C in the dark to avoid bleaching of
the fluorophores.
2.12.2 Adherence of thymocytes on poly-L-lysine and antibody coated glass slides
Materials:
- Poly-L-lysine solution (stock obtained from Sigma, Cat.No. P8920, for use diluted
1:10 in destilled water)
- Anti-mouse-CD3 (clone 145-2C11, BD Pharmingen, Cat.No. 553057) and anti-
CD28 (clone 37.51, BD Pharmingen, Cat.No. 553294) antibody
- Teflon-coated 10-well slides (Polyscience Inc., Cat.No. 18357)
Teflon-coated 10-well slides were coated with poly-L-lysine for the adherence of cell
suspensions by adding 50 ml poly-L-lysine solution to each well. After incubation for 5 min at
RT, liquid was aspirated and the slides were dried at 60°C for 1 hr. Thymocyte cell
suspensions were prepared in PBS as described in paragraph 2.9.4 and 4x105 thymocyte in
50 ml PBS were added per well of poly-L-lysine coated slides. Slides were incubated on ice
for 20 min, then dipped in ice-cold PBS to remove non-adherent cells and fixed in 3 %
paraformaldehyde in PBS for 10 min at 37°C.
Antibody coated slides for the adherence of thymocytes were prepared as follows. Anti-
mouse-CD3 and –CD28 antibodies were diluted in PBS to a final concentration of 100 mg/ml.
Each well of teflon-coated 10-well slides received 10 ml of this antibody mix and slides were
subsequently incubated o/n at 37°C in a cell culture incubator. The next day, slides were
washed 3 times well by well and blocked with DMEM / 10 % FCS / 2mM glutamine for 30 min
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at 37°C. Thymocyte cell suspensions were prepared in DMEM / 10 % FCS / 2mM glutamine
and 4x105 thymocyte were incubated on antibody coated slides for 30 min in a cell culture
incubator at 37°C / 5% CO2. Following adherence slides were dipped in PBS to remove non-
adherent cells and fixed for staining with 3 % paraformaldehyde in PBS for 10 min at 37°C.
2.12.3 Activation of bone marrow derived macrophages (BMM)
Materials:
- Teflon-coated 10-well slides (Polyscience Inc., Cat.No. 18357)
- Culture medium: DMEM / 10 % FCS / 2 mM glutamine
- Phorbol-12-myristate-13-acetate (PMA, Sigma, 1 mM stock solution in DMSO)
- Recombinant mouse Interferon-g (BD Pharmingen, Cat.No. 554 587, 9.25 U/ml)
1x105 day 6 bone marrow derived macrophages (BMM) were allowed to adhere per well of
teflon-coated 10-well slides in DMEM / 10 % FCS / 2 mM glutamine for 2 hrs at 37°C / 5 %
CO2. After adherence the culture medium was replaced by normal culture medium (for
stimulation with PMA) or by culture medium containing 1000U/ml interferon-g. BMM were
incubated o/n  at 37°C / 5 % CO2. The next day, medium was replaced by culture medium
containing either 100nM PMA or 1000 U/ml interferon-g and the cells were incubated at 37°C
/ 5 % CO2 for additional 4 hrs. Finally, the slides were dipped in PBS and fixed in 3 %
paraformaldehyde in PBS (37°C, 10 min) for subsequent staining.
2.12.4 Immunohistological analysis of cryosections (courtesy of C. Blum and H.R.
Rodewald, University of Ulm, Germany)
Organs (spleen, thymus and lymph nodes) were embedded in OCT medium (Sakura
Finetek), snap-frozen and 5-µm sections were cut with a cryostat. Sections were air-dried,
acetone-fixed for 8 min and stored at –70°C. Sections were then rehydrated and blocked in
PBS / 2% (w/v) BSA with 0.1% NaN3. and  220 µg/ml mouse IgG (Jackson ImmunoResearch
Laboratories,). Antibodies, diluted in PBS / 2% (w/v) BSA, were added directly onto the
sections and incubated for 60 min at room temperature in a wet chamber. Antibodies used
were: Allophycocyanin (APC)-labeled anti-mouse CD4 (rat IgG2a, clone RM4-5) (Caltag
Laboratories), fluorescein isothiocyanate (FITC)-labeled anti-mouse CD8  (rat IgG2a, clone
53-6.7) (BD Biosciences), fluorescein isothiocyanate (FITC)-labeled anti-mouse B220 /
CD45R (rat IgG2a, clone RA3-6B2) (BD Biosciences), R-Phycoerythrin (PE)-labeled anti-
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mouse Thy1.2 / CD90.2 (mouse IgG2b, clone 5a-8) (Caltag Laboratories) and R-
Phycoerythrin (PE)-labeled anti-mouse I-Ab (mouse IgG2a, clone AF6-120.1) (BD
Biosciences). Sections were counterstained with DAPI (Serva) for 5 min. After washing the
sections were mounted in Fluoromount (Southern Biotechnology Associates). Images were
taken on a Zeiss Axioskop with ORCA ER camera (Hamamatsu) and images were
processed by using OPENLAB software (Improvision, Coventry, U.K.).
2.13 Biochemical methods
2.13.1 Preparation of total cell lysates from murine tissue
Materials:
- 1x lysis buffer
- Protease inhibitors (1x CLAAP, 1x PMSF)
Single cell suspensions were prepared as described in paragraph 2.9.4. One million (1x106)
cells were transferred to a 1.5 ml Eppendorf tube and washed three times in 1 ml ice-cold
PBS (centrifugation steps: 300 x g, 2 min, 4°C). After centrifugation the supernatant was
removed and the pellet was resuspended with several pipetting strokes in 10 pellet volumes
of 1x lysis buffer supplemented with protease inhibitors. The lysate was subsequently
cleared by centrifugation at 20'000 x g, 4°C for 10 min and the supernatant was transferred
to a new 1.5ml Eppendorf tube. The lysate was either further processed immediately or
stored after quick-freezing in liquid nitrogen at –80°C until use.
2.13.2 Determination of protein concentrations
Materials:
- Bradford reagent (Biorad)
- BCA reagent (Pierce)
- Standard protein solution at 1 mg/ml dissolved in dH2O (Biorad, Cat No. 500-
0005)
- 96-well flat bottom plates (Corning Costar)
- Microplate reader (Bucher) and corresponding software (SoftMax‚Pro, version
1.2.0)
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Protein concentrations were determined using the Bradford method (Bradford, 1976) or
alternatively the BCA method (Smith et al., 1985) if the protein solution of interest contained
detergents such as Triton X-100 or NP40.
Measurements were performed in 96-well flat bottom plates supplied with different volumes
of the sample (1 – 10 ml) and the standard protein solution (0, 1, 2, 3, 5, 7, 10 ml). 200 ml of
either 1x Bradford reagent or BCA solution (prepared according to the manufacturer’s
protocol) were then mixed with the samples by pipetting. After incubation for 5 min at RT in
case of the Bardford assay or 30 min at 37°C for the BCA assay samples were measured on
a microplate reader determining either the OD595 (Bradford) or the OD562 (BCA). Protein
concentrations were calculated from the resulting OD values using the standard curve and
taking sample volume and dilution factors into account.
2.13.3 SDS-PAGE using the Biorad Protean II minigel system
Materials:
- Protean II minigel system (Biorad)
- 5 x reducing sample buffer
- 10 x SDS-PAGE electrophoresis running buffer
- 30 % (w/v) acrylamide / 0.8 % (w/v) bisacrylamide in destilled water (filtered
through 0.2 mm filter and stored at 4°C)
- 2 M Tris-HCl, pH 8.8
- 0.5 M Tris-HCl, pH 6.8
- 10 % ammonium persulfate (APS) dissolved in destilled water (stored at 4°C)
- TEMED
- Biorad broad range SDS-PAGE standard
Using the casting station supplied with the Protean II minigel system two minigels (7 x 10 cm
in size, 0.75 mm thick) were prepared simultaneously using gel solutions as indicated in table
2. First the running gel was prepared and overlaid with isopropanol until complete
polymerization. After complete removal of the isopropanol layer the stacking gel was poured
on top of the running gel and an appropriate comb was inserted avoiding trapping of air
bubbles. Fully polymerized gels were mounted into the Protean II minigel running chamber,
SDS-PAGE electrophoresis running buffer was added and the comb was gently removed to
free the sample slots which were subsequently flushed with buffer. Protein samples of
interest were mixed with 5 x reducing sample buffer, heated to 95°C for 5 min and loaded
onto the gel after brief centrifugation (Eppendorf 5415D table top centrifuge, 13'000 rpm, 1
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min, RT). Empty slots were loaded with an equivalent amount of 1 x reducing sample buffer.
Gels were run at constant voltage (60 V for the stacking gel, 80 – 100 V for the running gel).
Table 7 Gel components required for the preparation of two minigels. Volumes in ml.
2.13.4 Coomassie staining of polyacrylamide gels
Materials:
- Staining solution (0.25 % (w/v) Coomassie Brilliant Blue R-250 in fixation solution)
- Fixation solution (10 % acetic acid, 45 % methanol in destilled H2O)
After SDS-PAGE, minigels were incubated in staining solution for 1 hr at RT under slight
agitation. Destaining and fixation was performed by incubation of stained gels in fixation
solution on a rocking platform. Fixation solution was exchanged several times. For
documentation fixed gels were transferred on a filter paper and dried under vacuum at 60°C
o/n.
2.13.5 Western blot analysis
2.13.5.1 Transfer of proteins after SDS-PAGE on nitrocellulose membranes
Materials:
- Semi-dry transfer cell (Biorad)
- Semi-dry transfer buffer
- Ponceau S solution (0.1 % in 5 % acetic acid, Sigma)
- Hybond C super nitrocellulose membrane (Amersham Bioscience)
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- Thin and thick filter paper, 7 x 10 cm in size (Whatman, type: 3MM Chr and
Schleicher&Schuell, type: GB002)
After SDS-PAGE, the gel, the membrane and the filter paper were soaked in semi-dry
transfer buffer. Using this components a sandwich was build up on the lower electrode
(=anode) of the semi-dry transfer cell in the following order: 1x thick filter paper, 1x thin filter
paper, nitrocellulose membrane, gel, 1x thin filter paper, 1x thick filter paper. Prior to fitting
the upper electrode (=cathode) air bubbles between the layers were removed by tightly
rolling a glass pipette over the sandwich. Transfer was performed for 36 min at 2.5 mA/cm3 =
0.17 A per minigel and appropriate voltage (usually between 12 and 25 V). To check the
effciency of the transfer the nitrocellulose membrane was incubated in Ponceau S solution
for 2 min at RT and subsequently rinsed with destilled water to visualize the protein bands.
The positions of the molecular weight marker bands were marked with a pen and the stained
membrane was digitalized as a reference using a desktop scanner (Hewlett-Packard, scanjet
8290).
2.13.5.2 Immunodetection
Prior to immunodetection Ponceau S stained nitrocelluose membranes were blocked by
incubation for at least 1 hr at RT or at 4°C o/n in 5% low fat milk powder in PBST
(PBST/milk) under agitation. The primary antibody was appropriately diluted in PBST/milk
and added as a drop (2 ml per 7 x 10 cm membrane) on a layer of Parafilm. Subsequently,
the blocked membrane was inverted on the drop of antibody solution avoiding the formation
of air bubbles and incubated for 30 – 60 min (depending on the affinity of the antibody) at RT.
After incubation with the primary antibody the membrane was washed extensively with
PBST/milk (6x 5 min, 100 ml per washing step) under agitation. Incubation with the
secondary HRP-labeled antibody (diluted 1:20'000 in PBST/milk) was performed for 30 min
at RT under agitation with 10 ml antibody solution per 7 x 10 cm membrane. Finally, the
membrane was washed 4 x 5 min with PBST/milk, 2 x 5 min with PBST and incubated with
ECL solution for 1 min at RT inverted on a layer of Parafilm. For exposure to ECL film the
membrane was drained from excess liquid with a filter paper and mounted into an
autoradiography cassette between transparent plastic sheets.
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2.13.6 Preparation of an IgG fraction from rabbit serum
Materials:
-     1 M Tris-HCl pH 8.0
- 100 mM Tris-HCl pH 8.0
-   10 mM Tris-HCl pH 8.0
- 100 mM glycine pH 3.0
- HiTrap‰ Protein A HP column (Amersham Cat.No. 17-0402-01)
- Slide-A-Lyzer 10'000 MWCO unit (Pierce, Cat.No. 66 425)
- Äkta P-920 FPLC system (Amersham)
IgGs of the rabbit anti-coronin-1 serum No. 1002 were affinity purified using a Protein A
column connected to an Äkta FPLC system. All solutions including the diluted starting
material were filtered through 0.2 mm filters to avoid clogging of the system. The whole
purification procedure was performed in a 4°C coldroom. As starting material, 2 ml serum
(No. 1002, third bleed or preimmune) were diluted in a 50 ml polypropylene tube (BD Falcon)
by adding 18 ml 100mM Tris-HCl pH 8.0.  Prior to loading on the column the FPLC system
as well as the column were washed with 30 ml 100 mM Tris-HCl pH 8.0 (0.5 ml/min). The
diluted serum was then run over the column three times at 0.3 ml/min. Subsequently, the
column was first washed with 30 ml 100 mM Tris-HCl pH8.0 and then with 30 ml 10 mM Tris-
HCl pH8.0 (0.5 ml/min). Elution of the IgGs from the column was performed at 0.2 ml/min
with 100 mM glycine pH 3.0. 500 ml fractions were collected into 1.5 ml Eppendorf tubes
containing 100 ml 1 M Tris-HCl pH 8.0 for the rapid neutralization of the fraction. Fractions
with the highest UV absorption were pooled (pool volume: 2 ml) and dialyzed o/n at 4°C
against 4 liters of PBS using a Slide-A-Lyzer 10'000 MWCO unit.
2.13.7 AlexaFluor‚633 labelling of rabbit IgGs
Materials:
- IgG fraction of serum 1002 (third bleed or preimmune serum) in PBS at a
concentration of 2 mg/ml
- AlexaFluor‚633 Protein labeling kit (Molecular Probes, Cat.No. A-20170) which
contains:
o AlexaFluor‚633 reactive dye in a vial with magnetic stirring bar
o 1 M sodium bicarbonate solution
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o Purification resin
o 10x elution buffer
o purification columns
Using the AlexaFluor‚633 protein labeling kit IgGs of the rabbit anti-coronin-1 serum No.1002
were labeled with the fluorescent dye AlexaFluor‚633 for intracellular FACS staining of
coronin-1. 0.5 ml IgG fraction (concentration 2 mg/ml) were mixed with 50 ml 1 M sodium
bicarbonate by briefly vortexing the tube and transferred to a vial containing the reactive
AlexaFluor‚633 dye and a magnetic stirring bar. The sample was then incubated on a
magnetic stirrer for 1 hr at RT in the dark. During incubation the gel filtration column was
prepared by packing the provided purification resin into the supplied purification column. The
sample was then loaded onto the column, allowed to enter the resin and 1x elution buffer (=
PBS / 2 mM NaN3) was added until elution was completed. While the sample was running
over the column two blue coloured bands formed: a faster running one which represented the
labeled IgGs and a slower running one which consisted of the non-coupled dye. The first
band was collected into 1.5 ml Eppendorf tubes. Coupling efficiency and concentration of the
AlexaFluor‚633 labeled IgGs was determined as described in the protocol of the
AlexaFluor‚633 protein labeling kit. Finally, the concentration of the AlexaFluor‚633 labeled
IgGs was adjusted to 1 mg/ml with 1x elution buffer and the samples were stored at 4°C until
use.
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3 RESULTS
3.1 Analysis of coronin expression
Coronin-1 has first been described in the slime mold Dictyostelium discoideum as an actin
binding protein localised to cell surface projections. Subsequently, coronin-like proteins have
been found in many species, from yeast to mammals. In mammalian organisms, the coronin
family of proteins consists of seven members (coronin 1 – 7) for which the degree of
homology ranges beyond 60% amino acid identity (reviewed in de Hostos, 1999, Rybakin
and Clemen, 2005). Expression of individual members of the coronin protein family has been
analysed by several authors but comprehensive expression data for all family members are
so far not available. We therefore analysed the expression of coronin 1 - 7 in murine tissues
by RT-PCR. Furthermore, coronin-1 expression in cells of the hematopoietic lineage was
analysed by flow cytometry. With respect to the generation and phenotypic analysis of
coronin-1 K.O. mice these expression data will be valuable in understanding a defect in
different cell types and will allow to assess to which extent a phenotype caused by coronin-1
deficiency could be masked by the expression of and potential functional redundancy
between members of the coronin protein family.
3.1.1 Analysis of the expression of coronin-1 - 7 in murine tissues and cell lines by RT-
PCR
Expression of the seven members of the coronin family of proteins in the mouse was
analysed by RT-PCR. For this purpose, specific primers have been either taken from
published data (for coronin 1 – 3: Okumura et al., 1998) or newly designed. Total RNA was
isolated from murine tissues or mouse cell lines, reversely transcribed and analysed for the
presence of coronin 1 - 7 transcripts by PCR. In order to allow a semi-quantitative
determination of coronin expression RT-PCR analysis of beta-actin or glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) transcripts was performed.
RT-PCR analysis of coronin expression in bone marrow, thymus and spleen revealed that all
members of the coronin family of proteins except coronin-4 are expressed (Fig.9). With
respect to the signal intensity obtained for beta-actin it can be concluded that in hemato- and
lymphopoietic tissues coronin-1, -2, -3 and -7 are prominently expressed, whereas coronin-5
and -6 are only present at low levels. For the analysis of the expression of coronin 1 - 7 in
neural tissues, reversely transcribed total RNA from the cerebellum and the diencephalon
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was used. Consistent with the restricted expression of coronin-1 in leukocytes only weak
expression in the brain was found (Fig.10). Of the other members of the coronin family
coronin-2 and -5 were found to be abundantly and coronin-3 and -7 weakly present in the
brain. Expression of coronin-4 and -6 could not be detected.
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In heart, skeletal muscle, kidney and liver (Fig.11) coronin-1 was found to be weakly
expressed which is probably due to the presence of blood cells in these tissues. The most
abundantly expressed members of the coronin family in these tissues were coronin-2 and -7.
Coronin-3 and -5 expression was detected but with tissue specific variations in its intensity.
Coronin-4 was absent as in all other tissues tested. Interestingly, coronin-6 showed a clearly
tissue-specific expression by being present in heart and muscle tissue but absent in kidney
and liver. To summarise, our results revealed that of the coronin family of proteins coronin-2,
-3 and -7 are cleary ubiquitously expressed in murine tissue. This is in accordance with
published data (for review see de Hostos, 1999, Rybakin and Clemen, 2005 and references
therein). Also Coronin-5 that was thus far described to be restricted in its expression to
nervous tissue (Nakamura et al., 1999) could be identified as being ubiquitously present.
Coronin-1, -4 and -6 can be considered as coronins with tissue-specific expression. It is
noteworthy that for coronin-4 and -6 any description of the gene product is thus far lacking.
The expression data for coronin-4 provided by Okumura et al., 1998 are not reliable since
our analysis of the published primer sequences revealed no sequence specificity for coronin-
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4. Coronin-6 has been only identified during a genome annotation project leaving the
question open whether a functional protein is expressed from this locus.
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Generation of antibodies directed against the members of the coronin family of proteins is
currently under progress. These antibodies will then allow to analyse coronin expression in
murine tissues at the level of the protein.
Currently available functional and biochemical data for coronin-1 were mainly obtained from
studies using murine primary cells and cell lines. In order to gain insight into the expression
of the seven coronin protein family members and therefore potential functional reduncancy in
murine primary cells and cell lines, coronin expression was analysed by RT-PCR in bone
marrow derived macrophages (BMM) and in the two murine macrophage-like cell lines J774
and RAW 264.7. As a respresentative for a non-leukocytic cell type, the murine fibroblast cell
line NIH3T3 was included in this analysis. All coronin family members except coronin-5 were
found to be expressed in murine macrophages (Fig.12 B-D). In NIH3T3 only expression of
coronin-2, -3 and -7 was detected (Fig.12 A). For the cell lines tested it can therefore be
concluded that coronin-1, together with coronin-4 and -6, is predominantly expressed in
leukocytes whereas coronin-2, -3 and -7 are ubiquitously present. Coronin-5 was absent
from all the cell types tested. In summary, the RT-PCR based analysis of the expression of
members of the coronin family of proteins confirmed the leukocyte-specific expression of
coronin-1. However, having established the presence of other coronin family members in
leukocytes a potential functional redundancy between the coronin famliy members should be
taken into account when analysing the phenotype of coronin-1 deficient leukocytes. In order
to gain insight into the expression of coronin-1 in distinct subset of cells originating from the
hematopoietic lineage, flow cytometric analysis was employed as described in the following.
3.1.2 Analysis of coronin-1 expression in leukocytes by flow cytometry
Coronin-1 expression was shown to be restricted to hemato- and lymphopoietic tissue
(Suzuki et al., 1995, Okumura et al., 1998, Ferrari et al., 1999, Nal et al., 2004). However, a
detailed analysis of coronin-1 expression in cells of the hematopoietic lineage is currently not
available. To determine coronin-1 expression in cells of the hematopoietic lineage by flow
cytometry, IgGs of the polyclonal rabbit anti-coronin-1 serum No.1002 (Gatfield et al., 2005)
were purified and coupled to the fluorophore AlexaFluor‚633. Single cell suspensions of
bone marrow, thymus, spleen and lymph nodes from wildtype C57Bl/6 mice were first
subjected to a staining with fluorophore-labeled monoclonal antibodies identifying the various
leukocyte subsets. Monoclonal antibodies directed against the pan B-cell markers B220 and
CD19 were used to detect on one hand all stages of B-cell development (B220+/CD19+) in
the bone marrow and on the other hand B-cells in the spleen and lymph nodes
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(B220+/CD19+). Mature B-cells in bone marrow, spleen and lymph nodes were identified by
being positive for CD19 and IgM (CD19+/IgM+).
A monoclonal antibody directed against CD11b was used to stain cells of the myeloid lineage
(CD11b+). The various stages of T-cell development in the thymus (double negative (CD4-
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CD8-) ,  doub le  pos i t i ve
(CD4+CD8+), CD4 (CD4+CD8-)
and CD8 (CD4-CD8+) single
positive thymocytes) as well as
peripheral T-cells (CD4+ or
CD8+) were detected by
expression of CD4 and CD8.
Following staining for leukocyte
surface markers, the cells were
fixed with PFA and stained for
c o r o n i n - 1  u s i n g  t h e
AlexaFluor‚633-coupled anti-
coronin-1 IgGs. Flow cytometric
analysis and determination of
the median f luorescence
intensity for the coronin-1
staining (Fig. 13) revealed that
coron in-1  is  expressed
throughout the development of
the B-cell and myeloid lineage in
the bone marrow. In the thymus,
coronin-1 expression was found
to be upregulated within single
positive thymocytes compared
to the double-positive and
double-negative thymocytes.
Among the various peripheral
leukocyte populations coronin-1 is expressed without any cell type specific differences.
3.1.3 Summary
Expression of the seven members of the coronin family of proteins was analysed by RT-
PCR. Coronin-2, -3, -5 and -7 were found to be ubiquitously expressed, whereas coronin-1,
-4 and -6 showed a restricted expression pattern. Detailed analysis of the expression of
coronin-1 in cells of the hematopoietic lineage by flow cytometry established the presence of
the coronin-1 protein in all leukocyte subsets. Phenotypic analysis of coronin-1 K.O. mice
should therefore account for this by focusing on the analysis of potential defects in cells of
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the immune system. With respect to the ubiquitous expression of some of the coronins,
functional redundancy between members of the coronin protein family can be expected.
3.2 Analysis of the coronin-1 locus and generation of coronin-1 knock-out mice
by targeting the coronin-1 gene in mouse embryonic stem cells
The cell biological function of coronin-1 in non-infected macrophages as well as in leukocytes
in general is unknown. Generation of coronin-1 deficient mice was chosen as a strategy to
gain insight into a role for coronin-1 in cells of the immune system.
Knock-out mice are generated from embryonic stem cells in which the functional gene
sequence is disrupted by the integration of a targeting cassette via homologous
recombination (Thomas and Capecchi, 1987, Capecchi, 1989, Joyner, 1999). The targeting
cassette usually carries a neomycin resistance marker (alternatively a hygromycin resistance
gene) for the positive selection of targeted ES cell clones. The neomycin resistance gene is
often flanked by recognition sites for Cre recombinase (loxP sites) which allows excision of
the resistance marker in cells expressing Cre recombinase (Lakso et al., 1992, Gu et al.,
1994). Excision of the resistance marker is required if ES cell clones are used for a second
round of gene targeting or if proximity of the strong promotor of the resistance gene could
interfere with the expression of adjacent genes (Joyner, 1999). In order to allow negative
selection of ES cell clones which have excised the resistance gene upon Cre expression, the
gene for thymidine kinase (TK) is often used together with the neomycin resistance gene in
the targeting cassette. Whereas the neomycin resistance marker confers resistance to G418,
expression of thymidine kinase renders cells sensitive to gancyclovir which is metabolized by
thymidine kinase into toxic compounds (Joyner, 1999).
In addition to resistance markers a reporter gene like the green fluorescent protein can be
included in the targeting cassette. Integration of the reporter gene in frame with the start
codon of the targeted gene allows analysis of the cell types in which the original promotor is
active. Positive ES cell clones are injected into blastocysts that are subsequently transferred
to foster mothers where they develop into chimaeric mice. Chimaeric mice are then analysed
for germline transmission of the transgene by crossing them to C57Bl/6 mice. Once germline
transmission has been established, appropriate breeding results in mice being homozygous
for the mutated locus.
Construction of the targeting vector requires intimate knowledge about the organisation of
the genomic locus for the gene of interest in order to ensure the precise integration of the
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targeting cassette. Integration of the targeting cassette via homologous recombination is
mediated by homologous genomic sequence flanking the targeting cassette.
3.2.1 In silico analysis of the coronin-1 locus
The mouse coronin-1 locus has been described to be located on chromosome 7 in an area
that corresponds to cytogenetic band 7F3 (Kung et al., 1999). Interestingly, a variety of
hematopoietic genes also map into this region which is noteworthy taking the leukocyte
specific expression of coronin-1 into account.  These hematopoietic genes are involved in
signal transduction and/or adhesion-related processes (Kung et al., 1999).
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The coronin-1 locus itself was shown to consist of eleven exons of which exon 1 encodes the
5’ untranslated region (UTR) and exon 11 contains the stop codon and the 3’ UTR. The start
codon is found in exon 2. Fig.14 displays a schematic overview of the coronin-1 locus.
The design of flanking homology regions for the targeting construct requires detailed
information on the genomic sequence. For this purpose the coronin-1 locus has been
analysed using the genome browser (http://genome.ucsc.edu) a web based tool suite
provided by the Genome Bioinformatics Group at the University of California, Santa Cruz
(Kent et al., 2002; Karolchik et al., 2003). Genomic sequence 12 kb 5’ and 14 kb 3’ of the
start codon of coronin-1 was retrieved from the databases and analysed for the localization
of restriction enzyme sites required for the targeting vector construction (as indicated in Fig.
14). In silico analysis of the coronin-1 locus also allowed the characterisation of regions rich
in repeats using the repeat masker algorithm available at the UCSC Genome Browser web
site. Especially long stretches of repetitive sequence were found to be closely located 3’ of
exon 11 (see Fig.15). Repetitive sequences should be excluded from the flanking homology
regions since they lead to unspecific, non-homologous integration of the targeting constructs.
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3.2.2 Overview of the different targeting vectors
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The efficiency of homologous recombination depends on a variety of factors such as the
accessibility of the locus, the length of the genomic sequence to be replaced by the targeting
cassette, and the length of the flanking homology regions and their content of repetitive
sequences. These factors and their influence on homologous recombination differ from locus
to locus and can only be determined empirically. Generally, it is believed that flanking
homology regions should be as long as possible and that the shorter the targeted sequence
is the higher is the efficiency of homologous recombination. It was therefore decided to
construct three targeting vectors to enhance the rate of homologous recombination at the
coronin-1 locus. Furthermore, targeting vectors were designed to replace the coronin-1
coding sequence by the coding sequence for enhanced green fluorescent protein (EGFP).
The fusion of the open reading frame (ORF) of EGFP with the original start codon of the
coronin-1 coding sequence should result in expression of EGFP as a reporter. Since exon 1
(encoding the coronin-1 5’ UTR) remains intact after successful homologous recombination
we expected EGFP to be expressed under the control of regulatory elements of the coronin-1
locus.
As shown in Fig.16 construct No.154 was designed to knock out exon 2 only whereas the
constructs No.206 and No.215 should result in the knock-out of the whole coding region
(exon2 - 11). All constructs consist of the same 1.8 kb long 5’ flanking homology region
(referred to as ‚left arm’) but differ in the length and position of the 3’ flanking homology
regions (referred to as ‚right arm’). The right arm of construct No.154 is 3.5 kb long, the
constructs No.206 and No.215 are identical but have a right arm of 2.7 kb and 7.3 kb length,
respectively. With respect to the repeat rich region 3’ of exon 11 the targeting vectors have
been constructed to either not include this region in the flanking homology sequence (as in
construct No.154) or to knock it out together with the coding region for coronin-1 (constructs
No.206 and No.215).
3.2.3 Construction of the targeting vectors
Construction of the targeting vectors is schematically shown in Fig.17 and Fig.18. Generally,
the targeting vectors No.154, 206 and 215 have been built up sequentially by first amplifying
corresponding genomic sequences by PCR, cloning them then into pBluescript SK(+) (pBSK)
and finally subcloning them together with the EGFP sequence into a modified
pBluescriptSK(+)  (modpBSK) as a carrier which does not contain the XhoI site any more. As
a last step the sequences comprising of a SV40 polyadenylation signal (SV40 pA) and the
neomycin resistance cassette (SV40pA-lox-TK-Neo-Hygro-lox, described in Hippenmeyer et
al., 2005) have been introduced.
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In particular, the left arm was amplified by PCR (PCR I, Fig.17) using the primers
TCP2860/TCP4675 and genomic DNA isolated from ES cells (Sv129/Ola).
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The primer TCP2860 included a NotI and the primer TCP4675 a NcoI and EcoRI into the
PCR product. Using the NotI and EcoRI sites, the PCR product was cloned into pBSK. For
the right arm of construct No.154 a PCR (PCR II, Fig.17) was performed with the primers
TCP4862 (includes a XhoI site)/TCP8373 (includes an EcoRI site) followed by cloning the
PCR product via XhoI and EcoRI in pBSK. The right arm for the constructs No.206 and
No.215 was generated by PCR employing the primers ONP9150/ONP12651 (PCR III,
Fig.17) and cloned into pBSK using the XhoI and EcoRI sites. As a 4.7 kb extension for the
right arm of construct No.215, the product of a PCR (PCR IV, Fig.17) using the primers
TCP11670/TCP16642 (includes a ClaI site) was cloned into pBSK via EcoRI and ClaI. In
order to appropriately introduce the coding sequence of EGFP a PCR was performed with
the primers GFP605/GFP1400 (includes a XhoI and EcoRI site) and plasmid DNA (pEGFP-
N2) as a template. The product of this PCR was cloned into pGEM‚-T Easy using single
deoxyadenosine overhangs. Before building up the final targeting vectors the individual parts
cloned into pBSK were sequenced to confirm the correctness of the sequences.
For the sequences of genomic origin it needed to be established whether found errors in the
sequence are due to error-prone PCR reactions or due to strain based individual differences
in the genomic sequence such as single nucleotide polymorphisms (SNPs). Whereas for the
PCR genomic DNA of Sv129/Ola origin was used, the sequence of the coronin-1 locus
retrieved from web based databases is of C57Bl/6J origin. In order to solve this problem, two
independent PCR reactions for each flanking homology region to be amplified from genomic
DNA were set up and the products were cloned into pBSK independently. Sequencing of
multiple plasmids allowed to settle the issue of the origin of sequence mismatches.
Practically, the sequences of multiple plasmids for a particular part of the targeting vectors
have been aligned to the genomic sequence of C57Bl/6J origin. A particular single nucleotide
mismatch of all plasmid sequences with the genomic reference was considered to be a
mouse strain specific SNP. As soon as single nucleotide mismatches occured between the
plasmid sequences an error was considered to originate from the PCR reaction. The
independent setup of two PCR reactions allowed to trace back which reaction was error
prone. Finally, only those plasmids were used for further cloning steps which had only
mismatches categorized as single nucleotide polymorphisms between Sv129/Ola and
C57Bl/6J genomic sequences.
By sequential subcloning steps the targeting vectors were then built up from the individual
parts as shown in Fig.18. First, a SmaI/EcoRI fragment of the left arm was subcloned into
modpBSK followed by inserting the EGFP sequence via NcoI/EcoRI. The left arm was then
completed by inserting the NotI/SmaI portion into the plasmid carrying the SmaI/EcoRI left
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arm fragment and 3’ of it the EGFP sequence. Based on the resulting plasmid the three
different targeting constructs were assembled by subcloning the appropriate right arms via
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XhoI/EcoRI 3’ of the EGFP sequence. For construct No.215 it was furthermore necessary to
introduce the right arm extension using EcoRI and ClaI sites. As a last step the
polyadenylation signal and the neomycin resistance cassette (SV40pA-lox-TK-Neo-Hygro-
lox) were inserted via XhoI. To confirm the proper assembly of all three targeting vectors the
final plasmids were sequenced around the restriction sites used for the sequential
construction of the targeting vectors from the individual parts.
3.2.4 Screening of gene-targeted ES cell clones by Southern blot analysis
For the targeting of the coronin-1 gene mouse ES cells (strain: E14.1, isolated from mouse
strain background Sv129/Ola) were transfected with the ClaI linearized targeting vectors by
electroporation and selected with G418. Table 8 provides an overview of the electroporations
performed and the clones picked. For construct No.154 an initial round of electroporation and
selection was performed in collaboration with Toru Miyazaki (University of Texas). 191
clones were picked and screened by Southern blot. In order to obtain more clones for
construct No.154 and to also apply constructs No.206 and No.215 for gene-targeting, ES
cells were electroporated with all three constructs independently at the transgenic mouse
core facility (TMCF) of the Biozentrum. 576 clones were picked for each construct and
prescreened by PCR in pools of five clones. Pools being positive according to the PCR
analysis were then split up and the positive clone within a pool was identified by Southern
blot.
Homologous recombination is a rare event and therefore most of the clones are expected to
display a random and/or multiple integration of the targeting construct. Successful
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homologous recombination is detected by Southern blot. The integration of the targeting
construct introduces new restriction sites into the genomic locus that lead to changes in the
restriction digest pattern of the genomic locus.
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As shown in Fig.19 the
correct integration of the
EGFP-SV40pA-lox-TK-
Neo-Hygro-lox cassette
into the coronin-1 locus
introduces new EcoRI,
BamHI and ScaI restriction
sites which results in
distinct fragment patterns
for the wildtype and the
knock-out locus. For the
Southern blot analysis of
the positive ES cells,
probes located at the
positions indicated in
Fig.19 were used. The first
round of screenings was
performed with the 5’
probe D I G 2  only and
allowed to identify the
following positive ES cell
clones for construct
No.154:  No.143 (clone
s e l e c t e d  b y  T o r u
Miyazaki), No.106 and
No.205 (clones selected at
the TMCF). For construct
No.206 only one positive
clone (No.831) out of 576
clones picked could be
identified. Among the 576
clones picked from an electro-poration of construct No.215 no positive clone was found. The
positive ES cell clones had then to be also tested for the correct integration at the 3’ end. The
results of the Southern blot analysis of the four positive ES cell clones are shown in Fig.20.
For all clones bands of the expected size could be detected. These results demonstrate the
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correct integration of the targeting constructs at the expected position within the coronin-1
locus.
3.2.5 Blastocyst injection of positive ES cell clones and establishment of transgenic
mouse lines
The establishment of transgenic mouse lines for the coronin-1 K.O. locus required the
generation of chimaeric animals. Injection of ES cells into blastocysts and transplantation of
these blastocysts into pseudo-pregnant foster mothers leads to chimaeric animals that are
derived to a certain extent from the injected ES cells. The ES cells that were used for the
gene-targeting are of Sv129/Ola origin and therefore carry an agouti-allele. This allele is not
present in the blastocyts of C57Bl/6xBDF-1 origin used for injection.
The agouti-allele which results in brown coat colour allows to estimate the degree of
chimaerism of a particular animal since regions of brown coat colour are of injected ES cell
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origin and black coat colour is contributed by the recipient blastocyst.  ES cells clones being
positive for the coronin-1 K.O. locus were injected into blastocysts at the TMCF. Table 9
shows the results of the several injections. In summary, for all four ES cell clones chimaeric
animals could be obtained.
Highly chimaeric animals are likely to have also germ cells of ES cell origin which is a
prerequisite for germline transmission of the mutated locus. Germline transmission of the
mutated locus is tested by breeding chimaeric male animals to C57Bl/6 females and
genotyping the agouti coloured offspring. Heterozygous founder animals can subsequently
be bred to generate homozygous K.O. animals.
Concerning the chimaeric animals listed in table 9 only the male animals with a high degree
of chimaerism where used to test them for the germline transmission of the coronin-1 K.O.
locus.  Female chimaeras were generally not used because they are often sterile due to the
contribution of the male ES cells to their germline. In chimaeric females most of the cells of
ES cell origin are expected to have a X0-genotyp.
Out of the total of the 14 chimaeras tested, 3 were shown to transmit the mutated coronin-1
allele to the next generation (see table 10). The resulting heterozygous animals were used
as founders for the generation of coronin-1 K.O. mouse lines by crossing them to C57Bl/6
animals.
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Southern blot analysis using an EcoRI digest and the 5’ probe DIG2 confirmed the proper
configuration of the coronin-1 K.O. locus (Fig.21). For future genotyping purposes a PCR
based screening strategy was developed as shown in Fig.21.
Continous crossing of heterozygous coronin-1 K.O. mice to C57Bl/6 animals is referred to as
backcrossing and is required to generate a so-called congenic mouse line. The genetic
background can very often have a profound influence on the phenotype of a transgenic
mouse line (Sanford et al., 2001; Doetschman, 1999). The rationale behind generating a
congenic mouse line by backcrossing is to bring the mutated allele into a defined inbred
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background such as C57Bl/6. The founder animals of a line still have a mixed background
consisting of Sv129/Ola (contributed by the gene-targeted ES cells) and C57Bl/6 (of
blastocyst origin and from crossing chimaeric males to C57Bl/6 females). With each
backcross of heterozygous animals with animals of a defined inbred background the
contribution of other genetic backgrounds is reduced. In a congenic mouse line all individual
animals are genetically identical for all alleles of a particular inbred background. Per
definition a mouse line is considered to be congenic after the tenth backcross generation
(Silver, 1995).
During the course of this work a coronin-1 K.O. mouse line originating from ES cell clone
No.143 could be backcrossed up to the third generation. Further backcrossing for this line
and others is in progress. The phenotypic analysis of coronin-1 K.O. mice presented in this
thesis was performed using homozygous animals and appropriate control littermates
generated by intercrossing heterozygous animals of the third backcross generation.
3.2.6 Summary
Genomic sequence of the coronin-1 locus was retrieved from web based databases. A
detailed characterisation of the locus allowed to design targeting vectors for gene-targeting in
mouse ES cells. Three targeting vectors (No.154, No.206 and No.215) have been
constructed and used for the electroporation of ES cells. A total of 1919 clones was picked
and screened for homologous recombination at the coronin-1 locus by PCR and Southern
blot. A total of four clones was identified, three clones for the knock-out of exon 2 (construct
No.154) and one clone for the knock-out of the whole coding region (construct No.206).
Blastocyst injection resulted in chimaeric animals for all of the four clones. Nevertheless,
germline transmission of the transgene could only be achieved for the exon 2 K.O. clones
No.143 and No.106. Appropriate congenic mouse lines are currently established by
backcrossing heterozygous coronin-1 K.O. mice to C57Bl/6 mice.
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3.3 Phenotypic analysis of coronin-1 K.O. mice
Coronin-1 was found to be specifically expressed in leukocytes. During embryogenesis
expression of coronin-1 appears at stage E14 and goes along with the development of
hematopoietic tissue (Nal et al., 2004). Due to this late and specific expression during
embryogenesis and in the adult mouse homozygous coronin-1 K.O. mice can be expected to
be viable. The phenotypic analysis of coronin-1 K.O. mice initially focused on the description
of the development of the immune system. It needed to be shown whether the deficiency for
coronin-1 affected generation of leukocyte subsets and whether these leukocytes are found
in normal numbers in the peripheral organs such as spleen and lymph nodes.
3.3.1 Homozygous Coronin-1 K.O. mice do not display an obvious phenotype
Homozygous coronin-1 K.O. mice and wildtype litttermates as a control were generated by
intercrossing heterozygous coronin-1 K.O. mice. Heterozygous animals originated from
blastocyst injection of ES cell clone No.143 and subsequent backcrosses of coronin-1 K.O.
mice to C57Bl/6 mice up to the third generation. Homozygous coronin-1 K.O. mice were born
at normal mendelian ratio and were viable. No obvious abnormalities in behaviour or
mortality were observed for these animals compared to wildtype littermates. Homozygous
coronin-1 K.O. were found to be fertile since appropriate breedings did not show any
alterations in average litter size and time between setting up the breeding and weaning of the
offspring.
3.3.2 Homozygous coronin-1 K.O. mice do not express coronin-1
Homozygous coronin-1 K.O. were analysed for the correct configuration of the coronin-1
K.O. locus by Southern blot. Genomic DNA was extracted from tail biopsies of homozygous
and heterozygous coronin-1 K.O. mice and wildtype littermates. The DNA was then digested
with EcoRI and analysed by Southern blot using the 5’ probe DIG2. As shown in Fig.22 A
wildtype mice are characterised by the detection of a single band at 10.7 kb whereas for
homozygous coronin-1 K.O. mice a single band of 5.4 kb could be identified. As expected,
heterozygous coronin-1 K.O. show both bands (see also Fig.21 A).
Analysis of coronin-1 expression was performed by subjecting lysates of single cell
suspensions of spleen and thymus to SDS-PAGE and subsequent Western blot analysis
using a polyclonal rabbit anti-coronin-1 serum (No.1002, third bleed, Gatfield et al., 2005). No
detectable coronin-1 expression was found in homozygous coronin-1 K.O. mice (Fig.22 B). In
addition, no lower molecular weight products were detected which would have been
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indicative for the generation of shorter versions of the coronin-1 protein from the remaining
exons 3 –11 in the coronin-1 K.O. locus.
Corresponding to the disappearance of coronin-1 expression in homozygous coronin-1 K.O.
mice appearance of EGFP expression was detected by Western blot in thymus and spleen
(Fig.22 B). EGFP was therefore found to be expressed under the control of regulatory
elements of the coronin-1 locus.
3.3.3 EGFP as a reporter for coronin-1 expression
The EGFP expression under the control of regulatory elements of the coronin-1 locus was
further analysed by flow cytometry. For this purpose IgGs of the polyclonal rabbit anti-
coronin-1 serum No.1002 (Gatfield et al., 2005) were purified and coupled to the fluorophore
AlexaFluor‚633. AlexaFluor‚633 labeled IgGs of the corresponding rabbit preimmune serum
served as a control for background binding. Single cell suspensions of bone marrow, thymus
and spleen of homozygous, heterozygous coronin-1 K.O. mice and wildtype littermates were
fixed with 2% PFA and stained with the appropriate AlexaFluor‚633 labeled rabbit IgGs. The
results of the flow cytometric analysis are shown in Fig.23. The AlexaFluor‚633 labeled anti-
coronin-1 IgGs reliably detected coronin-1 expression in bone marrow, thymus and spleen of
wildtype and heterozygous coronin-1 K.O. mice and confirmed the absence of coronin-1
expression in homozygous coronin-1 K.O. mice. For homozygous coronin-1 K.O. mice, which
possess two alleles of the coronin-1 K.O. locus, a two-fold higher signal intensity for EGFP
expression was found compared to their heterozygous littermates (see Fig.23).
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The analysis of heterozygous coronin-1
K.O. animals allowed to test to which
extend EGFP expression matches the
expression of coronin-1. As shown in
Fig.23 (A and B) for cells of the bone
marrow as well as of the thymus a perfect
match between the signal intensities for
EGFP and coronin-1 staining could be
detected in heterozygous coronin-1 K.O.
mice. All events were aligned on a
diagonal line in EGFP versus coronin-1
flow cytometry dot plots. For the spleen
this perfect match between EGFP and
coronin-1 signal intensities was not
observed (Fig.23 C). We therefore further
analysed coronin-1 and EGFP
expression in splenic lymphocyte subsets
of wildtype and heterozygous coronin-1
deficient mice. As shown in Fig.24 A,
CD4 and CD8 positive T-lymphocytes
were found to express both coronin-1 and
EGFP at high and discrete levels. In
contrast to this finding, the two major
splenic B-cell subsets, marginal zone as
well as follicular B-cells, displayed
discrete and high expression of coronin-1
but not of EGFP. Taken together, these
results demonstrate that EGFP
expression from the coronin-1 K.O. locus
is well suited as a reporter for coronin-1
expression in cells of the bone marrow and the thymus but not in all splenic cell subsets.
Especially for splenic B-cells EGFP cannot be used as a reporter for coronin-1 expression.
This could be explained on one hand by differences in protein stability between EGFP and
coronin-1 and on the other hand by differences in expression of coronin-1 and EGFP under
the control of regulatory elements of the coronin-1 locus. The mRNA for EGFP transcribed
from the coronin-1 K.O. locus does not contain the original coronin-1 3’-UTR which could be
responsible for regulating mRNA stability and translation depending on the cell type. Further
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functional characterisation of the UTRs of the coronin-1 locus would allow to gain insight into
the regulation of coronin-1 expression dependent on the developmental stage of leukocyte
subsets and its corresponding functional requirements for coronin-1.
3.3.4 Homozygous coronin-1 K.O.
mice do not display developmental
defects in the bone marrow and
the thymus
Leukocytes are generated from
precursors originating from the bone
marrow (see Fig.2). Specifically, the
crucial developmental stages of the
entire B-cell and myeloid lineage are
found in the bone marrow (see
paragraph 1.4.1). T-lymphocytes
develop in the thymus from so far
unidenti f ied precursors which
immigrate from the bone marrow into
the thymus (Miller and Osoba, 1967,
and Fig.7). Taking the specific
expression of coronin-1 in all
leukocyte subsets into account it was
investigated whether coronin-1
expression was required for the
development of leukocyte subsets.
3.3.4.1 Flow cytometric analysis of
leukocyte subsets in the bone
marrow
Using flow cytometry and antibodies
directed against the various leukocyte subtypes the composition of leukocyte populations in
bone marrow and thymus was analysed. B-lymphocyte development in the bone marrow can
be tracked using CD19 (or equivalently B220), c-kit and IgM surface expression as markers
(Fig.4, for review see Ceredig and Rolink, 2002, and references therein). The earliest stage
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being specific for the B-cell lineage is referred to as Pro-B and is characterised by being
negative for CD19/B220 but
highly positive for c-kit. Pro-
B cells give raise to first Pre-
BI and subsequently Pre-B2
cells which are positive for
CD19/B220 but gradually
loose c-kit expression. From
Pre-B2 cells immature B-
cells (CD19+/B220+/IgM+++/
IgD-) are generated which
then develop into mature B-
cells (CD19+/B220+/IgM++/
IgD++). Analysis of the
myeloid l ineage was
per fo rmed emp loy ing
antibodies directed against
CD11b which is expressed
by all developmental stages.
The results of the flow
cytometric analysis of B-cell
a n d  m y e l o i d  c e l l
development in the bone
marrow is shown in Fig.25.
Al l  analysed subsets
appeared normal with no
differences in relative
numbers indicating that
coronin-1 deficiency does
not affect B-cell or myeloid
cell development.
3.3.4.2 Analysis of T-cell development by flow cytometry and histology
T-lymphocyte development in the thymus proceeds through a series of well-defined
differentiation steps which are classically characterised based on the surface expression of
CD4 and CD8 (Zuniga-Plücker, 2004 and Fig.7). CD4-CD8- double negative (DN) thymocytes
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represent the earliest stage of T-cell development. DN thymocytes then become CD4+CD8+
double positive (DP) thymocytes and lastly mature into single positive (SP) CD4+ or CD8+ T-
cells which emigrate from the thymus to establish the peripheral T-cell pool. T-cell
development is dependent on the organisation of the thymus into discrete cortical and
medullary areas, each of which is characterised by the presence of particular stromal cell
types, as well as thymocyte subsets at defined maturation stages. DN and DP thymocytes
are found in cortical regions whereas maturation of single positive T-cells through positive
and negative selection occurs in the medulla (refer to Fig.7).
To assess T-cell development in coronin-1 deficient mice, flow cytometry of single cell
suspensions as well histological analysis of thymic cryosections were employed. For flow
cytometry, single cell suspensions of thymi of homozygous coronin-1 K.O. mice and wildtype
littermates were subjected to a staining with antibodies directed against CD4 and CD8 which
allowed the determination of the relative numbers of the various thymocyte subsets. Absolute
numbers for DN, DP and SP thymocytes were obtained by determining first the total cell
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count of the thymic cell suspension and then referring the percentage of a certain cell type
(as determined by flow cytometry) to the total cell counts. As shown in Fig.26 all analysed
thymocyte subsets (DN, DP and SP) were found to be present in normal relative and
absolute numbers. No detectable difference between wildtype and homozygous coronin-1
K.O. mice was observed.
In collaboration with Hans-Reimer Rodewald and Carmen Blum at the University Ulm,
Germany, thymi of homozygous coronin-1 K.O. and wildtype littermates were analysed
histologically. For this purpose, cryosections were fixed in acetone and stained with
fluorophore-labeled monoclonal antibodies directed against CD4 and CD8. Consistent with
the results of the flow cytometric analysis of thymocyte subsets in the thymus no differences
in the overall structure as well as in the distribution of thymocyte subsets in cortical and
medullary regions within the sections was observed (Fig.27). We therefore conclude that
T-cell development in the thymus occured normally in the absence of coronin-1 expression.
3.3.5 Coronin-1 deficiency affects the peripheral immune system
Mature lymphocytes generated in the bone marrow and the thymus emigrate into the
periphery to establish defined lymphocyte pools with their discrete, organ-dependent
function. Having shown no developmental defects for the B-, T- and myeloid cell lineage in
the bone marrow and thymus of coronin-1 K.O. mice it was analysed whether coronin-1
deficiency could affect lymphocyte populations in the periphery, namely peripheral blood,
spleen and lymph nodes.   
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3.3.5.1 Analysis of leukocyte populations in the spleen and lymph nodes of coronin-1
deficient mice
Analogous to the analysis of T-cell development in the thymus (section 3.3.4.2) the
composition of leukocyte populations in the spleen and lymph nodes of coronin-1 deficient
mice was analysed by flow cytometry of single cell suspensions and by histology of
cryosections. For flow cytometry fluorophore labeled monoclonal antibodies were used to
detect B-cells by CD19 (CD19+), T-lymphocytes by CD4 (CD4+) or CD8 (CD8+) and myeloid
cells by CD11b (CD11b+) expression. Relative and absolute numbers for the various
leukocyte subsets in spleen and lymph nodes were determined as described in section
3.3.4.2.
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In the spleen, numbers of both CD4+ and CD8+ T-lymphocytes were found to be reduced by
about 50% in homozygous coronin-1 K.O. mice compared to wildtype littermates. In contrast,
CD19+ B-cells as well as CD11b+ myeloid cells were only slightly diminished (Fig.28). For
lymph nodes, an about 5-fold reduction in total cell counts was observed due to an absolute
reduction of T-, B- and myeloid cells. However, the relative proportions of B- and myeloid
cells were enriched, whereas T-cells were strongly diminished (Fig.29).
These observations were further substantiated by histological analysis of cryosections.
Generally, the bulk of the spleen is composed of red pulp, where removal of red blood cells
takes place. Lymphocytes surround the arterioles entering the spleen, forming areas of white
pulp. The inner region of the white pulp is divided into a periarteriolar sheet (PALS),
containing mainly T-cells and a flanking B-cell corona (see Fig.5 A). Compared to wildtype
littermates splenic cryosections of homozygous coronin-1 K.O. mice (Fig.30) were
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characterised by a strong depletion of T-cells (as detected by anti-Thy1.2 staining) from the
PALS, which were, instead, enriched in B-cells (as detected by anti-B220 staining).
Histologically, lymph nodes consist of an outermost cortex and an inner medulla. The cortex
is composed of an outer layer of B-cells which are organised into lymphoid follicles, and
extensive paracortical areas (also referred to as T-cell zones) made up mainly of T-cells (see
Fig.5 B). In comparison to wildtype littermates, lymph nodes of coronin-1 deficient mice were
found to be severly reduced in overall size and to be largely depleted of T-cells in the
paracortical areas (Fig.31). In conclusion, the absence of coronin-1 expression leads to a
paucity of T-lymphocytes in secondary lymphoid organs.
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3.3.5.2 Coronin-1 deficient mice display abnormalities in peripheral blood composition
Given the specific depletion of T-lymphocytes from secondary lymphoid organs, the blood
composition of homozygous coronin-1 K.O. mice was analysed. For this purpose, tail blood
of homozygous coronin-1 K.O. mice and wildtype littermates was subjected to hematological
analysis on an automated ADVIA hematology system (done in collaboration with Imke
Albrecht and the Hämatologielabor, Kantonspital Basel, Switzerland). As summarised in
table 11 leukocyte counts were
found to be reduced in homozygous
coronin-1 K.O. mice when compared
to wildtype littermates. In contrast, all
other parameters were not affected.
Since the ADVIA analysis revealed
that a reduction of lymphocyte
counts accounts for the reduction in
peripheral leukocyte numbers,
peripheral blood lymphocytes (PBL)
were prepared and stained for flow
cytometry to assess the contribution
of individual lymphocyte subsets.
Results of this analysis are shown in
table 12. Absolute T-lymphocyte
numbers in peripheral blood were
drastically reduced whereas B-cells
(CD19+) and myeloid cells (CD11b+)
were less severly affected. These
results further corroborate the finding
that the absence of coronin-1
expression leads to a strong
deficiency within the peripheral T-
lymphocyte population.
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3.3.6 Reconstitution of hematopoietic and lymphoid organs in wildtype and coronin-1-/-
mixed bone marrow chimaeras
Homozygous coronin-1 knock-out mice were shown to have a strong deficiency within the
peripheral T-lymphocyte population. In order to adress the question at which stages of T-
lymphocyte development the defect occurs the ability of coronin-1 deficient bone marrow
cells to reconstitute peripheral lymphocyte compartments was analysed. Therefore, a 50:50
mixture of bone marrow cells of WT (Ly5.1+/GFP-) and coronin-1-/- (Ly5.2+/GFP+) origin was
transferred into sub-lethally irradiated six weeks old C57Bl/6 mice. As a control, mice were
reconstituted with either WT or coronin-1-/- cells only. Six weeks later the chimaeric mice
were analysed by flow cytometry for reconstitution of B- and T-lymphocyte compartments
and for the relative contribution of WT and coronin-1-/- cells. The same experiment was
performed with coronin-1-/- mice as recipients which allowed to test whether the absence of
coronin-1 expression in cells other than those of the hematopoietic lineage (such as stroma
cells) would have an effect on the reconstitution of hematopoietic and lymphoid organs.
Flow cytometric analysis employed monoclonal antibodies directed against the various
leukocyte subsets. The origin of the cells in the different cell populations was determined by
expression of the Ly5 allelic marker (Ly5.1 or Ly5.2 positive).
3.3.6.1 Reconstitution of the bone marrow
In the bone marrow of mixed bone marrow chimaeras the following B-cell and myeloid cell
compartments were analysed: early stages of B-cell development (CD19lo/c-kithi),
intermediate to mature stages of B-cell development (CD19hi/IgMlo-hi) and cells of the myeloid
lineage (CD11b+). For all leukocyte compartments in the bone marrow an approximate 50:50
ratio of cells of wildtype (Ly5.1+/GFP-) versus coronin-1-/- (Ly5.2+/GFP+) origin was observed
reflecting the capacity of coronin-1-/- cells to reconstitute the bone marrow equally well as
their wildtype counterparts (Fig.32 A). These results were independent of the genetic
background of the recipient mice (Fig.32 B) indicating that the absence of coronin-1
expression in hematopoietic as well as non-hematopoietic cells does not affect the
development of leukocyte subsets in the bone marrow.
3.3.6.2 Reconstitution of the thymus
Analysis of the reconstitution of thymic cell compartments in mixed bone marrow established
an approximate 60:40 ratio of cells of wildtype (Ly5.1+/GFP-) versus coronin-1-/-
(Ly5.2+/GFP+) origin (Fig.33). Similar to the reconstitution of the bone marrow no strong
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dependence of thymic reconstitution on the background of the recipient mice was observed
(Fig.33 B). It should be nevertheless noted that for the CD4 and CD8 single-positive cells a
deviation from the 60:40 ratio found for DN and DP subsets towards a 80:20 ratio was
apparent which was more pronounced in mixed bone marrow chimaeras set up with coronin
-1-/- recipients. This could be indicative for a role of coronin-1 in the late steps of T-cell
development just before exit of the T-cells from the thymus. It remains to be established to
which extent coronin-1 could be required at this stage either on the side of the T-cell itself or
in antigen-presenting cells (and perhaps also stroma cells) which interact with T-cells to
ensure proper maturation. However, cells of coronin-1-/- origin gave rise to the various
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thymocyte subsets which supports the earlier described finding (section 3.3.4.2) that coronin-
1 deficiency does not affect T-cell development in the thymus.
3.3.6.3 Reconstitution of peripheral lymphoid organs
The B-cell compartment in spleen and lymph nodes was found to comprise on average of
60% WT Ly5.1+ and 40% coronin-1-/- Ly5.2+ cells (Fig.34 and Fig.35). Since the peripheral B-
cell compartments were found to be not severly compromised in the absence of coronin-1
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expression (see paragraph 3.3.5), this ratio was used as a reference for the relative
contribution of coronin-1-/- cells to the reconstitution of those populations not affected by
coronin-1 deficiency. Not all Ly5.2+/CD19+ positive cells were found to express EGFP which
is due to specific downregulation of EGFP expression in B-cells (see section 3.3.3 and
Fig.24). In contrast to the B-cell compartment, the T-lymphocyte populations in spleen and
lymph nodes were mostly derived from WT cells indicating that coronin-1 deficient cells are
unable to efficiently reconstitute the peripheral T-cell compartments (Fig.34 and Fig.35). The
analysis of chimaerism in peripheral T-cell populations is hampered by the presence of
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Ly5.2+ cells which most probably are of recipient origin and reflect a pool of radiation
resistant peripheral T-cells. Since all T-lymphocytes in homozygous coronin-1-/- deficient
mice were found to express EGFP, EGFP instead of Ly5.2 is a reliable marker to determine
the contribution of coronin-1 deficient cells to the reconstitution of peripheral T-cell
compartments. Taking this into account, we conclude that coronin-1 is involved in peripheral
T-lymphocyte survival in and/or homing to peripheral lymphoid organs.
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3.3.7 Summary
Homozygous coronin-1 deficient mice appeared healthy and fertile. These mice do not show
any detectable coronin-1 expression but instead do express EGFP under the control of
coronin-1 regulatory elements. EGFP expression was shown to be a reliable reporter for
coronin-1 expression in T-lymphocyte and myeloid cell subsets, but not for certain B-
lymphocyte subsets. Analysis of the development of the immune system employing flow
cytometry of bone marrow and thymic cell suspensions and histological analysis of the
thymus revealed no differences between homozygous coronin-1 deficient mice and wildtype
littermates. However, in the periphery of homozygous coronin-1 deficient mice a strong
deficiency within the T-lymphocyte population was observed. Relative and absolute numbers
of CD4 and CD8 positive T-cells in spleen, peripheral blood and lymph nodes were found to
be strongly reduced whereas other leukocyte subsets were not as severely affected. In
mixed bone marrow chimaeras coronin-1 deficient bone marrow precursors were shown to
be unable to reconstitute peripheral T-lymphocyte subsets but not the B-lymphocyte and
myeloid compartments. In conclusion, the deficiency for coronin-1 expression does not affect
the development of the immune system but leads to a specific depletion of T-lymphocytes
from secondary lymphoid organs.
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3.4 Phenotypic analysis of coronin-1 deficient T-cells
Homozygous coronin-1 deficient mice were found to display a strong deficiency within the
peripheral T-lymphocyte population. In order to explain this specific defect, coronin-1
deficient T-lymphocyte were subjected to an in-depth functional analysis. The absence of T-
cells from the peripheral lymphoid organs could be due a failure to properly develop in the
thymus, a deficiency in T-cell homing or the inability of T-cells to survive in the periphery.
Since both the cellularity as well as the organisation of the thymus in wildtype and coronin-1
deficient mice were normal (section 3.3.4.2) coronin-1 is unlikely to play a major role during
T-cell development.
3.4.1 Coronin-1 deficient T-cells undergo apoptosis
Lymphocytes that fail to receive survival signals, and those that are clonally deleted because
they are self-reactive, undergo apoptosis. T-lymphopenia as observed in coronin-1 deficient
mice could be due to increased apoptosis within the peripheral T-cell pool. Apoptosis was
studied using flow cytometry and APC-labeled AnnexinV. AnnexinV binds to
phosphatidylserine exposed on the cell surface of apoptotic cells and can therefore be used
to determine the percentage of apoptotic cells within a given cell population. Counterstaining
with propidium iodide (PI) was used to differentiate between apoptotic and necrotic cells the
latter being propidium iodide positive since they fail to extrude the dye from the cytoplasm.
Including fluorophore-labeled monoclonal antibodies directed against CD3 and CD19 allowed
to independently check for apoptosis in T-cells and B-cells, respectively.
Staining of thymic cell suspensions of homozygous coronin-1 K.O. mice and wildtype
littermates revealed identical annexinV and PI positive cell populations (Fig.36 A). This
confirms the finding that coronin-1 deficiency does not lead to defects in thymic T-cell
development since a defect in the processes of positive and negative selection would have
resulted in increased apoptosis of certain subsets of thymocytes. In contrast, both within the
spleen and the lymph nodes the percentage of CD3 positive cells undergoing apoptosis was
significantly increased (Fig.36 A). Interestingly, the percentage of apoptotic cells within the B-
lymphocyte compartment (as identified by CD19 surface expression) was similar between
wildtype and coronin-1 K.O. mice (Fig.36 B). We therefore conclude that apoptosis occurs
specifically in the peripheral T-cell populations of coronin-1 deficient mice resulting in
peripheral T-cell depletion.
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3.4.2 Characterisation of T-cell subsets in coronin-1 K.O. mice
Further flow cytometric characterisation of peripheral T-cell subsets for the surface
expression of markers identifying naïve versus memory and regulatory T-cells was required
to analyse to which extent the subset composition of peripheral T-cell pools in wildtype and
coronin-1 K.O. mice differs. As an initial set of markers CD62L and CD44 were chosen.
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Naïve T-cells emigrating from the thymus are characterised by the expression of CD62L (L-
selectin) which is required for homing of lymphocytes to lymphoid organs (Gallatin et al.,
1983). As shown in Fig.37 A analysis of CD62L expression by T-lymphocytes (CD3+) from
spleen and lymph nodes revealed that, in contrast to wildtype mice, the few T-cells present in
coronin-1 deficient mice were mostly CD62L negative. In thymic cell suspensions of coronin-
1 K.O. mice and wildtype littermates the fraction of CD62L positive cells was found to be
similar indicating that the lack of CD62L positive cells in the periphery is not due to defects in
the thymus. Rather, the absence of CD62L positive cells may be the result of the deletion of
naïve, CD62L positive cells in the periphery or due to the expansion of the small number of
CD62L negative coronin-1 deficient T-cells.
In a depleted lymphoid compartment, i.e. under lymphopenic conditions, naïve T-cells were
shown to begin slow proliferation which is independent of cognate antigen recognition but
___________________________________________________________________RESULTS
129
nevertheless requires recognition of MHC-bound self-peptides (Goldrath and Bevan, 1999,
Seddon and Zamoyska, 2002). These expanding subsets of T-cells have an activated or
memory-like phenotype as characterised by an increase in CD44 expression (Greenberg and
Ridell, 1999; Mackall et al., 1997). Flow cytometric analysis of CD44 expression on T-cells in
splenic and lymph node cell suspensions from wildtype and coronin-1 deficient mice showed
that coronin-1 deficient T-cell have increased CD44 expression levels (Fig.37 B). This
suggests that T-lymphopenia caused by coronin-1 deficiency leads to lymphopenia-driven
proliferation of T-cells with a memory-like phenotype to compensate for the depletion of
naïve, CD62L positive T-cells.
3.4.3 Homing and survival of coronin-1 deficient T-cells in vivo
The observations that coronin-1 deficient T-cells are more prone to apoptosis and are mostly
CD62L negative prompted us to assess the capacity of coronin-1 deficient T-cells to home to
lymph nodes and to survive within the periphery in vivo. To do so, splenic cell suspensions
were prepared from either homozygous coronin-1 deficient mice or as wildtype control from
mice transgenic for GFP expressed under the ubiquitin promotor (Ubi-GFP, kind gift from
D.Finke, University of Basel). These cell suspensions were then adjusted to contain an
equivalent amount of CD4 and CD8 positive T-cells. A suspension equivalent of 8x106 T-cells
was injected into C57Bl/6 recipient mice via the tail vein. Four or twenty hours post injection
the mice were sacrified and peripheral blood lymphocytes (PBLs) as well as single cell
suspensions of spleen, inguinal and mesenteric lymph nodes were prepared. Flow cytometry
using fluorophore-labeled monoclonal antibodies directed against CD4 and CD8 allowed to
determine the percentage of GFP positive T-cells within a given cell suspension.
Four hours post injection CD4 and CD8 positive cells of wildtype (Ubi-GFP) origin could be
detected in spleen, inguinal and mesenteric lymph nodes. At the later, twenty hour timepoint
wildtype cells were found at similar percentages among the PBL and spleen cell populations
whereas their percentage in mesenteric and inguinal lymph nodes increased (Fig.38). This is
indicative for the successful homing of wildtype cells to the lymph nodes. In contrast, coronin-
1 deficient CD4 and CD8 positive T-cells were found to home to inguinal and mesenteric
lymph nodes less efficiently. Between the four and twenty hour timepoint no pronouced
increase in the percentage of coronin-1 deficient CD4 and CD8 positive T-cells in mesenteric
and inguinal lymph nodes was observed. We therefore conclude that coronin-1 deficient T-
cells are defective in homing to the lymph nodes. At the four timepoint this is also reflected
by a two-fold higher percentage of coronin-1 deficient T-cells among the PBLs compared to
wildtype cells. Given the same number of wildtype and coronin-1 deficient T-cells injected per
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recipient animal, this suggests
that T-cells of coronin-1 K.O.
origin accumulated in the blood
due to their inability to home to
the lymph nodes. Interestingly,
at the twenty hour timepoint
percentages of wildtype and
coronin-1 deficient T-cells
among the PBLs were then
found to be similar. Since at the
same time the percentage of
coronin-1 deficient T-cells in the
inguinal and mesenteric lymph
nodes did not significantly
increase, we conclude that T-
cells of coronin-1 K.O. origin not
only display a defect in homing
to the lymph nodes but also in
survival in an in vivo context.
These f indings are in
a g r e e m e n t  w i t h  t h e
observations that coronin-1
deficient T-cells are on one
hand more prone to apoptosis
(see paragraph 3.4.1) and on
the other hand are mostly
CD62L negative (see paragraph
3.4.2). Whether coronin-1
deficient T-cells undergo
apoptosis because they do not enter the lymph nodes where they would receive stimuli
promoting their survival or whether they undergo apoptosis before they reach the lymph
nodes needs to be adressed in future experimental work. This further investigations could
include performance of homing assays using defined CD62L positive or negative coronin-1
deficient T-cell subsets and analysis of the requirements, such as cytokines, for the survival
of coronin-1 deficient T-cells in in vitro culture.
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3.4.4 Coronin-1 deficient T-cells do not respond to allogeneic MHC stimuli in a mixed
lymphocyte reaction
As the depletion of peripheral T-lymphocytes can occur as a result of deficient T-cell
stimulation, the capacity of wildtype and coronin-1 deficient T-cells to respond to allogeneic
MHC stimuli was analysed. For this purpose, purified splenic T-cells were cocultured with
Mitomycin C treated BALB/c spleen cells in a mixed lymphocyte reaction (MLR). The
allogeneic MHC stimuli present on non-proliferating BALB/c spleen cells lead to the
stimulation of the C57Bl/6 T-cells of wildtype and coronin-1 K.O. origin. As a result of
stimulation T-cells start to proliferate. In a MLR, this proliferation is used as a read-out for the
ability of T-cells to respond to allogeneic MHC stimuli.
The results of a MLR with wildtype and coronin-1 deficient splenic T-cells are shown in
Fig.39 A. In contrast to wildtype T-cells, which responded as expected to the presence of
appropriate stimuli by proliferation, the proliferation of coronin-1 deficient T-cells was
drastically reduced. These results can be explained on one hand by defects in TCR signaling
leading to defective proliferation or on the other hand by a severe defect of coronin-1
deficient cells to survive in the coculture.
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Further experimental work like analysis of TCR stimulation and downstream signaling
pathways or a cytokine mediated (e.g. IL-2) rescue of coronin-1 defcient T-cells in in vitro
culture is required to thouroughly understand the inability of coronin-1 deficient T-cells to
respond to allogeneic MHC stimuli by proliferation.
In order to check whether coronin-1 has a role in antigen presenting cells such as dendritic
cells, coronin-1 deficient spleen cells were analysed for their capacity to stimulate BALB/c
derived splenic T-cells. In a MLR using varying amounts of wildtype or coronin-1 deficient
spleen cells as stimulators and a fixed amount of BALB/c spleen cells as responders, no
difference in proliferation was observed up to a 1:2 ratio of stimulators versus responders
(Fig.39 B). Increasing the amount of stimulators relative to the responders resulted in a
reduction of proliferation of BALB/c spleen cells stimulated by coronin-1 deficient spleen
cells. In contrast, using increasing amounts of wildtype spleen cells as stimulators revealed
as expected a plateau in proliferation of the responding BALB/c spleen cells. In conclusion, in
the absence of coronin-1 expression spleen cells show a similar capacity as wildtype cells to
stimulate responding BALB/c cells as long as the responders are provided in excess. It
needs to be adressed by additional experiments why as soon as coronin-1 deficient
stimulators are in excess over the responding cells a reduction in proliferation of the
responders is seen. It has to be noted at this point that from a total of 8x105 cells per well
proliferation data could be inconsistent due to the high density of cells per well. It might be
that under circumstances of high cell density coronin-1 deficient cells are more prone to cell
death due to limiting nutrients or cytokines which would ultimately lead to a less efficient
stimulation of responding cells.
3.4.5 Coronin-1 deficient T-lymphocytes show no defects in the actin and tubulin
cytoskeleton
Upon encountering an antigen presented on APCs T-cells rapidly undergo substantial
membrane and cytoskeletal rearrangements which result in the formation of the
immunological synapse between the T-cell and the APC. Formation of the immunological
synapse is required for the specificity of the immune response by stabilizing and favoring
continous TCR-antigen interaction and consequent activation of T-cells (reviewed in Dustin
et al., 2000; Krummel et al., 2002; van den Merwe, 2002). The immunological synapse is
characterised by a tight collar of polymerized actin at the T-cell-APC interface and the
reorientation of the microtubule-organizing center (MTOC) towards the bound APC (Geiger
et al., 1982; Ryser et al., 1982). Coronin-1 has been described as an F-actin interacting
molecule that crosslinks the leukocyte plasma membrane with the F-actin cytoskeleton
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(Gatfield et al., 2005). This
opens the possibility that
coronin-1 has a role in T-cell
activation events involving
membrane dynamisms and
regulating actin cytoskeleton
rearrangements.
To analyse potential defects
of cytoskeletal organisation
in coronin-1 deficient T-cells,
thymocytes from wildtype
and coronin-1 deficient mice
w e r e  a n a l y s e d  b y
immunofluorescence staining
for F-actin and tubulin and
s u b s e q u e n t  c o n f o c a l
microscopy. In non-activated
t h y m o c y t e s  t h e
morphological appearance
as well as the F-actin and
the tubulin cytoskeleton were
indistinguishable comparing
thymocytes from coronin-1
K.O. mice and wildtype
l i t t e r m a t e s  ( F i g . 4 0 )
suggesting no gross defects
in T-lymphocyte cytoskeletal
structure and/or morphology. Adhesion of thymocytes on glass slides coated with anti-CD3
and anti-CD28 antibodies allowed to study the cytoskeletal rearrangements occuring upon
crosslinking of the TCR. CD3 and CD28 are essential components of the TCR signaling
complex and crosslinking these molecules with appropriate substrate-bound antibodies
mimicks the clustering of the TCR during formation of the immunological synapse. As shown
in Fig.41, adhesion of thymocytes on glass slides coated with poly-L-lysine and subsequent
staining for F-actin or tubulin revealed an indistinguishable cortical localization of these
cytoskeletal components in wildtype and coronin-1 deficient thymocytes. Upon adhesion to
anti-CD3/anti-CD28 coated glass slides, thymocytes of both wildtype and coronin-1 K.O.
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origin were similarly capable to polarize the actin and the tubulin cytoskeleton towards the
site of adhesion. In summary, these data demonstrate that coronin-1 deficiency does not
affect the morphological appearance and cytoskeletal organisation of non-activated as well
as activated T-lymphocytes. We therefore conclude that the absence of coronin-1 does not
affect cytoskeletal organisation in T-cells upon activation.
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3.4.6 Summary
In order to explain the defect in peripheral T-lymphocyte compartments of homozygous
coronin-1 K.O. mice, coronin-1 deficient T-lymphocytes were subjected to an in-depth
functional characterisation. Absence of coronin-1 was found to result in enhanced apoptosis
of T-cells in spleen and lymph nodes. In the thymus, no differences in apoptosis were
detected further corroborating the finding that T-cell development is not defective in coronin-
1-/- mice. T-cells in the periphery of homozygous coronin-1 K.O. mice were mostly CD62L
negative which may be the result of the specific deletion of naïve, CD62L positive cells in the
periphery or due to the expansion of a subset of CD62L low expressing T-cells. Furthermore,
peripheral, coronin-1 deficient T-cells showed increased expression of CD44 which indicates
lymphopenia-driven proliferation of T-cells with a memory-like phenotype to compensate for
the depletion of naïve, CD62L positive T-cells.
CD62L is crucial for the homing of T-lymphocytes to lymph nodes therefore a homing assay
was performed assessing the ability of coronin-1 deficient T-lymphocytes to home to the
lymph nodes of wildtype recipient mice. This experiment revealed that coronin-1 deficient T-
cells were not only defective in homing to secondary lymphoid organs but to be also
incapable of surviving in the periphery. Since coronin-1 was shown to interact with F-actin
the organisation of the actin and tubulin cytoskeleton in coronin-1 deficient thymocytes was
investigated. The morphological appearance of the F-actin as well as the tubulin cytoskeleton
in resting and anti-CD3/CD28 activated thymocytes were indistinguishable comparing
thymocytes from homozygous coronin-1 K.O. mice and wildtype littermates.
In a mixed lymphocyte reaction coronin-1 deficient T-cells were severly affected in their
ability to proliferate as a response to allogeneic MHC stimuli. In summary, we conclude that
coronin-1 plays a crucial role in the maintainance of T-cell functions such as activation
through the TCR, homing to secondary lymphoid organs and survival in the periphery.
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3.5 Phenotypic analysis of coronin-1 deficient macrophages
Coronin-1 was identified as a crucial factor in mediating mycobacterial survival in
macrophages (Ferrari et al., 1999). As in T-cells, coronin-1 could play a role in regulating
actin dependent processes in macrophages such as cell motility, phagocytosis and
activation. Using macrophages derived from the bone marrow of coronin-1 deficient mice we
adressed in an initial series of experiments actin cytoskeleton organisation and phagocytosis
in these cells.
3.5.1 Coronin-1 deficient bone marrow-derived macrophages do not show defects in
actin cytoskeleton organisation
The organisation of the actin cytoskeleton was studied in resting as well activated BMM by
immunofluorescence staining for F-actin and subsequent microscopic analysis. Macrophage
activation is characterised by an enhancement of microbicidal mechanisms and antigen
presentation by extracellular stimuli (Janeway et al., 2001). Morphologically, activated
macrophages can be identified by their ability to spread on a glass substratum which
requires rearrangements of the actin cytoskeleton (Bechard et al., 1988). In vitro
macrophage activation can be achieved by either cytokines such as Interferon-g or by
phorbolesters, such as phorbol-12-myristate-13-acetate (PMA), which are potent stimulators
of protein kinase C.
Activation of BMM isolated from wildtype and coronin-1 K.O. mice with either Interferon-g or
PMA resulted in spreading of the cells on glass slides. Neither morphological differences nor
abnormalities in F-actin cytoskeleton organisation were observed between wildtype and
coronin-1 deficient BMM (Fig.42 A). In order to measure the area covered by spreaded
macrophages digital image analysis was used. Determination of the area covered by
wildtype or coronin-1 deficient macrophages upon activation revealed no significant
differences (Fig.42 B). We therefore conclude that absence of coronin-1 expression does not
affect actin cytoskeleton organisation and activation of BMM as determined by their ability to
spread on a glass substratum. Further experimental work needs to adress to which extent
coronin-1 deficiency affects other activation-induced macrophage functions, e.g. increased
phagocytosis rates, increased phagosome-lysosome fusion (Ishibashi and Arai, 1990),
activation of NADPH oxidase and induction of NO-synthase (Bogdan et al., 2000).
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3.5.2 Coronin-1 deficient bone marrow-derived macrophages are not defective in
phagocytosis
Phagocytosis of microorganisms by host phagocytic cells is a crucial host defense
mechanism. The process of phagocytosis involves rearrangement of the cytoskeleton and
cell membrane to ingest the microbial particle (Greenberg, 1999; Underhill and Ozinsky,
2002). Coronin-1 as an actin-associated protein has been implicated in phagocytosis in
Dictyostelium and murine macrophage cell lines since deletion or RNAi mediated
downregulation of the coronin-1 gene resulted in cells with impaired phagocytosis (de Hostos
et al., 1993, Yan et al., 2005).
To analyse the contribution of coronin-1 to receptor mediated phagocytosis, bone marrow
macrophages derived from either coronin-1-/- mice or wildtype littermates were incubated with
human serum treated GFP expressing Lactobacillus casei or IgG coated fluorescent
polystyrene beads for 30 min at 37°C. The rate of uptake was determined using flow
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cytometry (Fig.43). Both wildtype as well as coronin-1-/- macrophages were found to have a
similar capacity to internalize cargo by either complement receptor or Fc receptor-mediated
phagocytosis. These data show that coronin-1 is not essential for proper receptor-mediated
phagocytosis.
3.5.3 Summary
Due to the prominent role of coronin-1 in mediating mycobacterial survival in macrophages
coronin-1 deficient bone marrow-derived macrophages were functionally analysed. Fc
receptor- as well complement receptor-mediated phagocytosis occurred normally in the
absence of coronin-1. The F-actin cytoskeleton in resting and activated coronin-1 deficient
BMM was found to be indistinguishably organised compared to their wildtype counterparts.
To that end, we conclude that coronin-1 plays a crucial role in maintaining T-cell but not
macrophage functions.
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4 DISCUSSION
Coronin-1 represents a member of the coronin family of proteins which are widely expressed
in eukaryotic organisms. Although a substantial body of functional and biochemical data
concerning coronin-1 has been delineated from the work with several eukaryotic organisms,
such as Dictyostelium and yeast, a precise functional activity in mammalian organisms has
not been defined for coronin-1 and other members of the coronin protein family. The aim of
the work described in this thesis was to gain insight into the cell biological function of
coronin-1 through the generation and phenotypic characterization of coronin-1 deficient mice.
Coronin-1 deficient mice appeared healthy and fertile. Taking the specific expression of
coronin-1 in leukocytes into account further analysis of cells of the immune system revealed
a strong defect within the peripheral T-lymphocyte population in coronin-1 deficient mice.
Whereas no developmental defects of the T-lymphocyte lineage in the thymus were
observed, the peripheral T-lymphocyte pool was strongly depleted in coronin-1 K.O. mice.
Peripheral T-lymphocytes were prone to apoptosis, expressed markers characteristic for
lymphopenia-driven proliferation and turned out to be unable to mount a proliferative
response to allogeneic MHC stimuli. This argues for a role of coronin-1 in differentially
regulating T-cell fate through the modulation of signaling pathways downstream of the T-cell
receptor.
4.1 Coronin-1 is required for peripheral T-cell survival but not for T-cell
development
The lack of peripheral T-cells, constituting a T-lymphopenic situation, as observed in coronin-
1 deficient mice could be on one hand a consequence of defects in T-cell development and
therefore T-cell output from the thymus or on the other hand be a result of defects in the
survival of peripheral T-cells.
The observation that T-cell development in the thymus occured normally in coronin-1
deficient mice as well as the ability of coronin-1 deficient bone marrow cells to reconstitute
the thymus indicate that coronin-1 is not required for T-cell development. Positive and
negative selection of T-cells in the thymus seemed to occur independently of coronin-1 since
coronin-1 deficient mice showed neither accumulation nor reduction in single-positive
thymocyte numbers. Consistent with this, no increase in apoptotic cell numbers compared to
wildtype littermates was found among the thymocyte subpopulations in coronin-1 deficient
mice.
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The reduction in peripheral T-cell numbers in coronin-1 K.O. mice is reminiscent of the
phenotype of mice with mutations in genes involved in lymphocyte migration (Fukui et al.,
2001, Matloubian et al., 2004). However, our data on the cellularity and composition of
thymocyte subsets argue against a defect of single positive thymocytes to egress from the
thymus which would otherwise result in the accumulation of mature T-cells. Furthermore,
compared to wildtype littermates normal numbers of single positive thymocytes in coronin-1
deficient mice acquired CD62L expression. CD62L as a crucial lymphocyte homing
determinant is expressed by mature single-positive thymocyte prior to their migration out of
the thymus into the periphery (Gallatin et al., 1983, Zuniga-Pflücker, 2004). Taken together,
these data indicate that the absence of coronin-1 does not affect the development of T-cells
which are competent to leave the thymus to establish the peripheral T-cell pool.
Once in the periphery, T-cells circulate for prolonged times between the secondary lymphoid
organs and the blood in a naïve state (Sprent and Tough, 2001). The survival of naïve T-cells
in the periphery requires continous engagement of their TCR as well as the exposure to
certain cytokines (Takeda et al., 1996, Tanchot et al., 1997, Rathmell et al., 2001, Vivien et
al., 2001). In coronin-1 deficient mice we found not only a drastic reduction of T-cell numbers
in secondary lymphoid organs and the peripheral blood but could also demonstrate that
coronin-1 deficient T-cells are more prone to apoptosis. In addition, the majority of peripheral
T-cells that are left in coronin-1 deficient mice lack CD62L expression. These data suggest
that after egress from the thymus, coronin-1 peripheral T-cells could have either a defect in
homing to secondary lymphoid organs or in survival within the periphery.
As outlined above, the thymus in coronin-1 deficient mice has the capacity to constantly seed
the periphery with mature T-cells. Judged by the normal CD62L expression of thymocytes,
thymic emigrants could be expected to be compentent to home to secondary lymphoid
organs. Since the organization of neither the actin nor the tubulin cytoskeleton was found to
be affected in coronin-1 deficient thymocytes we propose that also the migration of mature T-
cells is not disturbed. Nevertheless, peripheral T-cell numbers are strongly reduced in
coronin-1 K.O. mice. The increase in apoptosis of peripheral coronin-1 deficient T-cells
indicates that the absence of coronin-1 causes a constant clearance of T-cells from the
peripheral T-cell pool. Apoptosis of peripheral T-cells could have several reasons and further
experimental work is required to determine the sequence of events leading to peripheral T-
cell death. Naïve T-cells that fail to interpret TCR dependent signals as well as the presence
of cytokines are elimininated through apoptosis (Nagata, 1997, Refaeli et al., 1998, Inaba et
al., 1999, Rathmell and Thompson, 1999). Analysis of the capacity of peripheral T-cells to
mount a proliferative response to allogeneic MHC stimuli revealed that coronin-1 deficient T-
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cells did not proliferate suggesting that T-cell activation through TCR engagement is
defective. To which extent coronin-1 deficient T-cells could be rescued in vitro by the addition
of cytokines such as interleukin-2 or -7 needs to be addressed. T-cell activation via the TCR
occurs in the T-cell zones of secondary lymphoid organs. Histological analysis of spleen and
lymph nodes from coronin-1 deficient mice demonstrated the absence of T-cells from T-cell
zones.
A homing assay performed with coronin-1 deficient peripheral T–cells supported the inability
of coronin-1 deficient T-cells to home to secondary lymphoid organs. However, the majority
of peripheral T-cells isolated from coronin-1 deficient mice does not express CD62L
rendering these cells in principle incapable of homing to secondary lymphoid organs.
Furthermore, the homing assay demonstrated that coronin-1 deficient T-cells are defective in
surviving in the periphery. Whether coronin-1 deficient T-cells undergo apoptosis because
they do not enter the lymph nodes where they would receive stimuli promoting their survival
or whether they undergo apoptosis before they reach the lymph nodes needs to be adressed
in future experimental work. These further investigations could include performance of
homing assays using defined CD62L positive or negative coronin-1 deficient T-cell subsets
and analysis of the requirements, such as cytokines, for the survival of coronin-1 deficient T-
cells in in vitro culture.
4.2 Towards a role of coronin-1 in regulating T-cell homeostasis
The composition of the peripheral T-cell
pool in coronin-1 deficient mice compared
to wildtype littermates showed pronounced
differences. Beside its reduction in overall
T-cell numbers, the coronin-1 deficient T-
cell pool is characterized by a decrease in
the percentage of CD3+CD62Lhi cells and
an increase of the relative number of CD44hi
cells (see Table 13). The relative reduction
of CD62L positive T-cells could be either
explained by the deletion of naïve, CD62L
positive cells or by the expansion of the
small number of CD62Llo T-cells. The latter
explanation is further substantiated by the relative increase of CD44hi T-cells in coronin-1
deficient mice which is indicative for T-cells with a memory-like phenotype which have been
_________________________________________________________________DISCUSSION
142
generated in the course of lymphopenia-driven proliferation (see paragraph 1.5.3). The
drastic reduction of peripheral T-cell numbers as observed in coronin-1 deficient mice
constitutes a T-lymphopenic situation which could induce the proliferation of memory-like T-
cells to compensate for the lack of peripheral T-cells.
To which extent T-cells generated by lymphopenia-driven proliferation are functionally
equivalent to naïve T-cells found in a non-lymphopenic environment is not yet fully
understood. Future experiments investigating homing, survival and stimulation of coronin-1
deficient peripheral T-cells should take this issue into account by for example using
specifically enriched populations of T-cells. It might be - as shown for the homing assay - that
functional differences between wildtype and coronin-1 deficient peripheral T-cells rather
reflect the altered composition of the peripheral T-cell pool than a defect in a particular T-cell
function per se. Only an in-depth characterization of the peripheral T-cell pool in coronin-1
K.O. mice would allow to draw further conclusions on how coronin-1 is involved in regulating
T-cell homeostasis. Markers employed for such kind of analysis should include CD5, CD25,
CD44, FoxP3, CD122, Ly6C, LFA-1 and CCR7. CD5 expression by double positive
thymocytes plays a significant role in modulating TCR signaling during positive and negative
selection (Azzam et al., 2001) and would therefore be a valuable marker in further analysing
potential defects in T-cell development in the absence of coronin-1. Currently it cannot be
excluded that subtle defects at the level of thymic T-cell development are responsible for
generating mature T-cells which ultimately can not survive in the periphery. At the level of
single positive coronin-1 deficient thymocytes these subtle defects could include the lack of
expression of molecules required for the homing to secondary lymphoid organs such LFA-1
and CCR7. Peripheral T-cells from coronin-1 K.O. mice should be carefully analysed for the
expression of markers which are expressed by T-cells which underwent lymphopenia driven
proliferation such as CD122, Ly6C and CD44 (Surh and Sprent, 2000).
Finally, coronin-1 K.O. mice should be analysed for a relative increase in naturally arising
CD4+CD25+ regulatory T-cells (Treg) using FoxP3 as a marker (Fontenot et al., 2003, Hori et
al., 2003, Khattri et al., 2003). Several reports have shown an relative increase in Treg
numbers under lymphopenic conditions (Peschon et al., 1994, von Freeden-Jeffry et al.,
1995). In addition to the characterization of the precise composition of the T-cell pool in
coronin-1 deficient mice by analysing the expression of surface markers, the turnover and
differentiation of identified subsets should be studied using BrdU labeling experiments
(Tough and Sprent, 1994) possibly resolving whether there is lymphopenia driven
proliferation and which T-cell subsets are subject to apoptosis in coronin-1 deficient mice.
The detailed characterization of the peripheral T-cell pool in coronin-1 deficient mice will be
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instructive in defining a functional role of coronin-1 in regulating T-cell homeostasis.
Depending on the subset of T-cells most affected by the absence of coronin-1 predictions
can be made in which signaling pathway downstream of the TCR, of molecules required for
homing and migration or cytokine receptors coronin-1 could play a regulatory role.
Furthermore, together with experiments specifically analysing the function of the immune
system it could be assessed to which extent coronin-1 K.O. mice are immunocompromised
or prone to develop autoimmune disease.
The disturbance of the peripheral T lymphocyte pool under lymphopenic conditions would not
only affect the response of coronin-1 K.O. mice to T-cell dependent as well as independent
antigens but could also render them more susceptible to autoimmune diseases. Several
studies have established a link between lymphopenia and autoimmune diseases based on
the lymphopenia driven proliferation of potentially autoreactive T-cells (Gleeson et al., 1996,
King et al., 2004, Khoruts and Fraser, 2005). Although these T-cells could be kept in check
by regulatory T-cells coronin-1 K.O. mice should be carefully analysed for typical symptoms
of autoimmune diseases such as diarrhoea, inflammatory bowel disease, the presence of
autoreactive antibodies and lymphocytic infiltration of organs like the intestine, the liver, the
lung and salivary glands.
4.3 Potential molecular mechanims of coronin-1 function in leukocytes
The phenotypic analysis of coronin-1 deficient mice as presented in this thesis established a
role for coronin-1 in regulating peripheral T-cell homeostasis. T-cell homeostasis relies on a
variety of receptor based mechanisms of which the most prominent ones are those
downstream of the TCR and cytokine receptors. As discussed in the following, coronin-1
might be involved in modulating the strength of downstream signaling through organizing
cytoskeletal structures or by providing a scaffold for the assembly of signaling complexes.
4.3.1 Coronin-1 could participate in regulating cytoskeletal rearrangements as
required for the function of immune receptors
The function of cells of the immune system relies on a variety of mechanisms which are
dependent on an actively reorganizing actin cytoskeleton. These mechanisms include
phagocytosis and macropinocytosis, cellular movements, formation of the immunological
synapse and subsequent T-cell activation (Das et al., 2002, Vincente-Manzanares et al.,
2002, Fenteany and Glogauer, 2004, Meiri, 2004). A common feature of these functions is
the induction of rapid rearrangements of the actin cytoskeleton by signaling through
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receptors expressed on the surface of immune cells. These receptors include the BCR, the
TCR, phagocytic receptors and adhesion molecules (Allen and Aderem, 1996, Fischer et al.,
1998, Fuller et al., 2003, Gruenheid and Finlay, 2003). The extracellular signals transduced
by these receptors are connected to intracellular actin reorganization by molecules linking
the plasma membrane with the actin cytoskeleton (Das et al., 2002, Schafer, 2002, Ivetic and
Ridley, 2004).
Coronin-1 was recently shown to link the leukocyte cytoskeleton to the plasma membrane via
two distinct domains (Gatfield et al., 2005). This suggests that coronin-1 may integrate
extracellular receptor-based signals with the rearrangement of cytoskeletal structures. Such
a role is supported by the work performed on coronin in Dictyostelium and yeast. Coronin in
Dictyostelium was shown to be required for the proper function of a variety of actin-based
processes such as phagocytosis, macropinocytosis, cell motility and cytokinesis (de Hostos,
1991 and 1993,  Maniak, 1995, Hacker, 1997). Saccharomyces cerevisiae Crn1p was shown
to be able to crosslink the actin and microtubule cytoskeleton as well as to modulate the
activity of the actin regulating Arp2/3 complex in vitro (Heil-Chapdelaine et al., 1998, Goode
et al., 1999, Humphries et al., 2002). Interestingly, coronin-1 was found to accumulate at
sites of actin cytoskeleton remodeling such as the cortical region, sites of phagocytosis and
the immunological synapse (Ferrari et al., 1999, Nal et al., 2004). However, to which extent,
with which consequences for downstream signaling and how coronin-1 exactly modulates
actin cytoskeletal dynamics in response to extracellular signals in mammalian cells remains
to be adressed.
Our analysis of cytoskeletal structures in resting and TCR stimulated thymocytes as well
resting and activated bone marrow derived macrophages did not reveal any differences in
actin or tubulin cytoskeleton organization between coronin-1 deficient and wildtype cells.
Phagocytosis as a macrophage function being strongly dependent on actin cytoskeleton
rearrangements was also found to be not defective in the absence of coronin-1. Although
these results argue against a role of coronin-1 in regulating T-cell and macrophage function
via cytoskeletal structures further experimental work is required to exclude this possibility.
Depending on the analysed function and the stimuli used coronin-1 could be differentially
required for inducing cytoskeletal rearrangements. Especially for T-cells a clear distinction
should be made between thymocytes and peripheral T-cells when analysing the organization
of cytoskeletal structures. Furthermore, actin dependent processes such as migration and
immunological synapse formation by T-cells in the presence and absence of coronin-1 need
extensive characterization.
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4.3.2 Coronin-1 could function in modulating the strength of signaling downstream of
the T-cell receptor
Based on its localization to the immunological synapse coronin-1 has been suggested to be
involved in the activation of T-cells (Das et al., 2002, Nal et al., 2004). Our observations that
coronin-1 deficiency does not affect T-cell development but their maintenance in the
periphery suggest that coronin-1 may modulate the strength of signaling downstream of the
TCR. Supporting evidence for this comes from the inability of coronin-1 deficient T-cells to
respond to allogeneic MHC stimuli. Besides its potential function in modulating actin
cytoskeleton dynamics coronin-1 could be required for appropriately assembling the TCR
sginaling complex. Coronin-1 binds to cholesterol enriched membrane microdomains also
refered to as rafts (Gatfield and Pieters, 2000) which have been shown to be essential for
proper functioning of TCR signaling (Harder, 2004). In addition, coronin-1 contains WD40
domains which represent an evolutionary conserved motif for protein-protein interaction
(Neer et al., 1994, Li and Roberts, 2001) and which could allow coronin-1 to recruit signaling
partners to sites of raft induced clustering of the TCR complex. An additional noteworthy
feature of coronin-1 is the presence of several putative PKC phosphorylation sites (Gatfield
et al., 2005). Two studies suggest a regulation of the subcellular localization and function of
coronin-1 in dependence of its phophorylation state (Itoh et al., 2002, Gatfield et al., 2005).
This opens the possibility that the capacity of coronin-1 to not only regulate cytoskeletal
organization but to also recruit certain interacting partners could be regulated differentially
dependent on the signals to be transduced.
In summary, these characteristics of coronin-1 could provide an explanation on how coronin-
1 is involved in differentially regulating TCR signaling in thymocytes and peripheral T-cells.
Activation of T lymphocytes through the TCR is based on the same principles both in the
thymus to regulate selection processes as well as in the periphery to allow the survival of
naïve T-cells. Currently it is hypothesized that the interpretation of signals received in the
thymus leading to positive and negative selection is distinct from the one that results in
survival or death of peripheral T-cells (Takeda et al., 1996, Kirberg et al., 1997, Starr et al.,
2003). Although it is not yet well understood how thymocytes and peripheral T-cells differ in
transducing TCR-based signals a further characterization of the involvement of coronin-1 in
signaling downstream of the TCR could provide valuable insight into differential regulation of
TCR signaling pathways. Further experimental work should adress activation of the various
subsets of coronin-1 deficient T-cells. In detail, the appropriate recruitment of important
downstream signaling partners to the TCR such as Lck, LAT, ZAP70 and PKCq should be
analysed. Are important signaling pathways downstream of the TCR such as Ca2+
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mobilization, Erk, Jnk and MAP kinase pathways affected in the absence of coronin-1 ? The
analysis of the phosphorylation state of coronin-1 in dependence of different TCR stimuli
ranging from anti-CD3 antibody mediated clustering of the TCR complex to peptide/MHC
stimulation of transgenic TCRs might allow to draw conclusions on the capacity of coronin-1
to modulate downstream signaling by being differentially phosphorylated.
4.3.3 The absence of coronin-1 expression does not affect other leukocyte subsets
Our analysis of the phenotype of coronin-1 deficient mice established a regulatory function of
coronin-1 in peripheral T-cell survival. Yet an open question is why other leukocyte subsets
such as macrophages and B cells seem to be not affected by the absence of coronin-1.
Analysis of the activation and phagocytic properties of bone marrow derived macrophages
detected no defect induced by the lack of coronin-1 expression. B cell numbers and subsets
were interestingly found to be not disturbed in the spleen of coronin-1 K.O. mice. However, in
peripheral blood and lymphnodes B cell numbers were found to be reduced but never to
such an extent as seen for T-cells. Whether the partial reduction of B cell numbers is a direct
effect of the deficiency of coronin-1 or whether it is a secondary effect either due to the
absence of T-cells in secondary lymphoid organs or the inability of T-cells to interact with B
cells remains to be analysed. Like T-cells, B cells require exposure to cytokines as well as
BCR dependent signals to survive in the periphery (Lam et al., 1997, Niiro and Clark, 2002,
Kalia et al., 2006, Milne and Paige, 2006). Signaling downstream of the BCR also relies on
the concerted recruitment of a variety of signaling molecules and rearrangements of the
cytoskeleton (Graziadei et al., 1990, Jugloff and Jongstra-Bilen, 1997, Niiro and Clark, 2002,
Pierce, 2002, Harnett et al., 2005). Coronin-1 could be involved in regulating BCR signaling
along similar principles as in T-cells. Nevertheless, B cells are not as strongly affected by the
absence of coronin-1 as T-cells. Further experimental work on the activation of coronin-1
deficient B cells is required to determine to which extent coronin-1 is involved in regulating B
cell functions. In addition, functional redundancy among the different mamalian coronins
should be taken into account. The RT-PCR based expression analysis of the seven
mammalian coronins revealed ubiquitous expression of coronin-2,-3,-5 and -7. Given the
high degree in structural similarity, subcellular localization and potential regulation by
phosphorylation these coronins could take over functions of coronin-1. This would provide an
explanation why some leukocyte subsets are more affected by coronin-1 deficiency than
others. RT-PCR based expression analysis and antibodies specifically recognizing the
various mammalian coronins in isolated leukocyte subsets could be used in the future to
further assess a potential functional redundancy among the mammalian coronins.
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5 SUMMARY
Coronins represent an evolutionary conserved family of WD-repeat actin-binding proteins for
which a role in regulating membrane and cytoskeleton related functions have been proposed.
In mammalian organisms seven members of the coronin protein family have been described
of which coronin-1 respresents the thus far best characterized molecule. Coronin-1 is
specifically expressed in leukocytes and was originally identified as a key player in mediating
the survival of pathogenic mycobacteria in infected murine macrophages by inhibiting the
fusion of the mycobacterial phagosome with lysosomes. Further analyses demonstrated the
capacity of coronin-1 to link the leukocyte plasma membrane with the underlying actin
cytoskeleton suggesting a regulatory role of coronin-1 in leukocyte specific functions.
However, a precise biological activity of coronin-1 in leukocytes and in mammalian
organisms in general has not yet been defined. The aim of this thesis was to contribute to our
understanding of the function of coronin-1 by generating and phenotypically characterizing
coronin-1 knock-out mice.
Coronin-1 deficient mice were found to be viable and fertile. In-depth analysis of the immune
system revealed that the lack of coronin-1 expression severly affected the homeostasis of
the peripheral T-cell pool. Whereas T-cell development could be shown to be independent on
coronin-1, peripheral T-cell numbers were found to be strongly reduced. The reduction of
peripheral T-cell numbers in coronin-1 deficient mice was accompanied by changes in the
composition and function of the peripheral T-cell pool. Coronin-1 deficient peripheral T-cells
were prone to apoptosis, expressed markers characteristic for lymphopenia driven
proliferation of T-cells and were unable to mount a proliferative response to allogeneic MHC
stimuli. These data suggest a regulatory role of coronin-1 in T-cell homeostasis most likely by
modulating the strength of signaling downstream of the T-cell receptor.
Based on the proposed role of coronin-1 in regulating cytoskeletal dynamics coronin-1
deficient T-cells as well as bone marrow derived macrophages were analysed for defects in
the organization of the cytoskeleton and for the functionality of actin based processes such
as phagocytosis. In both cell types no defects in the organization of the actin or the
microtubule cytskeleton could be detected in the absence of coronin-1. Coronin-1 deficient
bone marrow derived macrophages were not defective in phagocytosis. We therefore
conclude that the phenotype established for coronin-1 deficient mice is specific for T-cells
and is not due to the impairment of functionally relevant rearrangements of the actin
cytoskeleton. Coronin-1 might well play a regulatory role on cytoskeletal dynamics, but
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probably not to such an extent that it would affect all coronin-1 deficient cells in a drastic
manner. As shown by RT-PCR based expression analysis of the seven members of the
mammalian coronin family of proteins other coronins could take over some of the funcions of
coronin-1 in a cell-type specific manner. In summary, the phenotypic analysis of coronin-1
deficient mice as presented in this thesis allowed to assign a function of coronin-1 in
maintaining T-cell homeostasis. The specificity of the defect caused by the absence of
coronin-1 will promote further analysis of a potential role of coronin-1 in modulating T-cell
functions such as activation through the TCR. The signals differentiating between the life or
the death of a T-cell in the periphery are largely ill-defined. The analysis of coronin-1
deficient mice established coronin-1 as a candidate molecule in differentially regulating T-cell
fate.
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7 ABBREVIATIONS
A Ampere
aa Amino acid
AB Antibody
AP Alkaline phosphatase
APC Allophycocyanin or antigen-presenting cells
APS Ammonium persulfate
BCA Bicinchoninic acid
BCR B-cell receptor
BM Bone marrow
BMM Bone marrow-derived macrophages
bp Base pair
BSA Bovine serum albumine
CD Cluster of differentiation
cDNA complementary DNA
CLAAP chymostatin, leupeptin, aprotinin, antipain, pepstatin
CLIP Class II linked invariant chain peptide
conc. Concentration
Coro Coronin
cpm Counts per minute
CR Complement receptor
DC Dendritic cell
dH2O Destilled water
ddH2O Double-destilled water
DMEM Dulbecco’s modified Eagle’s medium
DMSO Dimethylsulfoxide
DNA Deoxyribonucleic acid
DNAse Deoxyribonuclease
dNTP Deoxynucleotidetriphosphate
DRiPs Defective ribosomal products
DTT Dithiothreitol
EBSS Eagle’s balanced buffered saline
ECL Enhanced chemiluminescence
E.coli Escherichia coli
EDTA Ethylendiamine tetraacetate
EGFP Enhanced green fluorescent protein
ER Endoplasmic reticulum
ES cell Embryonic stem cell
EtBr Ethidium bromide
EtOH Ethanol
FACS Fluorescence assisted cell sorting
Fc Immunoglobulin constant region
FcR Fc receptor
FCS Fetal calf (bovine) serum
Fd Farad
FITC Fluorescein isothiocyanate
FPLC Fast performance liquid chromatography
g gram
G418 Geneticin
GAPDH Glyceraldehyde 3-phosphate dehydrogenase
GM-CSF Granulocyte-macrophage colony-stimulating factor
GPI Glycosylphosphatidyl inositol
GTPase Guanosinetriphosphatase
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hr Hour
hrs Hours
HBBS Hank’s balanced buffered saline
HEPES Hydroxyethylpiperidine-ethanesulfonic acid
h.i. Heat inactivated
HRP Horseradish peroxidase
IFN Interferon
Ig Immunoglobulin
Ii Invariant chain
IL Interleukin
IMDM Iscove’s modified Dulbecco’s medium
i.p. Intra-peritoneal
ITAM Immunoreceptor tyrosine-based activation motif
kb Kilobases
kDa Kilo Dalton
K.O. Knock-out
l Liter
LB Luria-Bertani
LIF Leukemia inhibiting factor
LPS Lipopolysaccharide
M mol/l
m Micro
mAB Monoclonal antibody
MACS Magnet assisted cell sorting
MCS Multiple cloning site
MEF Mouse embryonic fibroblast
MEM Minimal essential medium
MeOH Methanol
MFI Median fluorescence intensity
MHC Major histocompatibility complex
MIIC MHC class II compartment
min Minute(s)
Mr Molecular weight
mRNA messenger RNA
MW Molecular weight
MWCO Molecular weight cut-off
n Nano
NEB New England Biolabs
neo Neomycin
NFAT Nuclear factor of activated T-cells
NFkB Nuclear factor kB
NK cells Natural killer cells
OD Optical density
o/n Overnight
PAGE Polyacrylamide gel electrophoresis
PAMPs Pathogen-associated molecular patterns
PBLs Peripheral blood lymphocytes
PBS Phosphate buffered saline
PBST Phosphate buffered saline with Tween
PCR Polymerase chain reaction
PE Phycoerythrine
PFA Paraformaldehyde
pH Potentia hydrogenii
p.i. post injection
PIPES Piperazine-1,4-bis(2-ethanesulfonic)acid
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PKC Protein kinase C
PMA Phorbol-12-myristate-13-acetate
pMHC Peptide:MHC complex
PMSF Phenylmethylsulfonylfluoride
PNS Post nuclear supernatant
rad Radiation absorbed dose
RNA Ribonucleic acid
RNAi RNA interference
rpm Revolutions per minute
RPMI medium Roswell Park Memorial Institute Medium
RT Room temperature
SAP Shrimp alkaline phosphatase
SB Sample buffer
SD Standard deviation
SDS Sodium dodecylsulfate
sec Second(s)
SH Src homology
SMAC Supramolecular activation cluster
SSC Sodium chloride, sodium citrate
TACO Tryptophan aspartate containing coat protein
TAP Transporter associated with antigen processing
TBE Tris-Borate-EDTA
TCA Trichloroacetic acid
TCR T-cell receptor
TE Tris-EDTA
TEMED N,N,N’,N’-tetramethylenethylendiamine
TMCF Transgenic Mouse Core Facility, University Basel
TNF Tumor necrosis factor
Tris Tris(hydroxymethyl)aminomethane
TX-100 Triton X-100
U Unit
UV Ultraviolet
V Volt
v/v Volume per volume
WASP Wiskott-Aldrich syndrome protein
WD Tryptophane-aspartate
w/o Without
w/v Weight per volume
WT Wildtype
ZAP-70 z-chain associated protein-70
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